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ABSTRACT
The purpose of this dissertation is to characterize the transcriptome of Borrelia
(Borreliella) burgdorferi to discover novel transcripts, important for pathogenesis.
As a spirochete and the etiological agent of Lyme disease, the foremost vectorborne bacterial infection in the world, B. burgdorferi fulfills a distinctive niche
among bacterial pathogens. Persisting in the disparate environments of a tick
vector and mammalian reservoirs, it is absolutely dependent on its hosts for
transmission and nutrient acquisition. B. burgdorferi harbors a complex fragmented
genome which is largely linear, unlike that of most prokaryotes, lacks an array of
classically described metabolic genes, and contains an unusually large percentage
of unique genomic sequences specific to Borrelia (Borreliella) species.
To date, few regulatory mechanisms have been identified which contribute
to the ability of the spirochete to sense and respond to its environment. Efforts to
use global transcript analysis to elucidate the molecular mechanisms of B.
burgdorferi host adaptation have proven challenging due to the low numbers of the
pathogen present during infection. Previously, our laboratory successfully
developed an in vivo expression technology based approach for B. burgdorferi
(BbIVET) to identify spirochete promoter sequences that are active during a
murine infection. This screen identified 233 unique putative promoters which
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mapped to locations across the entire genome. These putative infection-active B.
burgdorferi promoters were not only located at the 5’ end of annotated open
reading frames (ORFs), but also mapped to unannotated locations antisense,
intergenic, and intragenic to ORFs. Given the limited characterization of the B.
burgdorferi transcriptome, this dissertation applies an RNA sequencing approach
(5’RNA-seq) to globally annotate the transcriptional start sites (TSSs) and 5’
processed ends of the spirochete’s RNA during in vitro cultivation. This resulted
in the discovery of numerous novel internal, intergenic, and antisense transcripts.
Synergistic analysis combining Northern blotting techniques, alignments of these
transcripts to BbIVET proposed promoters, and interrogation of promoter activity
via in vivo live imaging of mice, confirmed the expression of a variety of RNAs
during laboratory culture and mammalian infection. Further, as a means to
improve quantitation of the expression of these transcripts, a new methodology
was developed and applied to measure B. burgdorferi promoter activity during
tick-pathogen interactions, in a strand specific manner. Finally, because the Lyme
disease spirochete harbors many unclassified and unique genomic sequences, the
mammalian infection-expressed gene bb0562, identified through BbIVET and
5’RNA-seq, was selected for targeted deletion and evaluation throughout B.
burgdorferi’s infectious cycle. This demonstrated that gene bb0562 encodes a
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membrane associated protein, whose presence is critical for establishing murine
infection through the bite of an infected tick. In sum, this work contributes
significant insight into the transcriptome of B. burgdorferi, provides an innovative
approach for the analysis of RNA transcripts at the tick-pathogen interface, and
identifies a novel gene critical for Lyme disease pathogenesis.
.
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CHAPTER 1:
INTRODUCTION

Preface

This chapter was composed entirely by P.P.A. Comments from M.W.J. were
incorporated into the final version presented here.

1

Scope
Lyme disease is a multistage, debilitating bacterial infection, caused by the Borrelia
burgdorferi sensu lato (Borreliella) group of spirochetes. The phylum Spirochaetes
are most notably characterized by their long, slender, helical morphology and
presence of periplasmic flagella (1), which are anchored on the cell-poles and span
the length of the bacterium between inner and outer membranes (2). Swimming
through their environment in corkscrew-like motions, spirochetes make up a
small, unique, and pathogenic subset of bacteria. Those most relevant genera of
Spirochaetes to human health include Treponema, Leptospira, Brachyspira, and
Borrelia (Borreliella) causing such illnesses as syphilis, leptospirosis, intestinal
spirochaetosis and relapsing fever/Lyme disease, respectively (3).
The following dissertation explores and further characterizes attributes of
the Lyme disease spirochete Borrelia (Borreliella) burgdorferi. Largely, the molecular
mechanisms of B. burgdorferi pathogenesis and gene regulation are sparse (4, 5).
Yet, in order to identify further genetic factors and regulatory networks that B.
burgdorferi uses to cause human infection, the bacterial transcripts that are present
during mammalian infection must first be defined. Herein, systemic and global
genetic evaluations of the organism are explored to reveal a complex B. burgdorferi
transcriptional network during pathogenesis, for the first time. This is combined
2

with the development of innovative methodologies, molecular dissections of
unique transcripts, and the characterization of a novel gene critical for
pathogenesis, collectively exposing dynamic and unique features of the human
pathogen, B. burgdorferi.
Discovery and Classification of the Lyme Disease Spirochete
It was through coordinated efforts of the concerned public, Connecticut State
Health Department, and Yale University School of Medicine which ultimately lead
to the identification of Borrelia burgdorferi and its association to Lyme disease.
Beginning with an unusual abundance of juvenile rheumatoid arthritis in Lyme,
Connecticut, two disturbed and perceptive mothers approached the State Health
Department in October of 1975 (6). Dr. Allen Steere of Yale University School of
Medicine began a clinical investigation of 51 Connecticut residents experiencing
recurrent asymmetrical joint swelling, of which 39 were children (7). It soon
became clear that a subset of patients had developed a red, expanding lesion,
characterized as an erythema chronicum migrans, soon after being bitten by an
Ixodes scapularis tick (8). Other symptoms were also documented such as
neurological (9) and cardiac (10) abnormalities. Clues to the infectious agent
responsible for the illness termed “Lyme disease” were emerging, including a
shortened duration of the erythema chronicum migrans and susceptibility of
3

arthritic symptoms with the administration of penicillin (11). However, it was the
isolation of a spirochete from Ixodes scapularis ticks collected from Shelter Island,
New York which linked a bacterial pathogen to Lyme disease. Willy Burgdorfer,
of Rocky Mountain Laboratories, National Institutes of Health, observed a
bacterial colonization of spirochetes to the midguts of I. scapularis ticks, and further
demonstrated that Lyme-diagnosed patient serum positively reacted to the tickassociated spirochetes (12).

10 µm

Figure 1–1. Micrograph of the Lyme disease spirochete Borrelia burgdorferi.
Fixed and stained with GelRed dye, viewed under fluorescent microscopy.
Subsequently classified into the genus Borrelia, and named after its founder,
Borrelia burgdorferi was designated the etiological agent of Lyme disease (13)
(Figure 1–1). Currently, 21 species of Borrelia have been sequenced (14) a variety
of which have pathogenic implications for human health. Broadly these can be
divided into two groups, those that cause Lyme disease and those producing
4

relapsing fever, both transmitted to humans by arthropod vectors. Relapsing fever
Borrelia spirochetes include B. recurrentis, B. duttonii, and B. hermsii. Lyme disease
pathogens are classified into the Borrelia burgdorferi senso lato complex, classically
B. burgdorferi sensu stricto contributes to Lyme disease in North America, whereas
B. afzelii, B. garinii, and B. bavariensis sp. nov. are the European and eastern Asian
strains. However more recently, additional Borrelia species have been isolated
from Lyme patients including B. bissettii, B. valaisiana, B. spielmanii, and B. lusitaniae
(15). Borrelia miyamotoi, discovered in Japan, and now also present in Russia, the
United States, and United Kingdom, leads to Lyme-like symptoms in human
infections, yet is more genetically similar to the relapsing fever spirochetes (16).
Recent phylogenic evaluations of Borrelia species have divided the genus into two
distinct genera, separating the relapsing and Lyme spirochetes into Borrelia and
Borreliella gen. nov. respectively, thus replacing Borrelia burgdorferi sensu lato
complex (17). Clearly, organisms of the family Borreliaceae contribute to a worldwide burden of arthropod transmitted human disease. This work focuses on
characterization of the North American Lyme disease pathogen, Borrelia
(Borreliella) burgdorferi, and its interaction with the tick vector, Ixodes scapularis, and
murine mammalian host.

5

Tick Transmission and the B. burgdorferi Infectious Cycle
Transmission of Lyme disease spirochetes are principally restricted to four species
of hard ticks within the Ixodes ricinus complex. These include I. scapularis in eastern
North America, I. pacificus in western North America, I. ricinus in Europe, and I.
persulcatus in Asia (5). Although, it is the interactions between B. burgdorferi and I.
scapularis which contribute the highest incidence of Lyme disease in the United
States (18).

Figure 1–2. Anatomy of an Ixodes scapularis tick.
Viewed at 40x at the Specimen Museum, West Virginia Wesleyan College,
Department of Biology and Environmental Science.
These are hard-bodied, slow feeding ticks which on average require up to 3 days
of adherence for B. burgdorferi transmission to the mammalian host (16) and can
6

feed for up to 7 days. Successful attachment of Ixodes ticks involves coordinated
maneuvers between the touch sensing pedipalp appendages and the saw-like
chelicerae (Figure 1–2). Feeding begins with sensing of the host’s skin, splaying of
the pedipalps, and chelicerae contact. This is followed by puncturing of the host’s
epidermis via alternative sweeping and shearing motions of the chelicerae and
burrowing of the hypostome, thus anchoring the tick to the bite site (19). During
the attachment phase, ticks inject saliva containing a variety of immune repressive
components including histamine binders, cytokine and complement inhibitors,
and anticoagulants to commence the blood meal (20, 21). Dampening the
mammalian inflammatory responses results in a painless bite, rendering the host
unaware of the tick’s attachment (22), which is also quite advantageous for B.
burgdorferi transmission and colonization of the mammalian host. Furthermore,
Ixodes ticks are relatively small, the size of a sesame seed at most (Figure 1–3), and
therefore easily hide in the fur coats of mammalian hosts and can go unnoticed by
humans.
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Figure 1–3. Ixodes scapularis developmental life-stages.
As the arthropod vector of Lyme disease, ticks acquire B. burgdorferi from infected
mammalian hosts. Ticks were reared experimentally and fed on C3H/HeN mice at
each life stage, viewed under light microscopy, and imaged relative to a sesame
seed.
B. burgdorferi is environmentally maintained via a complex infectious life
cycle, in which humans are considered incidental hosts (Figure 1–4). Ticks have 3
distinct life stages, larvae, nymphs, and adults, each playing a significant role in
the survival and dissemination of B. burgdorferi. Larval I. scapularis, typically
reared in the spring, are free of B. burgdorferi as there is no evidence to support
transovarial transmission from infected adult female ticks to their offspring (23).
Rather, colonization of the tick occurs via feeding on an infected host. For B.
burgdorferi this is mainly attributed to Peromyscus leucopus, the white-footed
mouse, whereas the European strains of Lyme-spirochetes B. afzelii and B. garinii
are tick-acquired via rodents and migratory birds respectively (5). Following the
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initial feeding, B. burgdorferi colonizes the tick midgut where they replicate (24).
Engorged, fed larvae ticks then begin an approximately month long molting
process, emerging as nymphs. These infected nymphs feed on a variety of small
vertebrate hosts including mice, squirrels, birds, and lizards.

Figure 1–4. The natural infectious cycle of B. burgdorferi.
An uninfected larval tick acquires B. burgdorferi from an infected mammalian host
prior to an approximate month-long morphogenesis process, during which
spirochetes persist in tick mid-guts. Molted fed larval ticks shed their exoskeleton,
emerging as nymphs. These infected nymphs then feed on an uninfected, naïve
9

vertebrate host transmitting B. burgdorferi and thus maintaining the environmental
reservoir. Humans are susceptible for B. burgdorferi infections from either infected
nymph or adult ticks, but considered incidental hosts for the pathogen as it does
not contribute to the environmental persistence of the spirochete.
However, not all species are competent as environmental reservoirs of B.
burgdorferi. Lizards, the primary host for I. pacificus, actively kill B. burgdorferi using
an alternative complement system within the tick midgut during the blood meal,
thus preventing transmission (25-27). Infected nymphs are also capable of biting a
human host, which is not included in the natural life cycle because of a lack of
documented evidence for human to tick transmission combined with the low
probability of an uninfected tick to locate and bite a human host undergoing an
active B. burgdorferi infection. The seasonal timing of both larval and nymphal
feedings also perpetuates the Lyme disease epidemic. The peak questing period,
the tick behavior pattern of seeking a host, for nymphs is May and June. This helps
facilitate an infected vertebrate population for larvae feeding, which have a
questing peak in August and September (28). Thus, this escalates the probability
for B. burgdorferi acquisition by the tick vector. Maturation to the adult tick life
stage also requires a molting process, post nymphal feeding. These adults
primarily feed on larger mammals such as deer, hence their common name “blacklegged deer ticks.” Deer are less important for the environment maintenance of B.
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burgdorferi, because like lizards, deer are incompetent hosts for B. burgdorferi; yet,
they play another vital role in the B. burgodorferi life cycle as adult ticks mate on
deer, ensuring a new generation of ticks are produced (5).

Clinical Manifestations of Lyme Disease
Following the bite from an infected I. scapularis tick the progression of Lyme
disease is characterized into three stages: (1) localized infection (2) disseminated
infection and (3) late stage infection. Immediately succeeding tick transmission B.
burgdorferi, being highly motile organisms, spread through the skin resulting in
the hallmark erythema chronicum migrans rash. This “bull’s-eye” appearance is
attributed to the infiltration of immune cells and inflammatory responses both at
the tick bite site and disseminating spirochetes, leaving a blanched centralized ring
(29). Additional host-responses at this stage in disease progression include mild
flu-like symptoms. Following establishment of the localized infection, B.
burgdorferi systemically disseminate to distal tissues. Using the bloodstream as a
conduit for migration, spirochetes associate and bind with vascular endothelia in
blood vessels followed by penetration of the endothelium for colonization of
underlying tissues (30, 31). The disseminated infection stage of Lyme disease can
persist for weeks to months following the initial tick bite. Common sites of distal
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colonization include the heart, central nervous system, joints, and additional skin
locations, sometimes resulting in secondary erythema chronicum migrans.
Symptoms are attributed to the presence of spirochetes residing in these tissues,
including excruciating headaches, mild neck stiffness, meningitis, neuritis,
atrioventricular blockage, or myopericarditis (29). If left untreated the disease
progresses into a final stage, designated as late infection, sometimes also referred
to as chronic Lyme. Characterized by long-term survival of B. burgdorferi, patients
can experience repeated episodes of pauciarticular arthritis and Lyme
encephalopathy, affecting memory, mood, sleep and language formation (29). Late
stage, persistent, inflammatory skin lesions, called acrodermatitis chronica
atrophicans, have also been reported but mainly with B. afzelii, the European strain
(18).
Incidence
With the presence of Lyme disease spirochetes spanning the globe, Lyme disease
is an emerging world-wide relevant infectious disease. Increasing 130%, the
confirmed cases in the United States jumped from 11,700 in 1995 to 27,203 in 2013
(32); however, this number is believed to be largely underestimated. Retrospective
analyses of United States health insurance claims from 2005-2010 identified
patients with clinician-diagnosed Lyme disease, and upon extrapolation of these
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findings to the US population predict annual incidence at ~329,000 cases (33). The
highest documented cases for Lyme disease peak in the summer months of June
and July, which immediately follows the peak nymph questing season. Reported
incidents are mainly concentrated to 14 northeastern and mid-western states,
amounting to more than 90% of total Lyme disease (32). The history of B.
burgdorferi human infections traverse at least 5,300 years with genomes of the
pathogen sequenced from the Tryolean Iceman, who was discovered in Ötztal
Alps and remains Europe’s oldest known natural human mummy (34).
Treatment and the Lyme Controversy
The treatment of Lyme disease is guided by clinical presentation of disease
symptoms, but typically involves antibiotic treatment over a duration of 2-3
weeks. Doxycycline is the preferred prescription for adults and amoxicillin for
children, as B. burgdorferi is only moderately sensitive to penicillin (35). Route of
administration is typically oral ingestion, but can include intravenous doses of
ceftriaxone or cefotaxime for severe conditions such as meningitis, encephalitis,
and myocarditis. Patients experiencing late stage arthritic symptoms have
responded well to antibiotic treatment over the course of 4 weeks (29). In some
cases, despite completion of the recommended antibiotic therapy, Lyme disease
symptoms such as fatigue, musculoskeletal pain, and loss of cognitive function
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continue, in what has been termed post-Lyme disease syndrome (36) The instances
of developing such an event seem to be associated with delayed antibiotic
treatment, and may also be connected to autoimmune responses, excessive
inflammation, immune dysregulation, or bacterial antigens persisting even after
clearance of spirochetes from tissues (37-40). While a vaccine was once available
for preventative medicine (41), it has since been pulled from the market due to
resistance from Lyme disease advocacy groups (42) and theoretical concerns of
developing autoimmune arthritis upon vaccination (43). This leaves awareness
and tick-repellent the most effective ways to avoid human exposure.
Lyme is perhaps one of the most controversial infectious diseases, in that
health professionals, researchers, and the lay press debate the validity of
diagnosis, post-Lyme disease syndrome, and antibiotic resistance. The two
“camps” of Lyme views are divided among academic scientists and physicians
which prescribe short-duration antibiotics for treatment and community-based
physicians and advocacy groups which argue for open-ended, invasive
antimicrobial and experimental approaches (44). Part of this division stems from
the lack of a reliable and objective diagnostic tool for Lyme disease. The current
gold-standard for potential Lyme patients is a two-tiered procedure which tests
for antibodies against the pathogen via an enzyme-linked immunosorbent assay
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(ELISA) and a Western immunoblot. The challenges associated with this detection
method include subjectivity of the Western blot and lack of standardization in test
preparations, combined with instances of false positives (45, 46). Furthermore,
these tests should only be ordered for patients displaying specific Lyme symptoms
(i.e. development of an erythema chronicum migrans following a tick bite),
whereas some lay persons and even physicians believe that nonspecific symptoms
alone, such as fatigue or arthralgia warrant a Lyme test (46). Yet this too becomes
complicated considering that development of an erythema chronicum migrans
only occurs between 70-83% of Lyme cases (47) and considering the manifestations
of Lyme disease are similar to other ailments including fibromyalgia, rheumatoid
arthritis, multiple sclerosis, mononucleosis, syphilis, and severe periodontitis (48).
Thereby, in the addition to false positive rates, the use of the two-tiered Lyme test
as a screening tool for nonspecific symptoms can result in misdiagnosis (46).
Alternative testing for Lyme disease, available by commercial laboratories, such
as urine antigen tests, lymphocyte transformation tests, and polymerase chain
reaction tests on inappropriate specimens have not been adequately established
and their validity use in clinical settings cautioned by the Centers for Disease
Control and Prevention (49). Improved and accurate diagnostics are currently
being developed to combat these issues (48).
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Escalating the controversy of Lyme further is the development and
legitimacy of post-Lyme disease syndrome and long term antibiotic treatment.
While recognizing prolonged symptoms of Lyme disease have been reported
despite antibiotic treatment, the National Institute of Allergy and Infectious
Diseases of the National Institutes of Health, does not endorse long-term antibiotic
treatment (50). A variety of independent and well-controlled clinical trials have
evaluated the efficacy of extended antibiotic courses, including intravenous
administration, and report no significant evidence that these measures are
beneficial (51-53). Such invasive and prolonged exposure to antibiotics can be
detrimental to a patient. In 2010, a 52-year-old woman who did not meet the
recommended criteria on the two-tiered diagnostic, but was subjectively scored
Lyme-positive by a physician, was prescribed 2-4 months of antibiotic treatment
and subsequently died of a Clostridium difficile infection associated to long-term
antibiotic

exposure

(54).

Other

prolonged

Lyme

antibiotic-associated

complications and death include cather-related blood stream infections,
pulmonary embolism, septic thrombophlebitis, and gastrointestinal bleeding (55,
56). It has also been argued that B. burgdorferi persistently infects patients, despite
antibiotic therapy. Several studies have explored this, and while remnants
including bacterial DNA and antigens have been reported, these studies have not
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successfully cultured B. burgdorferi from animal models following antibiotic
treatment (39, 57, 58). Ongoing human clinical studies are using disease-free ticks
to examine re-isolation of B. burgdorferi in Lyme patients following completion of
antibiotic therapy (59). Controversy surrounding Lyme is often perpetuated in the
media, including celebrity endorsement, which has described “Lyme patients”
suffering with undiagnosed Lyme disease for years, traveling from doctor-todoctor, until successfully diagnosed and treated with alternative medications.
Clearly, further scientific studies combined with simplified and descriptive
narration to the public is warranted. In-depth understandings regarding the
biology of B. burgdorferi and its ability to survive in the mammalian host is essential
for comprehending pathogenesis and development of Lyme disease.
The Unusual B. burgdorferi Genomic Architecture
Spirochetes, among themselves are distinctive members of the bacterial
community uniquely defined by their coiled morphology and periplasmic flagella.
Yet, the genomic structure and genetic makeup of B. burgdorferi further
differentiates the organism, even among its most closely related genera. Unlike
most all prokaryotic organisms, Borrelia and Borreliella species have a predominate
linear organization of genes. Furthermore, the genetic arrangement is segmented
among a main linear chromosome and a variety of circular and linear plasmids,
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the number of which fluctuates depending on the species. Collectively, this creates
the most complex genetic arrangement of nearly all bacteria (60). In B. burgdorferi
characterized strain B31, the first sequenced Lyme-spirochete, there is one 910,725kb linear chromosome and 21 circular (cp) and linear (lp) plasmids (61) (Figure 1–
5). The linear genetic elements have covalently closed telomeres (62), which
require ResT, the telomere resolvase, for successful replication (63). Circular and
linear plasmids can be lost during in vitro propagation of the spirochete, except for
cp26, where resT is transcribed (60).

Figure 1–5. The segmented genome of B. burgdorferi strain B31.
The genomic sequence is fragmented among one linear chromosome, 11 linear
plasmids (lp), and 10 circular plasmids (cp). Plasmids names are based on
structure and sequence length in kilobase pairs (kb) (e.g. cp9 is a circular plasmid
at approximately 9 kb in length). Other B. burgdorferi strains have disparity in
plasmid content.
Housekeeping genes are for the most part, confined to the chromosome, whereas
lipoproteins are mainly encoded on the plasmids (60). All plasmids are distinct,
however repetitive, carrying paralogous genes from other plasmids, while also
having large stretches of non-coding sequences and pseudogenes (61, 64). The
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copy number of each plasmid has been estimated to be one per chromosome (65,
66), which is approximately one per cell (67). Yet, the partitioning of these
plasmids to daughter cells and the mechanism by which all plasmids are stably
maintained during replication is not fully understood (68). The genome is highly
A+T rich, at ~72% (60). The annotation of the B. burgdorferi B31 genome estimates
815 chromosomal open reading frames (ORFs) encoding mainly housekeeping
functions (64). Approximately 58% of plasmid associated-ORFs were originally
annotated to encode hypothetical proteins, sharing no similarity to other bacterial
species (61). Largely, these have remained functionally uncharacterized today.
Further, B. burgdorferi lacks the ability to synthesize many nucleotides, amino
acids, fatty acids, and enzyme cofactors, abilities likely selected against during
coevolution with the tick and mammalian hosts (61, 69). Instead, at least 52 gene
products serve as scavengers, transporters, and recyclers to repurpose these
components from the environment for spirochete growth, metabolism, and
reproduction (60, 70). Iron utilization is seemingly not essential for B. burgdorferi,
which have no detectable amount when grown in culture and lack orthologues to
the usual bacterial genes for iron-requiring metalloproteins (61, 71). Glycolysis
following fermentation of sugars to lactic acid is the only known mechanism for
energy production, as genes encoding components for oxidative phosphorylation
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and the citric acid cycle also appear to be missing (61, 69). Growth media, BarbourStoenner-Kelly (BSK) (72), for in vitro cultivation of B. burgdorferi is highly nutrientrich, supplementing the range of components the spirochete would scavenge in
the environment. However, this growth medium is undefined and complex,
rendering advanced in vitro nutritional and metabolic studies challenging. With
such a limited and compact genetic makeup, combined with residing in various
and disparate environmental niches, B. burgdorferi has likely evolved efficient
mechanisms for sensing, colonizing, and persisting in its immediate host.

Molecular Mechanisms of B. burgdorferi Host Adaptation
There is a dynamic and coordinated response of the spirochete inhabiting a host,
despite the few regulatory and DNA binding proteins characterized in B.
burgdorferi. One classic and most notable change includes differential expression
of outer surface proteins (Osp). Metaphorically described as a “rain forest” of
proteins (73), the vast proteomic composition of the spirochete’s membrane
fluctuates depending upon its particular environmental niche. Following B.
burgdorferi acquisition of the tick, the spirochete upregulates OspA and OspB, of
which is critical for a successful colonization since OspA interacts with the tick
binding receptor TROSPA in the midgut (74). However, as an infected tick feeds,
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B. burgdorferi must release its attachments in the midgut and traverse through the
salivary glands for successfully transmission. This requires a downregulation in
ospA, ospB, and other surface exposed proteins, production of the mammalian host
essential lipoprotein OspC, and physical penetration of the tick midgut and
salivary gland tissues (5, 74). The coordination of these environmentally regulated
surface patterns cannot be altered, otherwise host immune responses will prevent
colonization (75). To combat the mammalian adaptive immune system
recognizing and clearing the pathogen, B. burgdorferi downregulates ospC
expression following dissemination from the tick-bite-site and upregulates VlsE
production (76). This lipoprotein uses antigenic variation for mammalian immune
avoidance via promiscuous recombination of its expression cassette (77, 78). Other
notable, regulated, and immunogenic surface proteins include BBK32, a wellstudied fibronectin binding protein, and the decorin binding proteins (DbpA/B)
(79). Seemingly, B. burgdorferi dramatically alters its genetic expression and
regulatory mechanisms depending on particular niches, besides the modulation
of surface protein composition.
A variety of studies have taken global approaches to analyze the
transcriptional profile of B. burgdorferi throughout the infectious lifecycle.
However, a major challenge in this approach is the low number of spirochetes
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present during an active infection (80). Thereby, researchers have created a variety
of mechanisms to mimic tick and mammalian environments on the bench. These
include alterations in temperature and pH of BSKII cultivation media (81, 82),
incubation of host cells with B. burgdorferi (83), and propagation in the presence of
human blood (84). Dialysis membranes inoculated with B. burgdorferi and held in
the peritoneal cavities of rats, have also been used to mimic gene expression
during mammalian pathogenesis (85). Several microarray approaches have
successfully characterized B. burgdorferi transcription of annotated open reading
frames in fed larval ticks, fed nymphal ticks, and rodent and non-human primate
models of Lyme disease (86, 87). Collectively these studies demonstrate B.
burgdorferi exhibit robust and dynamic changes in gene expression, based the
bacteria’s perception of its environment and/or growth condition. However, the
mechanisms responsible for mediating these observed differences have only been
partially characterized.
To date, relatively few transcriptional regulators have been identified in B.
burgdorferi. The main defined molecular mechanism for environmental sensing
and responding includes the alternative σ-factor, RpoN-RpoS pathway.
Classically as first discovered in Escherichia coli under situations of stress, the RNA
polymerase σ-factor, σ70 (RpoD), which binds and activates the promoters of
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housekeeping genes, is replaced with the alternative-σ38 or σS (RpoS), activating
global stress response genes (88). However, in B. burgdorferi RpoS activation and
downstream regulation is not a general stress response, but specific for
mammalian infectivity and expression of virulence factors, such as ospC (89, 90).
Control of RpoS is mediated by another alternative σ-factor, RpoN (91), a novelty
to B. burgdorferi in that this interaction requires the enhancer binding protein BosR
(92) and the two-component regulatory system response regulator, Rrp2 (93-95).
Two-component signaling serves as a quick and versatile method for bacteria
responding to environmental cues. These typically consist of a histidine protein
kinase (Hk) which senses environmental stimuli and subsequently phosphorylates
the response regulator protein (Rrp), causing activation of a downstream effector
domain to elicit a response (96). Surprisingly, in B. burgdorferi the upstream
histidine kinase, Hk2, has no effect on the Rrp2-RpoN-RpoS pathway and acetyl
phosphate serves as the phosphodonor to Rrp2 (94, 97). Given this, it has been
hypothesized that acetate, the precursor to acetyl phosphate, present in the blood
during tick feeding may serve as one chemical stimuli for B. burgdorferi to
modulate its genetic profile in preparation for mammalian transmission (76).
While the Rrp2-RpoN-RpoS system is strongly active during tick transmission and
mammalian infection, controlling the expression of over 100 genes (85, 95, 98), this
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system is suppressed during B. burgdorferi acquisition of the tick. Spirochete
adaptation to the tick happens quickly, with evidence that within 24 hours of
feeding on an infected mammal B. burgdorferi can colonize the midgut of larval
ticks (99). Subsequently the two-component system Hk1-Rrp1 is activated, via
unidentified ligands, which results in production of cyclic-di-GMP, essential for
tick adaptation and colonization (100-102). Other tick-dependent gene regulation
includes the activation of OspA, as described previously, which is believed to be
induced by the production of the neuroendocrine stress hormones adrenaline and
noradrenaline found at the bite-site of the feeding tick (103). Once established
within the tick, B. burgdorferi replicate while the tick digests its blood meal,
preparing to molt into its next life stage (5, 24). Gene regulation in the unfed
nymph is believed to be controlled, at least in some part, by the stringent response
(104). Flat, unfed nymphs, which can go months and often over the winter season
without feeding, are nutrient deprived for B. burgdorferi (5). This triggers the
production of the nucleotide alarmones guanosine tetrasphate (ppGpp) and
guanosine pentaphosphate (pppGpp) via the RelBbu mediated stringent response
(104). Numerous genes are controlled in this starvation-response network of
regulation, allowing persistence of B. burgdorferi through the tick molt and until
flat ticks feed (104). This mechanism also switches the carbon source of spirochetes
24

to glycerol, via activation of the glp operon, which is plentiful in flat ticks as it
serves as a natural antifreeze for over-wintering ticks (105). With the feeding of an
infected flat tick on a mammalian host and the influx of blood to the tick midgut,
B. burgdorferi begin dissemination within ~48-72 hours (16). Thus, this triggers the
regulatory mechanisms essential for a mammalian host and restarting the cycle of
gene regulation (i.e. activating the Rrp2-RpoN-RpoS pathway) (5). Limited
knowledge of other transcriptional regulators and DNA binding proteins
throughout the infectious life cycle exist. The few identified include carbohydrate
responsive regulators XylR1&2 (106), Bpur (107), BpaB (108), and EbfC (109).
Likely, B. burgdorferi harbors many additional modes of gene regulation to quickly
respond to environmental and stress stimuli. One roadblock preventing the
discovery of these additional factors, is the limited depiction of transcription
expression, especially during mammalian infection where the number of
infectious organisms remains low.
In Vivo Expression Technology and its Application to B. burgdorferi
In Vivo expression technology (IVET) is a method for identification of putative
promoter sequences active during the microbe’s interaction with a particular
environment or host organism (110, 111). Via this method, environmental stimuli
directly select for expressed microbial loci (112). Its functionality is based on the
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premise that deletion of a biosynthetic gene can lead to attenuation of growth and
persistence of a pathogen in a particular environment which can restored by
complementation of the biosynthetic gene. However, the complementation
process is mediated via a genetic screen to identify promoters that are
transcriptionally active in that environment. In this manner, a genomic library of
DNA fragments is cloned upstream of the essential biosynthetic gene, serving as
putative promoter sequences to the complemented biosynthetic gene. Only active
promoter sequences in an environment of interest initiate transcription. These
promoter sequences can be recovered, sequenced, and thereby concluded to be
active in the tested environment (110-113). IVET is a powerful and versatile
method for the identification of promoters which has discovered numerous
virulence genes among pathogenic bacteria and fungi in a wide variety of host
environments (112-116).
While, as described previously, several studies have attempted to define
gene expression during murine infection, they have been limited in recovering
sufficient B. burgdorferi samples for direct analysis and/or mimicked mammalian
infection-like conditions (86, 87). IVET was recently applied to B. burgdorferi
(BbIVET) in hopes of identifying novel genes that are expressed during a murine
infection (117). This approach bypasses the barricade of low bacterial numbers
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during infection, and can directly detect mammalian active sequences of the B.
burgdorferi genome. The pncA gene, a biosynthetic enzyme which converts
nicotinamide to nicotinic acid, was utilized as the reporter for BbIVET. The
expression of pncA is required for spirochete survival in the mouse, but
dispensable when cultured in rich nutrient, complex media (118). This allowed
genetic library preparations to be completed in culture, before screening through
the murine host. Thereby, in the BbIVET system, a mammalian active promoter
drives expression of pncA during the infection, thus allowing these spirochetes to
survive in the mammalian host. Subsequent infectious spirochetes were then
isolated and DNA fragments upstream of pncA sequenced to discover genes
expressed in a murine model of Lyme disease. Over 200 putative promoters were
recovered from this genetic screen, yet surprisingly a large portion of these
sequences were not located directly upstream of annotated genes (117). At that
time, the biology of B. burgdorferi concerning transcriptional activity other than
annotated genes and housekeeping RNAs was largely underexplored.
The Complex Transcriptomes of Bacteria
The annotation and role of regulatory RNAs in bacterial transcriptomes followed
significantly later than mRNAs and housekeeping transcripts. This is in part,
attributed to genetic screens that rarely selected for regulatory RNA loci, the lack
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of using strand-specific RNA-sequencing (RNA-seq) methods, the compactness of
bacterial genomes, and the observation that RNA-mediated gene regulation often
has subtle phenotypes compared to virulence-associated proteins (119). However,
with the discoveries and functional characterizations of small regulatory cis and
trans acting RNAs (120), riboswitches (121), and RNA-based thermosensors (122),
these mechanisms have become central for pathogen adaptation and virulence
(123). Global transcriptome depictions began to emerge with the development of
5’RNA-seq, also referred to as differential RNA-seq, which maps the 5’ end of all
RNA transcripts in a bacterial population and differentiates transcriptional start
sites (TSSs) from processed 5’ ends (124). RNA processing is a crucial posttranscriptional alteration for maturation of transcripts including housekeeping
transcripts such as 5’ end processing of tRNAs and internal processing of rRNAs,
which are cleaved by RNA nucleases RNaseP and RNaseIII respectively (125, 126).
There are at least 13 other characterized RNases in model organism E. coli with
defined activities including exoribonucleases RNase T, PH, D, II and BN which
can process the 3’ end of tRNAs and RNase II and polynucleotide phosphorylase
(PNPase) which contribute to mRNA degradation (127). The development of
5’RNA-seq revolutionized bacterial genetics globally mapping TSSs and instances
of processing across the genome. Applied to a variety of model and pathogenic
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organisms, nuances of transcription including internal, antisense, and intergenic
initiation of RNA polymerase (RNAP) have been widely observed, contributing to
a much more complex depiction of bacterial transcriptomes (124, 128-130). While
regulatory RNAs had already been acknowledged as important players of
bacterial gene regulation, stress response, and pathogenesis, following 5’RNA-seq
there were global annotations of putative regulatory RNAs. The mechanisms of
action for these transcripts are diverse and complex, involving interactions among
target mRNAs, RNases, and RNA chaperones. Regulatory RNAs are either
transcribed in cis, antisense to its target mRNA and having perfect
complementarity, or in trans, transcribed elsewhere in the genome and containing
limited complementarity (126). RNAs expressed in trans often require an RNA
chaperone for mediating interactions with target mRNAs, either Hfq, CsrA/RsmA
or ProQ (131). Collectively regulatory RNAs modulate gene expression at three
distinct times (1) transcription initiation (2) post-transcription via mRNA stability
and (3) translation initiation (Figure 1–6). Binding to mRNA targets can either
promote or repress gene expression, depending on the situation. For instance,
RNA-RNA interactions can cause secondary structural changes which prevent
ribosomes from accessing the ribosome binding site (RBS) impeding transcription,
or could trigger a secondary structure alteration which exposes a previously
29

concealed RBS initiating translation. Recruitment of RNases can also have
opposing effects, either degrading targets completely or processing them for
maturity (120, 123). Yet generally, these mechanisms are likely over simplified
with much more complex regulatory networks in place. For example, early
transcription termination of a cis-regulatory action can result in the production of
a new trans-mediated regulatory event via the terminated product (132).
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Sterically blocking or exposing the ribosome binding site (RBS) alters translation
of mRNA transcripts negatively or positively, respectively. The RNA-chaperone
Hfq, classically mediates RNA-RNA interactions.
Various adaptions of these mechanisms are also reported such as transcriptional
interference, specific for cis-acting RNAs and their close proximity to target
transcripts, promoting transcription termination via collision of polymerases,
occlusion of promoters, and sitting-duck inference mechanisms (133). Still other
levels of RNA-mediated regulation don’t require two independent RNA
transcripts such as cis-regulation in untranslated regions of mRNAs, i.e.
riboswitches and RNA thermometers. Rather, these transcripts coordinate
expression changes by ligand binding or thermodynamic changes which alter
secondary structures of the mRNA (134, 135). Additionally, the regulatory RNAs
csrB/C function as molecular sinks to sequester the global transcriptional
regulators CsrA/RsmA away from target mRNAs by high affinity binding sites,
altering gene expression of the corresponding mRNA (136). Collectively,
pathogens exploit a wide variety of genetic tools to quickly and efficiently respond
to environmental niches and stress responses, of which RNA-mediated regulatory
systems play a distinguishing role.
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The Missing Regulatory RNA Network of B. burgdorferi
Efforts to identify and characterize regulatory RNAs in the Lyme disease
spirochete have only produced a single trans acting small RNA, dsrA, and a
homolog to the RNA chaperone, Hfq, (137, 138). Despite the presence and
important regulatory role of CsrA in B. burgdorferi, the associated sequestering
RNAs, csrB/C, have yet to be annotated or characterized (139-141). The RNA
helicase, HrpA, is involved in B. burgdorferi transcript processing and translation
of at least 180 proteins and required for mammalian infection (142, 143). Unique
to B. burgdorferi is the absence of RNaseE, which is classically important for mRNA
turnover, although orthologs to endoribonucleases RNaseIII and RNaseY are
present. Transcript decay in B. burgdorferi has revealed a diversity in the turnover
rate of various transcripts critical for the infectious cycle, with some mRNAs of
typical short half-lifes (rpoS) and others unexpectedly long (ospA, ospC, flaB) (144).
Combined, these studies suggest the pathogenic importance and presence of a
regulatory RNA network in B. burgdorferi. The following chapters detail
experimental evaluations of B. burgdorferi transcriptional processes and their role
in a model of Lyme disease pathogenesis. This includes globally mapping the
spirochete’s transcriptome, characterizing novel transcripts during mammalian
infection, testing functional roles for cis-acting RNA transcripts with their
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corresponding mRNAs, developing original methodologies for quantitating
complex transcription during tick-spirochete interactions, and identifying a novel
gene in the pathogenesis of B. burgdorferi throughout its infectious life cycle.
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CHAPTER 2:
IN VIVO EXPRESSION TECHNOLOGY AND 5’ END MAPPING OF THE
BORRELIA BURGDORFERI TRANSCRIPTOME IDENTIFY NOVEL RNAs
EXPRESSED DURING MAMMALIAN INFECTION

Preface
The first complete draft of this chapter was written by P.P.A. Comments from
M.W.J., co-authors, and reviewers were incorporated into the final version
presented here.
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license which permits non-commercial use, distribution and reproduction in any
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Abstract
Borrelia burgdorferi, the bacterial pathogen responsible for Lyme disease,
modulates its gene expression profile in response to the environments
encountered throughout its tick-mammal infectious cycle. To begin to characterize
the B. burgdorferi transcriptome during murine infection, we previously employed
an in vivo expression technology-based approach (BbIVET). This identified 233
putative promoters, many of which mapped to un-annotated regions of the
complex, segmented genome. Herein, we globally identify the 5’ end
transcriptome of B. burgdorferi grown in culture as a means to validate non-ORF
associated promoters discovered through BbIVET. We demonstrate that 119
BbIVET promoters are associated with transcription start sites (TSSs) and validate
novel RNA transcripts using Northern blots and luciferase promoter fusions.
Strikingly, 49% of BbIVET promoters were not found to associate with TSSs. This
finding suggests that these sequences may be primarily active in the mammalian
host. Furthermore, characterization of the 6,042 B. burgdorferi TSSs reveals a variety
of RNAs including numerous antisense and intragenic transcripts, leaderless
RNAs, long untranslated regions, and a unique nucleotide frequency for initiating
intragenic transcription. Collectively, this is the first comprehensive map of TSSs
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in B. burgdorferi and characterization of previously un-annotated RNA transcripts
expressed by the spirochete during murine infection.
Introduction
Borrelia burgdorferi or Borreliella burgdorferi (17) is the spirochetal agent of Lyme
disease, the foremost vector-borne bacterial disease in the world (32). B. burgdorferi
is naturally maintained in an enzootic cycle between an arthropod vector, Ixodes
sp. ticks, and diverse small vertebrate reservoir hosts, such as the white-footed
mouse Peromyscus leucopus (5). Humans may become infected with B. burgdorferi
through the bite of an infected tick, resulting in Lyme disease (1). The survival and
pathogenesis of B. burgdorferi requires that the bacterium appropriately modifies
its transcription profile in response to the distinct tick vector and mammalian host
environments encountered throughout its infectious cycle (76, 87, 145). The
paradigm example of this is the down-regulation of ospA, encoding outer surface
protein A, and up-regulation of ospC, encoding outer surface protein C, during B.
burgdorferi transmission from the feeding tick to the mammalian host (99, 146-149).
Elucidation of the transcriptional activity of a pathogen during infection is critical
for understanding the molecular mechanisms used by the pathogen to cause
disease. Yet, despite the well characterized transcriptomes of other pathogens
(150-154), B. burgdorferi’s paucibacillary nature (80) has led to technical challenges
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toward global elucidation of the spirochete’s transcription profile during
mammalian infection.
Global transcriptome approaches performed using B. burgdorferi cultivated
in modified growth conditions used to simulate tick or mammalian environments
have allowed interrogation of the spirochete’s gene expression profile in response
to diverse stimuli. Temperature and pH shift of bacterial cultures in complex
medium (81, 82), co-incubation of spirochetes with host cells (83) and growth of B.
burgdorferi in blood (83, 84), or in dialysis membrane chambers (DMCs) in the
peritoneal cavities of rats (85, 87, 155), have resulted in the discovery of a number
of B. burgdorferi genes that are expressed under mammalian infection-like
conditions and contribute to pathogenesis (145). However, these modeled
conditions are unable to fully recapitulate the complex tissue environments that B.
burgdorferi encounters during an active infection. Recently, an amplificationmicroarray approach was used to define the transcription profile of annotated
open reading frames and pseudogenes in fed larval ticks, fed nymphal ticks and
mammalian host adapted B. burgdorferi cultivated in DMCs (87). This analysis
provided stage-specific mRNA expression levels and insights into the
transcriptional network that the spirochete uses to sense and respond to the
environmental cues it receives as it transitions between the tick vector and
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mammalian host (87). Microarray analysis of B. burgdorferi gene expression in a
non-human primate model of neuroborreliosis revealed genes that are specifically
induced in the central nervous system during infection (86). Targeted analyses of
specific gene subsets have identified a number of B. burgdorferi genes that are
upregulated during mouse infection (80, 145, 156). In addition, global mutagenesis
approaches have identified a number of genes that contribute to murine infection
(157, 158). Nonetheless much remains to be discovered about the B. burgdorferi
transcriptome and how it contributes to the spirochete’s pathogenesis.
To overcome the challenges of identifying B. burgdorferi genes expressed
during murine infection, our lab developed an in vivo expression technology
(IVET)-based approach for B. burgdorferi (BbIVET) (117). IVET is a powerful and
versatile promoter identification method and has been used with pathogenic
bacteria and fungi in a wide variety of host environments, and led to the discovery
of a number of previously uncharacterized virulence genes (112-116). This
approach does not rely on the recovery of bacterial RNA from mouse tissues for
transcriptional analysis and thus is not hindered by low bacterial numbers during
infection. BbIVET was the first genetic screen of this type to identify B. burgdorferi
putative promoter sequences that are transcriptionally active during a murine
infection. Moreover, the experimental design of the BbIVET screen was such that
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the recovered infection-active promoters could be active both in culture and
during infection or specifically active during infection alone. We previously
reported the BbIVET-identified sequences that mapped upstream of annotated
open reading frames (ORFs) (117). Unexpectedly, many sequences discovered
through BbIVET were internal, antisense, or intergenic to ORFs. This suggested
the presence of novel transcripts in these genomic regions; however, due to the
lack of B. burgdorferi RNA-seq studies that report transcripts other than annotated
mRNAs, the significance of these findings were unknown.
Since their development, 5’RNA-seq protocols have been used to globally
define transcription start sites (TSSs) and processed RNA 5’ ends across bacterial
genomes. The initial use of this technique revealed the complexity of the
Helicobacter pylori transcriptome through the discovery of global antisense
transcription, numerous small regulatory RNAs (sRNAs), and previously
unrecognized intragenic TSSs (124). Furthermore, 5’RNA-seq applications in other
organisms have identified high instances of leaderless transcripts (128), novel
regulatory RNA networks (129, 159, 160), strain-specific sRNAs (161), and a high
prevalence of un-annotated small proteins (162), as well as provided valuable
resources for future genetic applications in model organisms (130).
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As a means to gain insight into the significance of the un-annotated
sequences identified through BbIVET, as well as work to elucidate the BbIVET
promoters that are principally active during infection alone, we have applied 5’
end RNA deep sequencing (5’RNA-seq) to B. burgdorferi grown in culture and
overlapped this TSS map with the BbIVET-identified sequences. We provide
substantial genome-wide data on the transcriptional start sites for B. burgdorferi
and validate the expression of a subset of these both in culture and during an active
murine infection. In total, this work contributes significant understanding to the
complex transcriptome of B. burgdorferi and identifies novel B. burgdorferi
sequences expressed during mammalian infection.
Materials and Methods
Bacterial Clones and Growth Conditions
Borrelia burgdorferi clones used in this study were derived from strain B31. Wildtype clone B31 A3 (163), which lacks cp9, was used for the cDNA library
preparations. All B. burgdorferi genetic manipulations used infectious low-passage
clone A3-68Δbbe02, which lacks cp9, lp56, and gene bbe02 on lp25 (164). All shuttle
vectors were created in DH5α E. coli, grown in LB broth or on LB agar plates
containing 300 µg/ml spectinomycin when appropriate, and transformed into B.
burgdorferi as previously described (165). Spirochetes were cultivated in liquid
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Barbour-Stoenner-Kelly (BSK) II medium supplemented with gelatin and 6%
rabbit serum (72) and plated in solid BSK medium as previously described (166).
B. burgdorferi cultures were grown at 35°C supplemented with 2.5% CO2 in the
presence of 50 µg/ml streptomycin and/or 200 µg/ml kanamycin when applicable.
RNA Isolation
In general, 45 ml of log phase (3-7x107 cells/ml) B. burgdorferi B31 A3 in BSK II
medium, as determined using a Petroff-Hausser counting chamber under dark
field microscopy, was pelleted at 3210 x g for 15 min, supernatant decanted, and
snap frozen in liquid N2. Total RNA was extracted using a hot phenol protocol
described previously (104). 50 µg total RNA was incubated with 10 U DNase I
(Roche) and 80 U rRNasin (Promega) at 37°C for 15 min. The RNA samples were
purified as described (104). RNA concentrations were measured and DNA
removal and RNA integrity was verified by gel electrophoresis. For RNA preps
used in deep-sequencing, RNA Integrity Number (RIN) was determined using the
Agilent 2100 Bioanalyzer. Samples with RIN numbers over 9.0 were selected for
RNA-seq library preparations.
cDNA Library Preparations
Two biological replicates of B. burgdorferi B31 A3 were grown to a density of 3x107
cells/ml in BSK II medium, the presence of all circular and linear plasmids
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confirmed by PCR with a panel of primers (163), and RNA isolated and DNase
treated, as above. Ribo-zeroTM rRNA Removal Kit for Gram-negative bacteria
(Epicentre) was used to remove ribosomal RNA, per manufacturer’s instructions.
Elimination of rRNA was confirmed using an Agilent 2100 Bioanalyzer. 1.5 µg
samples of RNA from each of the two B. burgdorferi cultures were incubated at
37°C for 1 hr with or without 45 U tobacco acid pyrophosphatase (TAP)
(Epicentre), 1X TAP buffer, and 40 U rRNasin (Promega). Samples were then
loaded into Heavy Phase Lock Gel tubes (5 PRIME) with an equal volume of
phenol stabilized:cholorform:isoamyl alcohol (25:24:1) (PCI), ethanol precipitated,
and reconstituted in 5 µl DEPC-H2O. 30 µM of 5’ RNA adapter (5’GUUCAGAGUUCUACAGUCCGACGAUC-3’), based on the Illumina adapter
sequence, (Oligonucleotide sequences © 2007-2009 Illumina, Inc., all rights
reserved) was ligated to the 5’ ends of the TAP+ and TAP- treated RNA samples
using 20 U RNA Ligase 1 (NEB), 1X RNA Ligase 1 Buffer, 10% DMSO, 1 mM ATP
(NEB), and 40 U rRNasin (Promega) in 20 µl DEPC- H2O and incubated at 20°C
for 6 hrs. Reactions were then loaded into Heavy Phase Lock Gel tubes (5 PRIME)
with equal volume PCI, ethanol precipitated, and reconstituted in DEPC-H2O.
Fragmentation of the 5’ ligated RNA samples was conducted using RNA
fragmentation reagents (Ambion) following manufacturer’s instructions with a
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fragmentation time of 4 mins at 70°C. Reactions were ethanol precipitated,
reconstituted in DEPC-H2O, and analyzed with an Agilent 2100 Bioanalyzer. RNA
libraries were then 3’ end dephosphorylated using 10 U T4 Polynucleotide Kinase
(PNK) (NEB), minus ATP, with 1X PNK buffer and 20 U rRNasin (Promega) at
37°C for 3 hrs. A subsequent PCI and ethanol precipitation was performed to
purify the libraries, which were then size selected on an 8% polyacrylamide 8 M
urea gel. RNA gel segments from ~150-300 nts were isolated and extracted
overnight in RNA gel elution buffer (10 mM Tris pH 7.5, 0.1% SDS, 2 mM EDTA,
0.3 M NaOAC) at 4°C with agitation. Gel slurries were loaded onto 0.2 µm aqua
Nanosep® MF columns (PALL), centrifuged at 14,000 xg for 2 min, and the eluates
were ethanol precipitated. The 3’ RNA adapter, based on the Illumina
multiplexing sequence and blocked on the 3’ end with an inverted dT (5’(p)AGAUCGGAAGAGCACACGUCU[idT]-3’), was 5’ phosphorylated using T4
PNK (NEB) per manufacturer’s instructions, and purified using illustra MicroSpin
G-25 columns (GE). 52 µM of phosphorylated 3’ RNA adapter was next ligated to
the libraries using 25 U RNA Ligase 1 (NEB), 1X RNA Ligase 1 Buffer, 10% DMSO,
1 mM ATP (NEB), and 40 U rRNasin (Promega) in 25 µl DEPC- H2O, and incubated
at 20°C for 6 hrs. To remove unincorporated adapter, size selection (~200-300 nts)
on an 8% polyacrylamide 8 M urea gel was performed and RNA extracted from
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gel, as described above. Adapter conjugated RNA library preps were converted to
cDNA with SuperScriptII reverse transcriptase (Invitrogen) and random
nonamers, per manufacturer’s instructions. 2 U of RNaseH (Promega) was used to
remove the remaining RNA from the libraries, and a subsequent 18 cycle PCR with
Phusion High-fidelity DNA polymerase (NEB) was used to add appropriate
barcodes using ScriptSeq Index Primers (Epicentre) (Table 2–1). Products were
analyzed on an Agilent 2100 Bioanalyzer and by KAPA qPCR (KAPABiosystems),
and prepared for sequencing with Illumina technology on a HiSeq 1500. Pooled
libraries (2 TAP+ and 2 TAP-) were clustered with TruSeq Rapid SR Cluster Kit
(Illumina) and sequenced on a rapid run with single-end 50 base-pair reads at the
analytical genomics core facility at Sanford Burnham Prebys Medical Discovery
Institute (Orlando, FL).
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Table 2–1. Oligonucleotides used in this study.
Number

Sequence (5’-3’)

Use

FWD

AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA

Forward PCR Amplification Primer

INDEX #4

CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACG
TGTGCTCTTCCGATCT
CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTCAGACG
TGTGCTCTTCCGATCT
CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACG
TGTGCTCTTCCGATCT
CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCAGACG
TGTGCTCTTCCGATCT
Luciferase Fusion Constructs

Reverse Primer, Barcode for B. burgdorferi 1312
Replicate #1, TAP+
Reverse Primer, Barcode for B. burgdorferi 1312
Replicate #1, TAPReverse Primer, Barcode for B. burgdorferi 1312
Replicate #2, TAP+
Reverse Primer, Barcode for B. burgdorferi 1312
Replicate #2, TAP-

1693

GAAGATCTAATATATTCTCCTTTTATATTAATATAACTTAATAC

Forward primer for ospAp

1694

GAAGATCTTGCAGATTTACAAAAAATACTCAA

Reverse primer for ospAp

1845

GAAGATCTTTTAATTTTAGCATATTTGGCTTTGC

Forward primer for ospCp

5'RNAseq

INDEX #5
INDEX #6
INDEX #7

1846

GAAGATCTTAATTTGTGCCTCCTTTTTATTTATG

Reverse primer for ospCp

1695

GAAGATCTTTCTTATTATACCATTTCTTATATCATTGA

Forward primer for Bbive12

1696

GAAGATCTAATTTACTTCTTCTGGCCTCT

Reverse primer for Bbive12

1866

GAAGATCTAATTCCGAACTTGATAGTGATTG

Forward primer for Bbive36

1867

GAAGATCTAATTCTTTATGCATTGCCCTA

Reverse primer for Bbive36

1705

GAAGATCTGATAAAAATCATAAATACTAAAAAGATTAGAATCA

Forward primer for Bbive45

1706

GAAGATCTAATTACAAGAAGTGATGGAAAAAAGA

Reverse primer for Bbive45

1707

GAAGATCTCAATTTTAGTTATCTCAAAAGCCA

1708

GAAGATCTACTTTTTTAGAAGAAGATGAGATTGA

1709

GAAGATCTAGTAGATATATACAGCCATGAAAATA

Forward primer for upstream processed region in
Bbive45
Reverse primer for upstream processed region in
Bbive45
Forward primer for Bbive74

1710

GAAGATCTTTTATAAAAGGCCAGAGAAAGAAGT

Reverse primer for Bbive74

1711

GAAGATCTAGGATCTATTATAACAGCTGTTTTA

Forward primer for Bbive76
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Number

Sequence (5’-3’)

Use

1712

GAAGATCTTAACTCAAACACACTGCG

Reverse primer for Bbive76

1699

GAAGATCTATATTCAATAGTAGCACAGGATTGT

Forward primer for Bbive86

1700

GAAGATCTAATTTTTTGAATAAGCTTAAGTCTATAGG

Reverse primer for Bbive86

1858

GAAGATCTAATTAGAAGATTTGTTAACTCAAATGTG

Forward primer for Bbive158

1859

GAAGATCTAATTCATCTTTGGGGTCTAGATT

Reverse primer for Bbive158

1860

GAAGATCTGAATTGAGTGCATTAGACTTTCTC

Forward primer for Bbive161

1861

GAAGATCTAATTAAGCTCTTGTATTTAATAATAATCAAATAC

Reverse primer for Bbive161

1870

GAAGATCTATTTTAAAGAATAAAACAAAGAGATTGATT

Forward primer for Bbive175

1871

GAAGATCTAATTTCTGTAAGCGATTTAA

Reverse primer for Bbive175

1703

GAAGATCTATTTAATAATAACATTTAAGCCATTATCACCA

Forward primer for Bbive203

1704

GAAGATCTAATTTACCTGTTTTAAATATTTTAAAAATAAAAGA

Reverse primer Bbive203

1862

GAAGATCTGAATTATATACATATAATCATTAATTTTATTTAAGTAT

Forward primer for Bbive252

1863

GAAGATCTAATTGATTTGGATCCACAGAATTC

Reverse primer for Bbive252

1691

GAAGATCTAATAAATTCCTTTAAAAAAAGACCTACATAAT

Forward primer for Bbive277

1692

GAAGATCTAATTATCCTTATACTAAGTTTCTCATTTTTGA

Reverse primer for Bbive277

1719

AAGGTCGTTGATCAAAGCT

1591

CATAGCTTTATGAAGTTGTTCAC

pJSB161 aadA 5'out, for directional PCR and
sequencing analysis
pJSB161 luc 5'out, for directional PCR and sequencing
analysis

Northern Probes
74

TTGTTTTTTGCAAGATGGTTAGAATTTTTTTATTTTAGTCTC

Sense to BB_0240, UTR region

75

ATCTCCAACAACAGAAATTAAAAACATTAGCAAAAAAGTTCC

Sense to BB_0240, coding region

39

GCAAAAGATGCCTCTTGAACTTTCAAGGCTTCTGCCTCTCCG

Sense to BB_0370, downstream Bbive45 iTSS

59

GTTTCAAAGCTTAACATACGATTAACAGAAAAATGCATGCCA

Sense to BB_0370, upstream Bbive45 iTSS
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Deep-Sequencing Analyses

Figure 2–1 Bioinformatics analysis overview.
Reads were mapped with NextGenMap v0.4.12 (167) against the B. burgdorferi B31
reference genome ensuring 90% sequence identity between the read and the
reference sequence. For the main analysis we removed reads with mapping quality
< 20 (1a). For the analysis of repetitive genomic regions (“MQ0-analysis”), we
configured NextGenMap to output up to 100 possible read alignments that share
the maximum alignment score (1b). Library-size normalized, strand- specific
coverage signals were extract from the resulting BAM files using CODOC software
(168) (2a+b) for visualization in a genome browser (3). For the MQ0 data, the
contribution of each individual read to the extract coverage signal was weighted
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by the number of alternative alignments written by NextGenMap to the BAM
respective “X0” BAM tag (2b). For example, a read that maps to three different
genomic regions with the same (maximum) score would contribute 1/3 to the
coverage signal at the respective regions. The BAM files were then inputted to a
tool that outputs the 5’ end signal (i.e., the number of reads having a 5’ end at the
respective genomic position) in a strand-specific manner. The MQ0 data was
weighted by X0 as described above (4a+b). These data served as input to the main
analysis pipeline, to call transcription start sites (TSSs) (5): First, the 5’ end signals
are normalized, then our method determines all positions in the input datasets
with sufficient average coverage in both categories (TAP+ and TAP-), and among
biological replicates, where the average TAP+ 5’ end signal is greater than the TAPsignal. Our method then calls peaks in the respective coverage segments and
categorizes found TSSs. Finally, peaks are annotated with gene Ids and nearby
BbIVET annotations, 5’ UTR regions are outputted for all primary and secondary
TSSs, and result files are written.
A schematic of the 5’RNA-seq analysis is presented in Figure 2–1. Reads were
mapped to the Borrelia (Borreliella) burgdorferi B31 genome (GenBank Ids:
AE000783, AE001583, AE000793, AE001582, AE000785, AE000794, AE000786,
AE000784, AE000789, AE000788, AE000787, AE000790, AE001584, AE000791,
AE000792, AE001575, AE001576, AE001577, AE001578, AE001579, AE001580, and
AE001581) using NextGenMap v0.4.12 (167) with default configuration but
ensuring at least 90% sequence identity between the read and the B. burgdorferi B31
reference genome.
The B. burgdorferi genome harbors a number of regions comprised of highly
repetitive sequence. This is particularly true for sequences residing on the cp32
replicons, lp56, lp21 and lp5 (169). The presence of extensive similarity between
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sequences found on multiple B. burgdorferi plasmids suggested that we may
encounter challenges in our ability to definitively map a portion of the 50 bp
sequence reads from 5’RNA-seq to their locations in the genome. A dot plot
comparing the sequences of all B. burgdorferi B31 plasmids to each other confirmed
regions of high sequence similarity, especially along the cp32s and lp56, as
expected (Figure 2–2A). The same analysis, however, revealed sub-sequences with
reduced similarity on these plasmids, which provided evidence that a
considerable fraction of the B. burgdorferi genome, including sequences on the
cp32s and lp56, is sufficiently unique to be mapped with good confidence (Figure
2–2B).

Figure 2–2. Dot plot of sequence similarities for the B. burgdorferi B31 genome.
As calculated by ARGOS (http://www.cibiv.at/~niko/argos/). Briefly, the B31
genome was converted into synthetic, overlapping reads (read length: 50 bp, step
size: 1 bp) that were then mapped back to the B31 genome using NextGenMap.
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The mapper was configured to output all possible mapping positions with a
minimum alignment score of half the possible maximum score for each individual
synthetic read. The resulting similarity matrix was binned (we used 1,000 bins of
size 1,521bp; values in a bin were averaged, bin indices are written in parentheses)
and plotted as a levelplot using the Lattice R package (170). A score of 1.0 (red
dots) corresponds to (near-) perfect sequence similarity between the respective
genomic regions, a score of 0.5 corresponds to the lowest detectable sequence
similarity. White dots correspond to similarities below the used score cutoff. Data
presented are the same among panels, displaying different lower score cutoffs. (A)
Extensive sequence similarity exists among the cp32s and lp56 (red diagonal
dotted-lines). Lower score cutoff at 0.5 (B) Upper 10% of the scored range (0.9
lower score cutoff) demonstrates that sub-regions can be mapped with good
confidence on these plasmids. Where a similarity score difference of 0.1
corresponds to approximately 10% sequence diversity between the mapped
synthetic reads.
For the main analysis we removed aligned reads with mapping quality values
below 20, therefore removing reads that cannot be aligned to a unique location in
the genome with high probability. We then extracted one dimensional, genomewide signals from the mappable alignments by counting reads that have their 5’
nucleotide mapped to a particular genomic position. These signals were
normalized by library size. 5’ ends were called in coverage segments of the TAP+
and TAP- signals using an in house method. This procedure excluded peaks below
a minimum threshold of 30, which corresponds roughly to a minimum of 30 reads
covering a genomic position, and requires a 5’ end to be sequenced in both
biological replicates. For each sequenced 5’ end, read counts were averaged
between biological replicates and the ratio of reads between the TAP+ and TAP50

libraries was then calculated. We observed a strong correlation between the 5’ end
read counts within the TAP+ and TAP- replicates (Figure 2–3).

Figure 2–3. Distribution and correlation of 5’ ends reads between the two
biological replicates.
5’RNA-seq coverage was normalized to the number of mapped reads, including
reads with a mapping quality of zero. (A) Boxplot indicating 5’ end read count per
library, outliers not displayed. (B) Corrplot (171) heat map matrix correlation plot,
comparing TAP+ and TAP- replicates. Pearson correlation coefficients at R=0.97
for the TAP+ replicates and R=0.70 for the TAP- replicates.
A 5’ end was determined to be a TSS if the nucleotide reads were at least two fold
higher in the averaged TAP+ compared to the averaged TAP- libraries. This is
based on the notion that TAP hydrolyses phosphodiesters on RNA 5’ ends and
that RNA ligase has specificity to only ligate the 5’ Illumina adapter to RNA
sequences harboring a 5’ monophosphate, thereby enriching TSSs to TAP+
libraries. Ideally, 5’RNA-seq would unambiguously distinguish TSSs from
processing events, thereby TAP- libraries would solely sequence processing
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events. However, practicality, 5’RNA-seq takes a snapshot of an actively growing
bacterial population. Given that in routine RNA transcript turnover the 5’
triphosphate is removed, combined with unintentional phosphate loss during
manipulation of RNA in library preparations, it is not surprising that some TSSs
are captured in the TAP- library. Hence a two-fold threshold was established, as
has also been applied to other studies utilizing 5’RNA-seq (159, 161). The 5’
nucleotides in the TAP+ libraries not identified as TSSs were defined as 5’
processed ends. The resulting TSSs were then associated with BbIVET and gene
annotations present in the Schutzer annotation set (172) (including tRNA
annotations from the UCSC database).

For the analysis that included the repetitive part of the genome,
NextGenMap was configured to output the top 100 possible alignments that share
the maximum alignment score for each read. These alignments were not filtered
for mapping quality and therefore also contained a considerable number of multimapped reads with mapping quality zero (MQ0) that map to multiple positions in
the reference sequence with equal probability. For such ambiguously mapped
reads, the BAM file therefore contained multiple alignment entries. We then
extracted a 5’ end from these alignments as above but this time each read
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contributed to this signal only with a weight 1/X0 to the signal where X0 is the
number of optimal alignments for this read in the dataset. In other words, a
uniquely mapped read would count as before; whereas, a read that mapped to
three different (repetitive) regions would contribute only 1/3 to the each of them,
thereby equally dividing its contribution among all possible (optimal) mapping
locations in the genome.
TSS Classifications
A TSS was termed primary if it was located within 300 nucleotides upstream the
annotated start codon of an ORF on the same DNA strand, and had the highest
average TAP+ read count of all such TSSs associated with the same ORF.
Secondary TSSs were those that fulfilled the above criteria with respect to
location but were not the TSS with the highest average TAP+ read count. The
delegation of antisense was assigned if the TSS was located within or just outside,
extending 100 nucleotides (nts) upstream or downstream, of an ORF on the
complementary DNA strand. An internal classification was assigned if the TSS
was located on the same DNA strand at any position between the second
nucleotide of the start codon and the last nucleotide of the stop codon of an ORF.
A TSS that was not classified into any of the above categories was identified as an
orphan. Each TSS was assigned to all of the categories for which it qualified. There
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were five cases for which a TSS was assigned the designation of primary for one
annotated transcript and secondary for another, and three cases for which a TSS
was secondary, internal, and antisense for three different annotated transcripts. In
each of these situations, the unusual pattern of TSS classification resulted from the
close proximity of the TSS to a small ORF or tRNA transcript.
Bbive-TSS association
A conserved Pribnow box sequence was identified, on average, at the -6 nucleotide
position relative to unique primary TSSs and we reasoned that a minimum of 20
nts of a Bbive sequence may be sufficient to contain a functional promoter, due to
the lack of strong conservation in the -35 region. According to this rationale, we
established the criteria that if a TSS was located at a position 20 nts or greater
downstream of the 5’ end of a Bbive sequence up to 6 nts beyond the 3’ end of the
Bbive sequence then it was considered a BbIVET associated TSS (Bbive-TSS).
Northern Blotting
10 µg of DNase treated (Roche) total RNA was separated using a
formaldehyde/MOPS agarose gel, modified from www.lonza.com/research and
(173). Briefly, RNA was denatured in 1X MOPS (20 mM MOPS, 5 mM NaOAC, 1
mM EDTA, pH 7.0), 3.7% formaldehyde, and 1X RNA loading dye
(ThermoScientific) at 70°C for 10 min, and incubated on ice for 3 min prior to
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loading. Following separation on a 1% agarose, 1X MOPS, 2% formaldehyde gel
at 150V at 4°C, RNA was transferred to Hybond XL membranes (Amersham
Pharmacia Biotech) via capillary action overnight (173). Membranes were UV
crosslinked with a UVC 500 crosslinker (Amersham Pharmacia Biotech) at 150 mJ,
probed with 50 nM DNA oligonucleotide probes (Table 2–1), and end-labeled
with ATP [γ-32P] by T4 Polynucleotide Kinase (NEB), at 42°C overnight with
ULTRAhyb oligo hybridization buffer (Ambion). Blots were washed twice with
2X SSC (3 M NaCl, 300 mM Na3C6H5O7), 0.5% SDS, exposed to a phosphor screen,
and imaged with a Typhoon Trio+ (GE).
Luciferase Promoter Fusion Constructs
B. burgdorferi shuttle vectors pJSB161 and pJSB175 carrying a promoterless or flaBpdriven B. burgdorferi codon optimized Photinus pyralis firefly luciferase gene (luc),
respectively, were generously provided by Dr. Jon Blevins (174). Generation of the
Bbive:luc fusion constructs was carried out as follows. Bbive putative promoter
regions, (1) the -1 nucleotide, as determined from 5’RNAseq, to the 5’ end of the
BbIVET sequence, or (2) the entire Bbive sequence, were PCR amplified using
Phusion High-fidelity DNA polymerase (NEB) from B31 A3 genomic DNA with
primer pairs that introduced a BlgII site at the 3’ and 5’ ends (Table 2–1). For BbiveTSSs which were located less than 100 nts downstream the 5’ end of the BbIVET
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sequence or for the analysis of processed 5’ ends, ~100 bp upstream the
TSS/processed 5’ end were BlgII cloned into pJSB161. The PCR generated DNA
fragments were digested with BlgII and ligated into BlgII digested pJSB161. The
ospAp:luc and ospCp:luc fusion constructs were generated in the same manner,
using primer pairs 1693, 1694 and 1845, 1846, respectively (Table 2–1). All plasmid
constructs were confirmed by PCR and sequence analysis.
Luciferase Assays
B. burgdorferi clones carrying the luciferase fusion constructs were grown to
logarithmic phase (4-7x107 spirochetes/ml) in BSK II medium and pelleted at 3210
x g for 10 min. Cells were washed twice with PBS (137 mM NaCl, 2.7 mM KCl, 10
mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) and resuspended to approximately 23x109 spirochetes/ml. 100 µl of each sample was used to measure the OD600 using
a BioTek Synergy 4. 92.5 µl of each sample was loaded into a black, solid bottom
96-well plate (Corning) and combined with 7.5 µl 10 mM D-luciferin (Regis) in
PBS. The relative luciferase activity (RLA) was determined by measuring photon
emission in each well for 1 second, 10 times using the EnVision 2104 Multilabel
Reader (PerkinElmer). RLA for each sample was averaged, subtracted from the
PBS control, and normalized to the OD600 reading for that clone, providing the
relative luciferase units (RLU) for each promoter fusion. Experiments were
56

conducted in biological triplicate and analyzed by two-tailed Student’s t-test
relative to pJSB161 using Graphpad Prism.
Ethics Statement
The University of Central Florida is accredited by the International Association for
Assessment and Accreditation of Laboratory Animal Care. Protocols for all animal
experiments were prepared according to the guidelines of the National Institutes
of Health and were reviewed and approved by the University of Central Florida
Institutional Animal Care and Use Committee.
Luciferase Assays during Murine Infection
Prior to infection and imaging, anaesthetized 6-8 week old female C3H/HeN mice
(Envigo) were depilated ventrally by shaving and treatment with odorless hair
removal creme (SallyHansen). One week prior to inoculation, and throughout the
duration of the study, mice were treated with 5 mg/ml streptomycin and 1 mg/ml
Equal sweetener in their water to maintain selection for the luciferase plasmid in
the B. burgdorferi clones. Groups of three mice were infected with 1x105 spirochetes
intraperitoneally. To detect luciferase activity, mice were intraperitoneally injected
with 150 mg/kg body weight sterile D-luciferin in PBS, 15 min prior to imaging.
The IVISTM 50 Imaging System (Xenogen Imaging Technologies) was utilized to
capture luminescence signals with a f/1 camera lens aperture, binning at 4, and 5
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min exposure time. Mice were imaged at various time points between 1 and 24
days post inoculation. To determine the inoculum doses, spirochetes were counted
using a Petroff-Hausser counting chamber and verified by the number of colonyforming units plated in solid BSK medium. All inocula were PCR verified to
contain all expected B. burgdorferi plasmids as previously described (175).
Immediately following the final IVIS reading time point, mice were sacrificed and
ear and bladder tissues were cultured for spirochete reisolation as described (176),
and all mice were confirmed positive for infection. Any background luciferase
signals detected in the mice inoculated with B. burgdorferi carrying the
promoterless luciferase gene were subtracted out of the readings.
Data Access
The complete BbIVET sequences, including Bbive boundaries and those that are
associated to TSSs are provided in Table 2–3. The 5’RNA-seq data has been
deposited to SRA at NCBI. An interactive genome browser containing all 5’RNAseq data and BbIVET sequences described herein can be found at
www.ucf.edu/research/interactive-genomics/lyme-disease. Supplementary tables
including a complete list of 5’ ends identified in this study with genomic location
and predicted annotation is available online at Nucleic Acids Research.
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Results
5’ End Identification across the B. burgdorferi Transcriptome.
In vivo expression technology (IVET)-based approaches are powerful methods to
identify transcriptionally active sequences, annotated as in vivo expressed (ive)
sequences, in an environment of interest (112). Previously our lab developed IVET
for B. burgdorferi (BbIVET) to identify putative promoters that are active during a
murine infection (117). This approach exploited the use of a promoterless
nicotinamidase, pncA, a gene required for B. burgdorferi survival in the mammalian
host, and a randomized, fragmented B. burgdorferi genomic library (Figure 2–4).
The promoter trap system, after screening through a mouse model of B. burgdorferi
infection, revealed 233 transcriptionally active sequences, herein referred to as B.
burgdorferi in vivo expressed sequences (Bbives). These putative promoters were
sufficient to drive expression of pncA thereby restoring infectivity to a B.
burgdorferi mutant lacking the essential gene. The design of the BbIVET approach
did not uniquely distinguish promoters that are specifically active in the
mammalian host, and a subset of these are likely active both in culture and during
infection. Further, this approach did not include assessment of B. burgdorferi
transcripts that are produced during the tick phase of the enzootic cycle. To
discover candidate genes that are expressed during mammalian infection, these
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sequences were mapped to annotated open reading frames (ORFs) in the B.
burgdorferi B31 genome under the parameter that a Bbive must be found within 300
nts upstream of an annotated start codon. 91 Bbives fell into this category; whereas
unexpectedly, the remaining 61% of the sequences discovered through BbIVET
mapped to genomic locations internal, antisense, or intergenic to ORFs.
Furthermore, given the highly repetitive nature of regions of the B. burgdorferi
genome, 34 Bbives exactly mapped to multiple genomic locations. To indicate these
instances, decimal delegations were assigned to nonspecific Bbives to indicate
every possible genomic location that the sequence may have derived from (e.g.
Bbive149.1 maps to lp25 and Bbive149.2 to lp36 but is the same nucleotide
sequence).
To validate the non-ORF associated promoters, discovered through
BbIVET, and to gain a deeper overall understanding of the B. burgdorferi
transcriptome, we identified genome-wide transcription start sites (TSSs).
Utilization of a 5’ end RNA-seq protocol (5’RNA-seq) defined the TSSs and 5’
processed ends of two biological replicates of B. burgdorferi clone B31 A3 grown to
log phase in culture. Native RNA transcripts contain a triphosphate at the 5’ end,
whereas those that are endogenously processed or degraded have a
monophosphate or hydroxyl group at the 5’ end. These characteristics were
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exploited in our 5’RNA-seq protocol to discriminate between 5’ ends. Samples
were either treated with or without Tobacco Acid Pyrophosphatase (TAP) during
the library preparation. RNA-seq libraries with TAP treatment captured all RNA
5’ ends; whereas, the TAP- libraries captured endogenously processed or
degraded 5’ ends (Figure 2–4).
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Figure 2–4. Simplified overview of B. burgdorferi in vivo expression technology
and 5’RNA deep sequencing.
The general method for determining B. burgdorferi in vivo expressed sequences
(Bbives) utilizes a genomic library screen in mice with a B. burgdorferi clone missing
the infection-essential pncA gene (left column). Specific details of this approach are
outlined in Ellis at el., 2014 (117). 5’RNA-seq exploits use of tobacco acid
pyrophosphatase (TAP) for differential ligation of transcript 5’ ends and
discrimination of transcriptional start sites (TSSs) from processed 5’ ends (right
column). Specific details of this approach are outlined in the Materials and
Methods.
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Illumina sequencing resulted in 265 million, 50 bp single-end reads from
across all four libraries, ranging from 60 to 70 million reads per library. This
theoretically corresponds to a total genomic coverage of about 1900X-2200X. Due
to the highly repetitive nature of some regions of the B. burgdorferi genome, reads
that were not uniquely mapped to a single genomic location were removed. This
resulted in 23 to 42 million reads (749X-1388X coverage) for the main analysis. 5’
ends were then called across libraries and categorized based on the TAP+
enrichment of TSSs, which discovered 6,042 potential TSSs and 30,716 processing
and/or degradation events. An online interactive interface is available to search
the 5’RNA-seq data at www.ucf.edu/research/interactive-genomics/lyme-disease.
Examination of tRNA loci provided validation of our TSS and processedend calling method. 5’ end processing is critical for maturation (125) and as
expected both TSSs and 5’ processed ends were detected for tRNA transcripts.
Furthermore, TSSs identified by 5’RNA-seq were compared to B. burgdorferi TSSs
that were determined by 5’ RACE or primer extension. The 5’RNA-seq identified
TSSs were found to be within three nucleotides of 70% of the previously described
TSSs in B. burgdorferi strain B31 (Table 2–2).
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Table 2–2. Comparison of 5’ RACE/Primer Extension 5’ end Determination and 5’RNA-seq Identified TSSs in B.
burgdorferi B31.

Gene

ORF
Annotationa

5' RACE /
Primer
Extension 5’
end Position

Reference

5'RNA-seq
TSS
Position

Avg.
TAP+
read
countb

Avg.
TAPread
countc

TAP+:TAPRatio

Nucleotide
Position
Difference
(nts)d

ospAe

BB_A15

9,421

(177)

9,421

19421

1407

13.8

0

chbC

BB_B04

3,849

(178)

3,849

1693

28.5

59.4

0

bb0360 operon

BB_0360-0364

368,456

(179)

368,456

3941.5

123.5

31.9

0

antigen IpLA7

BB_0365

374,265

(180)

374,190

1097.5

172.5

6.4
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cheYI operon

BB_0551

561,955

(181)

561,958

1433

55.5

25.8

3

bbb22

BB_B22

19,338

(182)

19,336

3020.5

160.5

18.8

2

bbb23

BB_B23

21,082

(182)

21,080

1609

59.5

27.0

2

bpur

BB_0047

46,423

(183)

46,423

191

60

3.2

0

BB_G29

24,469

24,347

222

BB_G31

26,453

None

BB_G33

28,014

bdrF2 operon

(184)

f

28,017

11

20.18182

122

g

N/A

N/A

N/A

N/A

293.5

25.5

11.5098

3

B. burgdorferi gene annotations with one letter code signifying plasmid amplicon (61, 169).
Average normalized read counts from two biological replicated 5’RNA-seq TAP+ libraries, for a given TSS.
cAverage normalized read counts from two biological replicated 5’RNA-seq TAP- libraries, for a given TSS.
dDifferences in TSS positions from 5' RACE/Primer Extension compared to 5'RNA-seq.
eThe two previously published TSSs for the ospC gene were not included, as these data were acquired using a B. burgdorferi strain other than B31 (185-187).
Nonetheless, the 5’RNA-seq defined TSS for ospC was found to be located one and four nucleotides away from the two previously defined sites of
transcription initiation.
fNo TSS was identified within 300 nucleotides of BB_G31 ORF.
gNot applicable.
a

b
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Furthermore, the 5’RNA-seq library preparation protocol used herein was also
performed in E. coli. These data were compared to E. coli TSSs identified by
Thomason et al., (2015), which used an independent enzyme, Terminator 5´Phosphate-Dependent Exonuclease (TEX) for TSS characterization by 5’RNA-seq
(130). A majority of the TSSs called in our E. coli data set were consistent with the
TSSs identified by Thomason et al. (manuscript in preparation, I.B., M.L., and R.S.).
Together these data provide support for the robustness of our 5’RNA-seq method.
5’ End Identification in Repetitive Genomic Regions
Although all of the data discussed herein are derived from the uniquely mappable
portions of the B31 genome, we acknowledge that there may be a biological
interest in B. burgdorferi genomic regions that contain repetitive sequences. In
addition, it is possible that the exclusion of such sequences from our analysis may
have affected the identification and categorization of the TSSs and processed 5’
ends, both of which, as will be detailed in the following section, were highly
dependent on the local genomic and transcriptional context. Therefore, we added
for reference, an additional analysis of the 5’RNA-seq library that included the 5’
nucleotide reads that mapped to repetitive regions and therefore had a mapping
quality score of zero (MQ0). We analyzed these data to determine TSSs as
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described above and provide the results online at Nucleic Acids Research in
Supplementary Data.
TSS Classification
TSSs were categorized relative to their orientation to annotated sequences through
a systematic classification assignment scheme. Because annotated sequences can
lie adjacent, divergent or convergent and often in close proximity to one another,
our classification scheme did not uniquely sort TSSs into single categories, similar
to previously applied approaches that used automated TSS classification
algorithms (130, 161). Therefore, a TSS could be assigned multiple classifications
(Figure 2–5A). Accounting for overlaps among categories (i.e., counting each TSS
for all categories to which it was assigned), 12% of the TSSs were classified as
primary, 10% as secondary, 13% as antisense, 63% as internal and 2% as orphan
(Figure 2–5B).
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Figure 2–5. Genome-wide identification and characterization of B. burgdorferi
TSSs.
RNA was isolated from log phase B. burgdorferi clone B31 A3, and treated with and
without TAP (tobacco acid phosphatase). (A) Schematic classification of the 6042
TSSs relative to the genome organization. Circled numbers indicate TSSs for each
category. The maximum nucleotide distances from the 5’ and/or 3’ of annotated
sequences, shown as black arrows, for a particular category of TSS are indicated
in red. (B) Graphical representation of the TSS classifications. as, antisense; o,
orphan; p, primary; s, secondary; i, internal. (C) Nucleotide frequency at the -100,
-1, +1 (TSS) and -1 nucleotide positions. A, adenine, T, thymine, G, guanine, C,
cytosine. (D) Consensus motif for promoter regions upstream of primary TSSs.
The nucleotide sequences from -40 to +1 of the 321 identified primary TSSs were
analyzed by MEME 4.11.2. (E) Distribution of 5’ UTR lengths among uniquely
classified primary and secondary TSSs. The data are shown as the percent of
mRNA sequences with a 5’ UTR of each bin length. 0-10 nucleotides (red bar), bin
size of 20 nucleotides, where the number shown is the middle length in each bin
(black bars). (F) Consensus ribosome binding motif for uniquely classified,
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primary 5’ UTRs. MEME 4.11.2 was used to analyze UTR sequences ranging from
10-293 nts in length for a conserved motif, which was found on average to begin 8
nts upstream of the annotated start codon. (G) Northern blot analyses validate a
long 5’ UTR. Total RNA was extracted from mid-log phase spirochetes and
separated by denaturing formaldehyde-agarose gel, blotted to nylon membranes,
and probed with 32P-labeled complementary probes, indicated by red and black
boxes. Genomic context of ORFs BB_0240-BB_0243 (wide black arrows), the
primary TSS (green bent arrow), putative transcripts and their position on the
Northern blot (broken line, green arrows, and marked with designated symbol)
are indicated. Marker sizes in nucleotides are indicated to the left of each blot.
Unique Initiating Nucleotide Usage for B. burgdorferi Transcription
Purine nucleotides are typically the most common initiating nucleotide in bacteria
(188, 189). Surprisingly, in B. burgdorferi cytosine had a similar frequency as
adenine at the +1 position for all TSSs identified in this study. The individual
nucleotide frequencies were measured at 32.2% A, 15.2% T, 20.9% G, and 31.6%
for TSSs despite the A/T-rich (71.8%) nature of the genome (Figure 2–5C and
Figure 2–6). As a comparison, the nucleotide frequency at the -100 position was
found to be 72.2% A + T (Figure 2–5C). This is consistent with the average
nucleotide frequency of 70.5% for all positions 100 nucleotides upstream and
downstream of the TSSs (Figure 2–6A and B). TSSs were found most commonly
flanked by a thymine at the -1 position (69.7%) and an adenine at the +2 position
(51.2%) (Figure 2–5C). Internal TSSs constitute the majority of the TSSs identified
and analysis among different TSS categories separately demonstrated that only the
internal TSSs have the higher G + C nucleotide frequency at the +1 nucleotide. The
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primary, secondary, antisense and orphan +1 nucleotide frequencies were similar
to the genome-wide average (Figure 2–6C-G).
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Figure 2–6. Nucleotide frequencies at positions ±100 nts relative to TSSs.
Nucleotide frequencies were calculated for genomic regions surrounding TSSs
(+1), 5’ to 3’. Nucleotide fractions (fraction) were plotted against TSS relative
positions (pos), where 1.0 fraction is equivalent to 100% frequency of a specific
nucleotide(s). The number of sequences (n) analyzed is indicated at the top of each
panel. In general, orange lines indicate the combined A + T fraction and purple the
combined G + C fraction at each position. Gray horizontal lines plot the calculated
average genome-wide nucleotide frequencies across the chromosome and all
plasmid replicons, A + T (71.8%) and G + C (28.2%). (A) All TSSs combined across
all categories, excludes any TSS that was located proximally to the end of a
plasmid in the B. burgdorferi genome. (B) Single nucleotide frequencies for all TSS
genomic regions -50 to +11 nts. Adenine (red line), Thymine (green line), Guanine
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(blue line) and Cytosine (black line). (C) Primary TSS regions. (D) Secondary TSS
regions. (E) Internal TSS regions. (F) Antisense TSS regions. (G) Orphan TSS
regions.
Identification of σ70 motifs in TSS promoter regions
As both a means of validation and Pribnow box discovery, sequences containing
the +1 nucleotide and corresponding 40 nucleotides upstream of all of the 321
unique primary TSSs (Figure 2–5A) were analyzed for conserved sequence motifs
using MEME 4.11.2 (190). Due to the abundance of A/T nucleotides in the B.
burgdorferi genome, a training set of 100,000 random 41 nucleotide subsequences
from the B31 reference genome was selected for a background control. Not
surprisingly, given that the 5’RNAseq library was generated from logarithmic
phase bacteria, which were expected to be expressing predominately sigma 70dependent transcripts, we detected a 29 bp motif containing a canonical Pribnow
box (beginning on average at the -6 position), in its consensus sequence, upstream
of 320 of the 321 primary TSSs (Figure 2–5D). However, these sequences lacked
strong conservation at the -35 region, which is consistent with observations made
in other bacteria (124, 130, 188). A similar conserved Pribnow sequence was
identified upstream of 88 of the 162 secondary TSSs (54.3%) and 656 of the 734
antisense TSSs (89.4%) (data not shown); these sequences also lacked a conserved
-35 region. In contrast, no conserved sequence motifs were detected upstream of
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the 3,568 unique internal TSSs. However, further analysis of internal TSSs with
high TAP+ read counts (greater than 500) revealed a similar conserved Pribnow
box in 109 out of 266 (41.0%) of these sequences (data not shown).
Leaderless and Long UTRs
Depending on their size and secondary structure, 5’ untranslated regions (UTRs)
may contain important RNA regulatory elements (191-193). Mechanisms of cisregulatory RNAs have yet to be explored in B. burgdorferi. To identify ORFs that
might be controlled by cis-regulatory RNAs we characterized the lengths of the 5’
UTRs associated with uniquely classified primary and secondary TSSs that were
only assigned to a single annotated transcript (on occasion, due to small ORFs, a
primary or secondary TSS was assigned to multiple ORFs and these were excluded
from the analysis). Our data indicated that the median 5’ UTR length in B.
burgdorferi is ~36 nts (Figure 2–5E), which is consistent with what has been
determined for other bacterial species (124, 128, 188, 194, 195). Approximately 19%
of the 5’ UTRs analyzed were less than 10 nts in length and a 29% subset of these
short sequences represented leaderless transcripts with a 5’ UTR length of zero
(Figure 2–5E). Approximately 17% of the 5’ UTRs were found to be between 100
and 293 nts in length, suggesting that these sequences may harbor additional
regulatory functions (Figure 2–5E). The 5’ UTR sequences greater than 10 nts in
72

length, were also analyzed for a ribosome binding site motif using MEME as
previously described (190). A conserved A/G rich, 11 nt sequence was found in
97.6% of the UTRs analyzed. Furthermore, this motif was primarily located near
the ORF, with a median distance of 8 nts upstream of the annotated starts of
translation (Figure 2–5F). Northern blot analyses validated the presence of the 195
nt 5’ UTR upstream the four-gene glp operon. Northern blot probes specific to the
BB_0240 UTR (red probe) and coding (black probe) regions, both revealed a ~4500
nt transcript (Figure 2–5G). These data demonstrated the presence of a large
transcript that included the 195 nt 5’ UTR, consistent with the predicted combined
size of the ORFs contained in glp operon (4300 nts), and several putative internal
transcripts. The UTR probe also detected a small RNA transcript (approximately
195 nts), consistent with the size of the 5’ UTR.
Correlating TSSs with BbIVET putative promoters
The global identification of B. burgdorferi TSSs not only contributed understanding
to the B. burgdorferi transcriptome but resulted in a 5’ end map of the annotated
and un-annotated transcripts expressed by the spirochete during growth in
culture, which could provide further insight into the sequences recovered from
BbIVET. Of the 233 unique Bbive sequences, 119 were found to be associated with
culture-expressed TSSs (Figure 2–7A and Table 2–3), suggesting that these
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promoters are active both in culture and during infection. Bbive-TSSs were
classified into the following categories: 39 primary, 37 secondary, 159 internal, 19
antisense, and 2 orphan (Figure 2–7B). In some cases multiple TSSs were
associated with the same Bbive and some TSSs were classified into multiple
categories.

Figure 2–7. B. burgdorferi in vivo expression technology (BbIVET)-identified
sequences with associated TSSs.
(A) Schematic representation of BbIVET associations with 5’RNA-seq TSSs.
Brackets designate the parameters for the association. Relative orientation of the
genome region (wide black bar with white arrows), Bbive sequence (thin black
arrow), and TSS (orange bent arrow) are indicated. The minimum and maximum
Bbive-TSS association distances were defined as 20 nts from the 5’ end and 6 nts
from the 3’ end of a Bbive sequence. (B) Categorization of Bbives that associate with
5’RNA-seq TSSs.
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Together these data validated the significance of the Bbive sequences located in
previously un-annotated genomic positions. Moreover, the comparative analysis
revealed that 114 Bbives were not associated with any detected TSS from the in
culture derived 5’RNA-seq dataset, suggesting that these sequences may be
primarily active during murine infection.
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Table 2–3. B. burgdorferi in vivo expressed sequences (Bbives) and their associated 5'RNA-seq TSSs.
Associated
5' end
Positions

RNAseq
Category

Avg. TAP+
read count

chr:405219

secondary

128

104071

upstream and internal to BB_0389
internal to BB_0101; upstream and
internal to BB_0102
antisense to BB_0106

113172

112923

upstream BB_0115; internal to BB_0116

No TSS

chr

126914

126720

internal to BB_0131

No TSS

6

chr

137716

137543

internal to BB_0137

chr:137621

internal

244

7

chr

137716

137595

chr:137621

chr

138142

138024

internal
secondary,
internal

244

8
9

chr

139464

139287

internal to BB_0137
upstream BB_0137; upstream and
internal to BB_0138
internal to BB_0140

10

chr

150376

150182

internal BB_0149

chr:150214

internal

96.5

chr:150264

internal

68.5

11

chr

162435

162264

internal BB_0161

chr:162357

internal

34

chr:174219
chr

174322

174174

upstream BB_0171; internal BB_0172

13

chr

178940

178800

upstream and internal to BB_0176;
internal to BB_0177

chr:178835

internal, primary
secondary,
internal
internal

14166.5

12

chr:178908

secondary

40.5

chr:183288

internal, primary
secondary,
internal
secondary,
internal

1324.5

Bbive#

Replicon

5'
Coordinate

3'
Coordinate

1

chr

405241

405085

2

chr

100030

100235

3

chr

103899

4

chr

5

Bbive Location

14

chr

183210

183335

internal to BB_0180; upstream BB_0181

15

chr

219320

219094

upstream BB_0213; internal to BB_0214

76

No TSS
No TSS

chr:138053

480

No TSS

chr:174248

chr:183316
chr:219120

36
32.5

59.5
49.5

Bbive#

Replicon

5'
Coordinate

3'
Coordinate

Bbive Location

Associated
5' end
Positions
chr:219152

RNAseq
Category

Avg. TAP+
read count

internal, primary

1455

chr:227500

internal

164.5

chr:227530

internal

442.5

16

chr

227737

227502

internal to BB_0221

17

chr

236009

235855

internal to BB_0230

chr:235950

internal

83

18

chr

237421

237313

upstream BB_0230; internal to BB_0231

chr:237308

internal, primary

51.5

chr:250892

internal, primary
secondary,
internal
internal

424.5

chr:261581

internal

47.5

chr:261672

internal

2870.5

chr:270945

internal

110.5

chr:295544

internal

73

chr:295594

internal

81724

chr:295630

internal

121

chr:295674

internal

452.5

19

chr

251007

250889

upstream BB_0244; internal to BB_0245

chr:250915
chr:250979

20

chr

106286

106145

upstream BB_0107; internal to BB_0108

21

chr

261734

261563

internal to BB_0253

22

chr

271048

270762

23

chr

279197

279030

25

chr

283812

283675

internal to BB_0259
upstream and internal to BB_0265;
internal to BB_0266
internal to BB_0270

26

chr

295721

295540

internal to BB_0285

40.5
60

No TSS

No TSS
No TSS

27

chr

297910

297672

upstream BB_0287; internal to BB_0288

No TSS

28

chr

301311

301124

internal to BB_0291

chr:301288

internal

149

chr:303446
chr

303555

303331

upstream BB_0293; internal to BB_0294

internal, primary
secondary,
internal

1047.5

29

77

chr:303469

246

Bbive#

Replicon

5'
Coordinate

3'
Coordinate

Bbive Location

Associated
5' end
Positions
chr:303515

RNAseq
Category
secondary,
internal
internal

Avg. TAP+
read count
45.5

30

chr

304887

304682

internal to BB_0295

chr:304826

31

chr

306190

306044

internal to BB_0297

No TSS

32

chr

310452

310243

internal to BB_0301

chr:310308

internal

766.5

33

chr

33539

33373

internal to BB_0035

chr:33467

internal

172.5

chr:334493

internal

40.5

chr:334530

secondary

67.5

chr:334554

secondary

59

chr:334606

secondary

63

chr:334653

primary

5732.5

34

chr

334685

334449

upstream and internal to BB_0327

35.5

35

chr

340869

341114

antisense to BB_0332; upstream
BB_0333

chr:340933

internal

64.5

chr:341084

internal, primary

852

36

chr

341995

341838

antisense BB_0333

No TSS

37

chr

34686

34461

internal to BB_0036

chr:34561

internal

74.5

38

chr

35403

35229

internal to BB_0036

chr:35235

internal

538

40

chr

353620

353763

upstream BB_0344; internal to BB_0345

No TSS

41

chr

360127

359990

internal to BB_0351

chr:359987

internal

893.5

42

chr

366011

365852

upstream BB_0355; internal to BB_0357

chr:365879

internal, primary

5633

43

chr

376955

376857

internal to BB_0368

No TSS

44

chr

377599

377347

internal to BB_0369

No TSS

45

chr

379905

379729

chr:379813

internal

243

46

chr

390393

390215

internal to BB_0370
upstream and internal to BB_0380;
internal to BB_0381

chr:390259

internal

41.5

47

chr

391886

391670

chr:391681

internal

124

chr:391704

internal

125

upstream and internal to BB_0381
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Bbive#

Replicon

5'
Coordinate

3'
Coordinate

Bbive Location

Associated
5' end
Positions
chr:391751

internal

46.5

primary

3928

internal

64.5

primary
secondary,
internal
secondary,
internal
primary

4510

23421

chr:448525

internal

163.5

chr:448549

internal

40

chr:46902

secondary

4242.5

chr:46943

secondary

9684

chr:46979

secondary

2597

chr:47007

secondary

1470.5

chr:47055

secondary

34938

internal, primary
secondary,
internal
internal

336.5

chr

399003

398873

internal to BB_0388

chr:398891

49

chr

432908

432686

internal to BB_0420

No TSS
chr:438308

50

chr

438601

438294

chr:438468
chr:438491
chr:438575

51

lp25

363

490

antisense to BB_E02

52

chr

448608

448490

upstream and internal BB_0429

54

chr

451787

451625

internal to BB_0434

No TSS

55

chr

464158

463999

antisense to BB_0445

No TSS

56

57

chr

chr

47076

478651

46898

upstream BB_0048

478517

internal to BB_0458

504338

internal to BB_0494; upstream and
internal to BB_0495

chr

504119

35

No TSS

chr:504282
chr:504310

79

164.5

No TSS

chr:504139
58

Avg. TAP+
read count

chr:391852
48

upstream BB_r02; upstream and
internal to BB_r03; internal to BB_r04

RNAseq
Category

65
49

3'
Coordinate

Bbive Location

Associated
5' end
Positions
chr:504733

Bbive#

Replicon

5'
Coordinate

59

chr

504689

504815

internal to BB_0495; upstream and
internal to BB_496

60

chr

510111

510324

internal to BB_0504

RNAseq
Category

Avg. TAP+
read count

chr:510154

secondary,
internal
internal

382.5

chr:510239

internal

37

chr:510289

internal

1779

primary

2656.5

41.5

61

chr

518278

518398

internal to BB_0512

No TSS

62

chr

53636

53475

upstream BB_0057; internal to BB_0058

chr:53494

63

chr

53984

53867

internal to BB_0058

No TSS

64

chr

544768

544618

antisense to BB_0536

No TSS

65

chr

561996

561865

upstream and internal to BB_0551

chr:561958

primary

1433

chr:570111

internal

37

chr:570159

internal

70

chr:570181

internal

146

chr:570222

internal

408.5

chr:575836

primary

246

chr:584185

primary

7076.5

chr:59223

internal, primary
antisense,
primary
internal

43.5

internal
antisense,
internal
antisense,
primary

44

66

chr

570082

570221

67

chr

575943

575830

68

chr

584337

584167

69

chr

59263

59054

71

chr

611014

611128

internal to BB_0558

upstream and internal to BB_0562
upstream and internal to chr.tRNA27LeuCCA; internal to BB_0571
upstream BB_0063; internal to BB_0064
antisense to BB_0591; upstream to
BB_0592

chr:611129
chr:620673

72

chr

620640

620992

internal to BB_0597

chr:620710
chr:620983

73

chr

645603

645737

upstream and internal to BB_0619

80

chr:645671

30.5
36

72.5
15130.5

Bbive#

Replicon

5'
Coordinate

3'
Coordinate

Bbive Location

74

chr

647805

647932

antisense to BB_0620

75

lp38

34759

34583

76

chr

659537

659884

77

chr

706476

706346

upstream and internal to BB_J46
internal to BB_0628; antisense to
BB_0629
antisense to BB_0668

78

chr

711340

711500

internal to BB_0672

79

chr

712960

712851

internal to BB_0674

Associated
5' end
Positions
chr:647833

RNAseq
Category

Avg. TAP+
read count

antisense

194

antisense

362

chr:711413

internal

247

chr:711438

internal

178

chr:712845

internal

105.5

chr:712781

antisense

218

chr:712871

antisense
secondary,
internal

170.5

internal

95.5

No TSS
chr:659711
No TSS

80

chr

712743

712960

antisense to BB_0674

81

chr

225040

224824

upstream BB_0219; internal to BB_0220

chr:224987

82

chr

721764

721561

antisense to BB_0681

No TSS

83

chr

728008

728203

No TSS

84

chr

737190

737390

internal to BB_0686
internal to BB_0696; upstream and
internal to BB_0697

85

chr

740345

740463

internal to BB_0703; upstream and
internal to BB_0704; upstream BB_0705

chr:737344
chr:740379
chr:740445

secondary,
internal
secondary

31

50
59

chr:745984

internal

61.5

chr:746049

internal, primary

1582.5

antisense to BB_0714

chr:751257

antisense

1165

764917

internal to BB_0726

No TSS

780259

780478

internal to BB_0738

chr:780380

internal

43.5

chr

786006

786173

internal to BB_0743

No TSS

chr

792538

792699

internal to BB_0749

chr:792612

internal

35

86

chr

745852

746090

internal to BB_0709; upstream BB_0710

87

chr

751413

751254

88

chr

764794

89

chr

91
92

81

Bbive#

Replicon

93

chr

795489

795209

internal to BB_0752

94

lp28-3

14091

13862

internal to BB_H20

No TSS

95

chr

83183

82975

96

chr

842441

842591

internal to BB_0087
internal to BB_0798; upstream and
internal to BB_0799

97

chr

84464

3'
Coordinate

Bbive Location

Associated
5' end
Positions
chr:795311

5'
Coordinate

84265

internal to BB_0088

RNAseq
Category

Avg. TAP+
read count

internal

50.5

internal

505.5

chr:83086

internal

65.5

chr:842489

primary

3879

chr:84277

internal

46.5

chr:84370

internal

34567.5

chr:84410

internal

75.5

chr:843552

internal

1106

chr:843604

internal

42.5

chr:795388

98

chr

843477

843633

internal to BB_0800

chr:843633

internal

38

99

chr

851547

851815

internal to BB_0806

chr:851804

internal

91

100

cp26

13502

12873

antisense to BB_B16

cp26:12981

antisense

46

cp26:14373

internal

33

cp26:14396

internal

69

cp26:14435

internal

34

cp26:14476

internal

42

cp26:18957

internal

105

cp26:18992

internal

40.5

internal

774

101

102

cp26

14547

14314

cp26

19040

18934

internal to BB_B17

internal to BB_B22

104

cp26

20320

20224

internal to BB_B23

cp26:20219

108.1

cp32-1

6352

6233

antisense to BB_P10

No TSS

108.2

cp32-3

6352

6233

antisense to BB_S10

No TSS

108.3

cp32-4

6363

6243

antisense to BB_R10

No TSS

108.4

cp32-6

6360

6240

antisense to BB_M10

No TSS

108.5

cp32-7

6352

6232

antisense to BB_O10

No TSS

82

Bbive#

Replicon

5'
Coordinate

108.6

cp32-9

6368

6249

antisense to BB_N10

Associated
5' end
Positions
No TSS

108.7

cp32-8

6352

6233

antisense to BB_L10

No TSS

108.8

lp56

9823

9703

antisense to BB_Q17

No TSS

109.1

cp32-3

796

950

internal to BB_S01

No TSS

109.2

cp32-8

796

950

internal to BB_L01

No TSS

109.3

cp32-6

796

950

internal to BB_M01

No TSS

109.4

cp32-1

796

950

internal to BB_P01

No TSS

109.5

cp32-4

796

950

internal to BB_R01

No TSS

109.6

lp56

34603

34759

internal to BB_Q51

No TSS

109.7

cp32-7

807

949

internal to BB_O01

No TSS

109.8

cp32-9

799

953

internal to BB_N01

No TSS

110.1

cp32-3

14141

13809

antisense to BB_S21

No TSS

110.2

cp32-1

14141

13809

antisense to BB_P21

No TSS

110.3

cp32-4

14094

13762

antisense to BB_R21

No TSS

110.4

cp32-6

14160

13828

antisense to BB_M21

No TSS

110.5

cp32-7

14148

13816

antisense to BB_O21

No TSS

110.6

cp32-8

14107

13809

antisense to BB_L21

No TSS

110.7

lp56

17640

17308

antisense to BB_Q28

No TSS

110.8

cp32-9

14240

13907

antisense to BB_N21

No TSS

120.1

cp32-6

28191

28347

internal to BB_M41; upstream BB_M42

No TSS

120.2

cp32-1

29103

29259

internal to BB_P41; upstream BB_P42

No TSS

120.3

cp32-8

29238

29394

internal to BB_L42; upstream BB_L43

No TSS

120.4

cp32-9

29004

29160

internal to BB_N42; upstream BB_N43

No TSS

120.5

cp32-4

28652

28808

internal to BB_R44; upstream BB_R45

No TSS

120.6

cp32-7

29153

29309

internal to BB_O43; upstream BB_O44

No TSS

3'
Coordinate

Bbive Location

83

RNAseq
Category

Avg. TAP+
read count

Associated
5' end
Positions
No TSS

Replicon

5'
Coordinate

3'
Coordinate

Bbive Location

120.7

lp56

32160

32316

internal to BB_Q49; upstream BB_Q50

120.8

cp32-3

28576

28732

No TSS

125.1

cp32-7

3271

3387

125.2

cp32-3

3272

3388

125.3

cp32-8

3272

3388

125.4

cp32-1

3272

3388

130.1

cp32-8

28906

29055

internal to BB_S44; upstream BB_S45
internal BB_O04; upstream and
internal to BB_O05
internal BB_S04; upstream and internal
to BB_S05
internal BB_L04; upstream and
internal to BB_L05
internal BB_P04; upstream and
internal to BB_P05
upstream and internal to BB_L42

130.2

cp32-1

28771

28920

upstream and internal to BB_P41

No TSS

130.3

cp32-6

27857

28008

upstream and internal to BB_M41

No TSS

130.4

cp32-3

28245

28393

internal to BB_S44

No TSS

133.1

cp32-8

7564

7618

internal to BB_L11; upstream BB_L12

No TSS

133.2

cp32-6

7574

7628

internal to BB_M11; upstream BB_M12

No TSS

133.3

cp32-3

7564

7618

internal to BB_S11; upstream BB_S12

No TSS

133.4

cp32-1

7564

7618

internal to BB_P11; upstream BB_P12

No TSS

133.5

lp56

11034

11088

internal to BB_Q18; upstream BB_Q19

No TSS

133.6

cp32-7

7566

7620

internal to BB_O11; upstream BB_O12

No TSS

133.7

cp32-9

7580

7634

internal to BB_N11; upstream BB_N12

No TSS

133.8

cp32-4

7574

7628

internal to BB_R11; upstream BB_R12

136.1

cp32-9

27859

28022

upstream BB_N41

136.2

lp56

31007

31162

upstream BB_Q48

No TSS
cp329:28019
No TSS

136.3

cp32-8

28096

28242

upstream BB_L41

No TSS

Bbive#

84

RNAseq
Category

Avg. TAP+
read count

primary

181.5

No TSS
No TSS
No TSS
No TSS
No TSS

3'
Coordinate

Bbive Location
upstream BB_P40

Associated
5' end
Positions
No TSS

Bbive#

Replicon

5'
Coordinate

136.4

cp32-1

27961

28107

139

lp36

16469

16415

antisense BB_K24

No TSS

141

lp17

13280

13631

upstream and internal to BB_D21

No TSS

142

lp21

3775

3428

antisense to BB_U05

144

lp25

14417

14099

internal to BB_E21

145

lp25

14828

14415

upstream and internal to BB_E21

RNAseq
Category

Avg. TAP+
read count

lp21:3463

antisense

36

lp25:14168

internal

34.5

lp25:14488

internal

41.5

lp25:14512

internal

2403

lp25:14540

primary

57.5

primary

114.5

primary

712.5

internal

93.5

antisense

81

147

lp25

490

359

antisense to BB_E02

No TSS

148

lp25

6534

6375

upstream and internal to BB_E07

lp25:6414

149.1

lp25

675

801

antisense to BB_E02

No TSS

149.2

lp36

1569

1685

internal to BB_K02a

No TSS

150

lp28-2

13618

13801

antisense to BB_G17

No TSS

151.1

lp28-2

67

173

upstream and internal to BB_G01

No TSS

151.2

lp36

139

244

upstream and internal to BB_K01

152

lp28-3

10700

10518

upstream BB_H13

No TSS
lp283:10536

154

lp28-3

25397

25203

156

lp28-4

14612

14718

intergenic between BB_H36b and
BB_H37
intergenic between BB_I22 and BB_I26

157

lp38

3661

3500

antisense to BB_J05

No TSS

158

lp36

1638

1400

antisense to BB_K02a

lp36:1597

159

lp36

21069

20845

No TSS

160.1

lp36

21976

21735

antisense to BB_K32
antisense to BB_K33; antisense to
BB_K34

85

No TSS
No TSS

lp36:21733

3'
Coordinate

Associated
5' end
Positions

RNAseq
Category

Avg. TAP+
read count

lp28-1:8210

antisense

95.5

primary

845.5

orphan

58.5

antisense

54.5

Bbive#

Replicon

5'
Coordinate

160.2

lp28-1

8453

8212

161.1

lp36

22487

22675

161.2

lp28-1

11609

11421

162

lp36

29333

29202

antisense to BB_F14a; antisense to
BB_F16
intergenic between BB_K35 and
BB_K37
intergenic between BB_F19a and
BB_F23
upstream and internal to BB_K46

163.1

lp36

31737

31868

antisense to BB_K49

No TSS

163.2

lp36

29385

29518

No TSS

164

lp36

4524

4613

166

lp36

6677

6795

167

lp38

15191

14910

168

lp38

17791

18025

antisense to BB_K47
intergenic between BB_K02a and
BB_K07
intergenic between BB_K09 and
BB_K10
intergenic between BB_J20 and
BB_J0058
internal to BB_J24; upstream BB_J25

169

lp38

18995

19160

internal to BB_J25; upstream BB_J26

No TSS

170

lp38

21243

21057

antisense BB_J27; internal BB_J28

lp38:21082

171

lp38

28404

28286

internal to BB_J37; upstream BB_J36

No TSS

172

lp38

28888

29037

intergenic between BB_J37 and BB_J41

No TSS

174.1

lp5

469

367

antisense to BB_T01

No TSS

174.2

lp21

458

356

antisense to BB_U01

No TSS

174.3

lp28-4

448

346

antisense to BB_I01

No TSS

175

lp54

23682

23860

upstream BB_A36

No TSS

177.1

lp56

15710

15406

antisense to BB_Q25

No TSS

177.2

cp32-9

11769

12005

internal to BB_N17; upstream BB_N18

No TSS

177.3

cp32-8

11680

11916

internal to BB_L17; upstream BB_L18

No TSS

Bbive Location

86

No TSS
No TSS
lp36:29262

No TSS
No TSS
lp38:15112
No TSS

Bbive#

Replicon

5'
Coordinate

177.4

cp32-3

11680

11916

internal to BB_S17; upstream BB_S18

Associated
5' end
Positions
No TSS

177.5

cp32-1

11680

11916

internal to BB_P17; upstream BB_P18

No TSS

177.6

cp32-4

11624

11860

internal to BB_R17; upstream BB_R18

No TSS

177.7

cp32-6

11690

11926

internal to BB_M17; upstream BB_M18

No TSS

180.1

lp56

19176

19063

antisense to BB_Q31

No TSS

180.2

cp32-4

15630

15517

antisense to BB_R24

No TSS

180.3

cp32-3

15675

15562

antisense to BB_S24

No TSS

180.4

cp32-1

15678

15565

antisense to BB_P24

No TSS

180.5

cp32-9

15775

15662

antisense to BB_N24

No TSS

180.6

cp32-8

15678

15565

antisense to BB_L24

No TSS

180.7

cp32-6

15694

15581

antisense to BB_M24

No TSS

180.8

cp32-7

15685

15572

antisense to BB_O24

No TSS

181.1

lp56

2230

2057

antisense to BB_Q04

No TSS

181.2

lp36

34634

34807

No TSS

182

lp56

25247

25330

186

lp56

42715

42568

antisense to BB_K52
internal to BB_Q40; upstream and
internal to BB_Q41
internal to BB_Q67

lp56:42648

188.1

lp56

51193

51058

upstream BB_Q84.1; internal BB_Q85

No TSS

188.2

lp17

1746

1881

internal to BB_D04

No TSS

189.1

lp56

52852

52717

upstream BB_Q88; upstream BB_Q89

No TSS

189.2

lp28-3

148

283

upstream BB_H02

No TSS

189.3

lp17

87

222

upstream and internal to BB_D001

No TSS

191

chr

7828

7692

upstream BB_0006; internal to BB_0007

chr:7719

192

chr

13876

13754

No TSS

193

chr

29691

29590

antisense to BB_0014
upstream BB_0031; antisense to
BB_0032

3'
Coordinate

Bbive Location

87

RNAseq
Category

Avg. TAP+
read count

internal

120.5

internal

37.5

No TSS

No TSS

Bbive#

Replicon

5'
Coordinate

3'
Coordinate

Bbive Location

194

chr

32573

32438

internal to BB_0035

195

chr

38475

38363

upstream BB_0038; internal to BB_0039

196

chr

78607

78466

197

chr

78153

198

chr

202

chr

Associated
5' end
Positions
No TSS

RNAseq
Category

Avg. TAP+
read count

chr:38374

internal, primary

42.5

chr:38447

internal

96

internal to BB_0082

chr:78568

internal

112

78468

antisense to BB_0082

No TSS

107394

107255

internal to BB_0109

chr:107333

internal

36.5

chr:111976
111912

upstream BB_0113; internal to BB_0114

internal, primary
secondary,
internal
secondary,
internal
secondary,
internal
internal, primary

118.5

112032

6712.5

chr:334995

internal

79.5

chr:335023

internal

154

chr:335063

internal

73

chr:112008
chr:146506

203

chr

146679

146509

upstream BB_0145; internal to BB_0146

204

chr

325394

325251

upstream BB_0318; internal to BB_0319

chr:146520
chr:146579

205

chr

334970

335194

internal to BB_0328

49
99
99

No TSS

206

chr

363137

362945

internal to BB_0353

No TSS

207

chr

370504

370378

antisense to BB_0362

chr:370386

antisense

385

208

chr

388977

388758

upstream and internal to BB_0379;
internal to BB_0380

chr:388893

internal

71

chr:388928

secondary

32

210

chr

412003

411877

internal to BB_0400

No TSS

211

chr

442064

441820

No TSS

212

chr

447655

447869

internal to BB_0421
antisense to BB_0427; upstream and
internal to BB_0428

antisense,
primary

4119.5

88

chr:447819

Bbive#

Replicon

213

chr

463318

463469

internal to BB_0444

214

chr

473092

473209

internal to BB_0453

No TSS

215

chr

499656

499378

No TSS

217

chr

500353

500590

218

chr

502436

502255

antisense to BB_0483
internal to BB_0484; upstream and
internal to BB_0485
antisense to BB_0490

219

chr

508623

3'
Coordinate

Bbive Location

Associated
5' end
Positions
chr:463342

5'
Coordinate

508883

internal to BB_0502; upstream and
internal to BB_0503

220

chr

509282

509444

upstream and internal to BB_0504

221

chr

572779

572924

222

chr

580320

580503

antisense to BB_0560
internal to BB_0567; upstream and
internal to BB_0568

chr:463409

chr

590246

590503

224

chr

612239

612017

225

chr

649896

649696

227

chr

681072

680959

upstream and internal to BB_0577

antisense to BB_0592; antisense to
BB_0593
internal to BB_0622
internal to BB_0642
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Avg. TAP+
read count

internal

35.5

internal

35.5

No TSS
No TSS

chr:509306

secondary,
internal
secondary,
internal
secondary

chr:509357

internal

chr:508750
chr:508787

32.5
31.5
35
45

chr:509438

internal

122

chr:572894

antisense

1627.5

chr:580486

primary

302

chr:590434

secondary,
antisense
internal

chr:590456

internal

109

chr:680968

internal

2767

chr:681006

internal

79

chr:681051

internal

75

chr:590306
223

RNAseq
Category

47.5
50

No TSS
No TSS

3'
Coordinate

Bbive Location
antisense to BB_0647

Associated
5' end
Positions
No TSS

Bbive#

Replicon

5'
Coordinate

RNAseq
Category

Avg. TAP+
read count

228

chr

686043

686310

231

chr

689233

689127

antisense to BB_0649

No TSS

232

chr

700974

700767

upstream and internal to BB_0660

chr:700860

internal

30.5

233

chr

715713

715978

internal to BB_0677

chr:715861

internal

38.5

235

chr

734479

734357

antisense to BB_0693

No TSS

236

chr

735383

735622

internal to BB_0694

chr:735527

internal

106

237
238

chr

795487

795609

antisense to BB_0752

No TSS

lp25

10756

10921

upstream BB_E17

No TSS

239

chr

891768

891983

internal to BB_0837

chr:891984

internal

293.5

240

cp26

23167

23062

upstream and internal to BB_B27

cp26:23059

internal

544

241

cp26

758

521

upstream and internal to BB_B02

No TSS

242.1

lp56

25942

26001

internal to BB_Q42

No TSS

242.2

cp32-9

22233

22295

internal to BB_N34

No TSS

242.3

cp32-4

21981

22085

internal to BB_R35

242.4

cp32-1

22183

22242

internal to BB_P34

internal

50

243.1

cp32-4

25187

25017

antisense to BB_R38

No TSS
cp321:22242
No TSS

243.2

cp32-3

26046

25876

internal to BB_S40

No TSS

243.3

cp9

7231

7393

internal to BB_C11

No TSS

243.4

lp56

29276

29106

No TSS

244.1

cp32-4

3057

3395

244.2

cp32-9

3060

3398

244.3

cp32-6

3054

3392

internal to BB_Q45
internal to BB_R04; upstream and
internal to BB_R05
internal to BB_N04; upstream and
internal to BB_N05
internal to BB_M04; upstream and
internal to BB_M05
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No TSS
No TSS
No TSS

Bbive#

Replicon

5'
Coordinate

3'
Coordinate

244.4

lp56

6586

6855

244.5

cp32-8

3052

3388

244.6

cp32-3

3052

3388

244.7

cp32-7

3051

3387

244.8

cp32-1

3052

3388

244.9

lp56

36866

36938

246

chr

665102

664984

248.1

cp32-8

364

248.2

cp32-6

248.3
248.4

Bbive Location
internal to BB_Q11; upstream and
internal to BB_Q12
internal to BB_L04: upstream to
BB_L05
internal to BB_S04: upstream to
BB_S05
internal to BB_O04; upstream BB_O05

Associated
5' end
Positions
No TSS
No TSS
No TSS
No TSS
No TSS

268

internal to BB_P04; upstream BB_P05
internal to BB_Q54; antisense to
BB_Q55
upstream and internal to BB_0632;
internal to BB_0633
antisense to BB_L01

364

268

antisense to BB_M01

No TSS

cp32-4

364

268

antisense to BB_R01

No TSS

cp32-3

364

268

antisense to BB_S01

No TSS

248.5

cp32-1

364

268

antisense to BB_P01

No TSS

248.6

cp32-9

364

268

antisense to BB_N01

No TSS

248.7

cp32-7

363

267

antisense to BB_O01

No TSS

248.8

lp56

34171

34075

antisense to BB_Q51

No TSS

249.1

cp32-8

28602

28772

internal to BB_L41; upstream BB_L42

No TSS

249.2

cp32-1

28467

28637

internal to BB_P40; upstream BB_P41

No TSS

249.3

lp56

31522

31689

internal to BB_Q48; upstream BB_Q49

No TSS

251

lp28-3

21574

21393

antisense to BB_H32

No TSS

252

lp28-1

7115

7262

No TSS

253

lp28-3

11555

11402

antisense to BB_F13; upstream BB_F14
intergenic between BB_H13 and
BB_H17
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No TSS
No TSS
No TSS

No TSS

RNAseq
Category

Avg. TAP+
read count

Bbive#

Replicon

5'
Coordinate

257

chr

552858

552741

antisense to BB_0542

Associated
5' end
Positions
chr:552739

3'
Coordinate

Bbive Location

258

lp28-4

13387

13521

internal to BB_I22

No TSS

259.1

lp28-4

8342

8475

internal to BB_I16

No TSS

259.2

lp28-4

17235

17173

antisense to BB_I28

No TSS

260

lp28-4

9319

9419

intergenic between BB_I16 and BB_I18

No TSS

261

lp17

14249

14344

No TSS

262

lp36

19551

19389

263.1

lp36

22777

22673

lp36:22708

263.2

lp28-1

11319

11423

266.1

lp38

22884

23004

internal to BB_D22
intergenic between BB_K56 and
BB_K32
intergenic between BB_K35 and
BB_K37
intergenic between BB_F19a and
BB_F23
internal to BB_J29

266.2

lp38

32016

32136

internal to BB_J43

No TSS

268.1

lp38

33448

33711

intergenic between BB_J45 and BB_J46

No TSS

268.2

lp38

24315

24578

intergenic between BB_J31 and BB_J34

No TSS

269

lp38

38647

38500

upstream and internal to BB_J51

lp38:38594

270.1

lp38

567

431

intergenic

No TSS

270.2

lp25

22593

22729

antisense to BB_E31

No TSS

270.3

lp28-4

21503

21589

No TSS

271

lp38

14715

14878

272.1

lp56

15094

15173

antisense to BB_I34
intergenic between BB_J20 and
BB_J0058
internal to BB_Q24; upstream BB_Q25

272.2

cp32-9

11693

11772

internal to BB_N17; upstream BB_N18

No TSS

272.3

cp32-8

11604

11683

internal to BB_L17; upstream BB_L18

No TSS

272.4

cp32-6

11614

11693

internal to BB_M17; upstream BB_M18

No TSS
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RNAseq
Category

Avg. TAP+
read count

antisense

113.5

orphan

31

primary

50.5

No TSS

No TSS
No TSS

No TSS
No TSS

Bbive#

Replicon

5'
Coordinate

272.5

cp32-3

11604

11683

internal to BB_S17; upstream BB_S18

Associated
5' end
Positions
No TSS

272.6

cp32-1

11604

11683

internal to BB_P17; upstream BB_P18

No TSS

272.7

cp32-4

11548

11627

internal to BB_R17; upstream BB_R18

No TSS

273

274

chr

chr

110572

111305

3'
Coordinate

110162

110939

Bbive Location

internal to BB_0111

upstream and internal to BB_0111;
internal to BB_0112

RNAseq
Category

Avg. TAP+
read count

chr:110180

internal

34

chr:110382

internal

253

chr:110521

internal

105.5

chr:110547

internal

103.5

chr:110975

internal

54

chr:111004

38.5

chr:282329

internal
secondary,
internal
internal

chr:282423

internal

71.5

chr:282450

internal

65.5

chr:282497

internal

39.5

internal

44.5

chr:111054

37.5
42.5

275

chr

282541

282297

internal to BB_0269

276

chr

290306

290165

upstream BB_0277; internal to BB_0278

No TSS

277

chr

325934

325799

internal BB_0319

chr:325847

279

chr

363370

363199

internal to BB_0353

No TSS

280

chr

378214

378049

internal to BB_0369

No TSS

281

chr

379570

379382

upstream BB_0369; internal to BB_0370

chr:379430

internal, primary

36

chr:398549

internal

118

282

chr

398703

398533

internal to BB_0388

chr:398621

internal

65

chr:398673

internal

265.5

283

chr

414474

414311

antisense to BB_0401; internal to
BB_0402
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No TSS

Bbive#

Replicon

5'
Coordinate

284

chr

515859

515734

285

chr

519563

519746

286

chr

758586

3'
Coordinate

758899

Bbive Location
antisense to BB_0509; antisense to
BB_0511
internal to BB_0512
internal to BB_0720

Associated
5' end
Positions

RNAseq
Category

Avg. TAP+
read count

chr:758670

internal

31.5

chr:758707

internal

42.5

chr:758796

internal
secondary,
internal
internal, primary
secondary,
internal

892.5

chr:752249

internal

2415

chr:752319

internal

36

chr:752384

internal

39

chr:817145

internal

506

chr:817186

primary

2474

internal

40

No TSS
No TSS

chr:632189
287

chr

632133

632297

internal to BB_0606, upstream BB_0607

chr:632219
chr:632247

288

289

chr

chr

724071

752138

724174

antisense to BB_0682; upstream
BB_0683

752448

internal to BB_0714; upstream and
internal to BB_0715

55
48

No TSS

290

chr

817227

817086

upstream and internal to BB_0775

291

chr

828305

828589

internal to BB_0790

chr:828327

292

cp32-6

21817

22010

internal to BB_M33; upstream BB_M34

No TSS

293.1

cp32-7

14000

13816

antisense to BB_O21

No TSS

293.2

lp56

17492

17308

antisense to BB_Q28

No TSS

293.3

cp32-9

14091

13907

antisense to BB_N21

No TSS

293.4

cp32-8

13993

13809

antisense to BB_L21

No TSS

293.5

cp32-4

13946

13762

antisense to BB_R21

No TSS

293.6

cp32-3

13993

13809

antisense to BB_S21

No TSS
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33.5

Bbive#

Replicon

5'
Coordinate

293.7

cp32-6

14012

13828

antisense to BB_M21

Associated
5' end
Positions
No TSS

293.8

cp32-1

13993

13809

antisense to BB_P21

No TSS

294.1

cp32-7

23948

24139

internal to BB_O35

No TSS

294.2

cp32-6

24054

24245

internal to BB_M35

No TSS

294.3

cp32-8

24179

24370

internal to BB_L36

No TSS

294.4

cp32-1

24044

24235

internal to BB_P35

No TSS

294.5

lp56

27734

27925

internal to BB_Q43

No TSS

294.6

cp32-9

24007

24198

internal to BB_N35

No TSS

294.7

cp32-3

24504

24695

internal to BB_S38

No TSS

294.8

cp32-4

23644

23835

internal to BB_R36

No TSS

295.1

cp32-8

15029

15196

internal to BB_L22; upstream BB_L23

No TSS

295.2

cp32-7

15036

15203

internal to BB_O22; upstream BB_O23

No TSS

295.3

cp32-1

15029

15196

internal to BB_P22; upstream BB_P23

No TSS

295.4

cp32-3

15026

15193

internal to BB_S22; upstream BB_S23

No TSS

295.5

cp32-6

15045

15212

internal to BB_M22; upstream BB_M23

No TSS

295.6

cp32-4

14982

15148

internal to BB_R22; upstream BB_R23

No TSS

296.1

cp32-4

23352

23228

antisense to BB_R36

No TSS

296.2

cp9

8683

8807

No TSS

297

lp25

10324

10153

299

lp38

15074

15191

antisense to BB_C12
upstream and internal to BB_E16;
internal to BB_E17
upstream BB_J0058

300

lp38

26452

26727

intergenic between BB_J34 and BB_J36

lp38:26473

3'
Coordinate

Bbive Location
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RNAseq
Category

Avg. TAP+
read count

antisense

49

No TSS
No TSS

Validation of BbIVET-Associated Transcripts
Fifty-one percent of the Bbives were associated to TSSs discovered by 5’RNA-seq,
indicating that these transcripts are expressed both in culture and in the
mammalian host. Although some of these sequences may provide housekeeping
functions, the finding that a large percentage of the Bbives fall into this category
does not exclude the possibility that these promoters, and the transcripts that they
control, contribute to B. burgdorferi pathogenesis. Indeed 5’RNA-seq identified
TSSs for a number of genes known to be critical for B. burgdorferi infectivity
including ospC, bosR, and vlsE (145). Validation of a subset of Bbive-TSSs was
carried out using Northern blot analyses and promoter fusion assays. Bbive45 is an
intragenic sequence that maps within the chromosomal gene BB_0370 and is
associated with an internal TSS and proximal to two processed 5’ ends (Figure 2–
8A and Table 2–3). Northern blot analysis using an oligonucleotide probe
complementary to the sequence downstream of both the internal TSS and the
processed 5’ ends revealed an ~500 nt transcript, which could be attributed to one
or more of these 5’ ends (Figure 2–8B, black probe). In contrast, this transcript was
absent when a probe targeted against sequence upstream of the three 5’ ends was
used (Figure 2–8B, red probe). Of note, bacterial transcriptomes are complex as a
result of compact gene organization as well as overlapping and antisense
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orientated transcript expression (196). As expected due to this complexity,
additional transcripts were also detected in these Northern blots, which may
represent the ~1.2 kb BB_0370 ORF itself and/or additional read-through
transcripts initiated further upstream.

Figure 2–8. Validation of BbIVET-associated RNA transcripts.
(A) Deep-sequencing screen shot for a Bbive-internal TSS, displaying only the
sequenced 5’ nucleotide, of overlaid biological replicates treated with (TAP+) and
without (TAP-) tobacco acid pyrophosphatase. Read count ranges are shown in
the upper left of each frame. The chromosome nucleotide coordinates, relative
orientation of the BB_0370 ORF (wide black bar), Bbive45 sequence (thin black
arrow), internal TSS (blue bent arrow), processed 5’ ends (scissors), putative
transcripts (broken line arrows), Northern probe locations (black and red boxes),
and luciferase fusion regions (brackets) are indicated. The predicted transcripts of
interest are marked with an asterisk. (B) Northern blot analyses of the Bbive45
internal TSS, as described in the Figure 2–5 legend. Probes located upstream (red)
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and downstream (black) of the putative internal TSS, are indicated. Marker
nucleotide sizes are indicated to the left of the blots. (C) Bbive45 promoter activity
and specificity. B. burgdorferi clones harboring specific promoter fusions were
grown to mid-log phase, and incubated with 750 µM D-luciferin. Relative
luciferase units (RLU) were normalized to cell density by OD600. Data represent
the mean ±SD from three biological replicates shown in log scale and were
analyzed relative to pJSB161 with the two-tailed Student’s t-test. Unless otherwise
indicated all fusion constructs demonstrated significantly greater RLUs than the
promoterless control, pJSB161 (p ≤ 0.01). n.s., not significantly greater RLU relative
to pJSB161. (D) Schematic representation of Bbive luciferase fusions. The bracket
designates the sequence selected for promoter fusion to luciferase in pJSB161.
Relative orientation of the genome region (wide black bar with white arrows), 5’
boundary of Bbive sequence (orange line), and TSS (orange bent arrow) are
indicated. (E) A variety of Bbives with associated TSSs have promoter activity in
culture. Spirochetes containing control promoters (flaBp, ospCp and ospAp) and
specific Bbives, fused to luciferase, were grown to mid-log phase, and analyzed as
described above.
The DNA sequence located directly upstream of a TSS is expected to
function as a promoter and initiate transcription, while the sequence directly
upstream of a processed end should not. To validate the ability of 5’RNA-seq to
distinguish TSSs and processed 5’ ends, as well as confirm the ability of Bbive45 to
function as a promoter, the promoter activities of sequences upstream of the
internal TSS or the processed 5’ ends in BB_0370 were measured using luciferase
transcriptional fusions. Upstream regions of the internal TSS or the dominant
processed 5’ end were cloned in front of the promoterless, B. burgdorferi codon
optimized firefly luciferase gene, in the B. burgdorferi shuttle vector pJSB161 (174).
This generated promoter fusions Bbive45:luc and Bbive45proc:luc, respectively
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(Figure 2–8A). The Bbive45:luc fusion, which carries the putative promoter for the
internal TSS of interest, demonstrated a significant increase in luciferase activity
relative to the promoterless reporter gene (Figure 2–8C). These data indicated that
this sequence functions as a promoter albeit to a lesser extent than the B. burgdorferi
promoter for the constitutive flagellar gene flaB. In contrast, the Bbive45proc:luc
construct did not exhibit any detectable promoter activity (Figure 2–8C). Together
these data support the ability of 5’RNA-seq to identify and distinguish TSSs and
processed 5’ ends and confirm a BbIVET identified sequence functions as a
promoter.
The luciferase transcriptional fusion validation approach was expanded to
a larger subset of Bbive-TSSs. DNA including the Bbive sequence to the TSS (Figure
2–8D), for 5 Bbives were fused to luciferase in pJSB161. Bbive12, 74, 76, 86, and 203
were found to be associated with TSSs, which were classified as primary, internal,
or antisense (Table 2–4). The activities of the Bbive promoters were compared to
that of the known constitutive flaB promoter and two environmentally regulated
control promoters, ospAp and ospCp. The genes encoding for the critical virulence
proteins, outer surface protein A (OspA) and outer surface protein C (OspC),
demonstrate inverse patterns of expression during the infectious cycle of B.
burgdorferi (99, 146, 147). The ospA gene displays low expression in the mammalian
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host and high expression in culture and the unfed tick. In contrast, ospC exhibits
high expression during mammalian infection and low expression in culture (117)
and the unfed tick. All five Bbive-TSS promoter fusions resulted in significant
levels of luciferase activity compared to the promoterless control (Figure 2–8E).
Furthermore, the promoter activities of all of the sequences except for Bbive74 were
found to be significantly higher than that of the mammalian induced ospCp.
Although 5’RNA-seq measures steady state levels of RNA transcripts and
promoter fusions quantify amounts of RNA polymerase activity, there was a
correlative trend of promoter strength to 5’RNA-seq read counts. The greater the
average TAP+ read count determined by 5’RNA-seq, the greater the average
relative luciferase units measured by promoter fusion (Table 2–4). Overall these
data provided experimental support for Bbive-TSS defined promoters across a
diversity of annotated and un-annotated transcripts.
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Table 2–4. BbIVET-associated TSS read counts and luciferase promoter fusion relative activity.
Promotera

Replicon

TSS
Positionb

Strand

Categoryc

Category Details
(Annotation)d

Avg. TAP+
Read Counte

AVG
RLUf

flaBp

chr

148715

-

primary

P:BB_0147 (flagellin)

9.39E+05

1.19E+06

ospAp

lp54

9421

+

primary

P:BB_A15 (ospA, outer surface
protein A)

1.94E+04

2.31E+05

ospCp

cp26

16883

+

primary

P:BB_B19 (outer surface protein C)

37.5

134.4

Bbive12

chr

174219

-

internal,
primary

1.42E+04

1.07E+04

Bbive45

chr

379813

-

internal

243

663.1

Bbive74

chr

647833

+

antisense

194

85.9

Bbive76

chr

659711

+

antisense

362

1.62E+03

Bbive86

chr

746049

+

internal,
primary

1.58E+03

4.66E+03

Bbive203

chr

146579

-

internal,
primary

6.71E+03

1.12E+04

I:BB_0172 (von Willebrand factor
type A domain-containing protein),
P:BB_0171 (hypothetical protein)
I:BB_0370 (tyrS, tyrosine--tRNA
ligase)
A:BB_0620 (beta-glucosidase)
A:BB_0629 (PTS system fructosespecific transporter subunit IIABC)
I:BB_0709 (hypothetical protein),
P:BB_0710 (dnaG, pseudo)
I:BB_0146 (glycine/betaine ABC
transporter ATP-binding protein),
P:BB_0145 (glycine/betaine ABC
transporter permease)

Control promoters and Borrelia burgdorferi in vivo expressed sequence identification numbers.
Replicon specific nucleotide position of 5’RNA-seq identified transcription start site (TSS).
cTSS category assignment.
dAnnotation of the TSS associated ORF (61, 169), where single letter abbreviations indicate the annotation for the TSS category.
eAverage normalized read counts from 5’RNA-seq TAP+ libraries, for a given TSS.
fPromoter activity for each TSS, as determined by luciferase activity in relative luciferase units (RLU), for spirochetes grown to log phase in liquid culture.
a

b
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Activity of Novel B. burgdorferi Promoters during Murine Infection
Luciferase-promoter fusion constructs can be used to assay promoter activity in
real time during an active infection. Therefore, the activities of the six Bbive-TSS
defined promoters were examined during murine infection using an In Vivo
Imaging System (IVIS). Spirochetes carrying the individual Bbive:luc fusions
(Table 2–4) or the promoterless, flaBp, ospAp or ospCp control constructs were
inoculated intraperitoneally into groups of three mice at a dose of 1x10 5 bacteria.
Bacterial bioluminescence was assessed in the live infected mice, following
delivery of D-luciferin, by photon emission using IVIS over a 10 day time course.
The 10 day time point was experimentally determined to have the highest
sensitivity of detection using B. burgdorferi carrying the luciferase gene driven by
the constitutive promoter, flaBp (Figure 2–9).
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Figure 2–9. Determination of optimal B. burgdorferi luminescence intensity,
using the flaB promoter.
C3H/HeN mice infected intraperitoneally with 1x105 B. burgdorferi containing
flaBp:luc (pJSB175). Mice were injected intraperitoneally with 150 mg/kg Dluciferin at various time points post infection, as indicated above each image, and
analyzed using the IVISTM 50 Imaging System (IVIS) with a 5 minute exposure.
All images were normalized to the same p/s range of 1.73e4 to 1.128e5 and
displayed on the same color spectrum scale (right).
B. burgdorferi infection of all mice was confirmed by reisolation of spirochetes from
tissues. Mice infected with spirochetes harboring the promoterless luciferase
construct

(pJSB161)

served

as

the

control

for

background

levels

of

bioluminescence. The ospAp and ospCp luciferase fusion activities in the mouse
were as expected based on their known patterns of expression, off and on,
respectively (Figure 2–10) (99, 146). All B. burgdorferi clones carrying the Bbive
luciferase fusions, with the exception of Bbive74, demonstrated luciferase activity
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at day 7 and/or day 10 post-infection (Figure 2–10), but not at earlier time points.
Variations in the levels of bioluminescence detected for each B. burgdorferi clone at
the two time points likely reflected sequence-and/or time-dependent regulation of
the Bbive-TSS promoters during infection. The Bbive74:luc fusion demonstrated
low but significant promoter activity in spirochetes grown in culture (Figure 2–
8E) but no detectable bioluminescence in the mouse (Figure 2–10). Cumulatively,
these data demonstrate culture and mouse infection activity of a panel of B.
burgdorferi promoters defined by BbIVET-identified sequences and the associated
TSSs for a diversity of transcript categories. Furthermore, these data show that
global TSS identification by 5’RNA-seq provides significant insight into the B.
burgdorferi transcriptome that validates un-annotated sequences discovered
through BbIVET.
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Figure 2–10. BbIVET-associated RNA transcripts expressed both in culture and
in the mammalian host.
C3H/HeN mice infected intraperitoneally with 1x105 B. burgdorferi containing
promoterless pJSB161, control promoters (flaBp, ospCp, or ospAp) or specific Bbive
luciferase fusions as indicated (left). Mice were injected intraperitoneally with 150
mg/kg D-luciferin 7 and 10 days post infection and imaged with the IVIS TM 50
Imaging System (IVIS) using a 5 minute exposure. Images were normalized to the
same p/s range of 1.73e4 to 1.128e5 and displayed on the same color spectrum scale
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(right). Data is representative of two independent biological replicates. asTSS,
antisense TSS; p/iTSS, primary or internal TSS; iTSS, internal TSS. Note that the
same color spectrum scale is used between figures.
Unlike other pathogen transcriptome studies (197-199) which benefit from
direct collection of bacterial cells from infected animals for RNA-seq, low
spirochete numbers present during a B. burgdorferi infection requires innovative
approaches to identify B. burgdorferi transcripts that are expressed in the
mammalian environment. Comparative analysis of the BbIVET and 5’RNA-seq
datasets revealed 114 Bbives with no associated culture-specific TSSs (Table 2–3).
Furthermore, considering the MQ0-analysis only 5 of the 114 Bbives contain unmappable TSSs. These sequences harbored sufficient promoter activity to be
captured in the BbIVET screen, suggesting they may control transcripts that are
specifically expressed during murine infection. Therefore, we generated luciferase
promoter fusions of Bbive36, 161, 175, and 252 which had no associated TSS by
5’RNA-seq. In addition, we tested Bbive277 and Bbive158, which had a lowcoverage TSSs. For these experiments the entire Bbive sequence that was originally
recovered from BbIVET (Table 2–3) was fused to luciferase and evaluated for
luminescence both in culture and during murine infection. Similar to the ospC
promoter, Bbive277, 36, 158, and 252 exhibited promoter activity in culture above
that of the promoterless control but significantly less than that of the flaB and ospA
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promoters (Figure 2–11A). These data demonstrated that these promoters display
activity in culture despite the lack of associated TSSs. However, no significant
promoter activity was detected for Bbive161 or Bbive175 during growth in culture
(Figure 2–11A). To assess the promoter activities of these Bbive sequences in the
mammalian host, groups of mice were infected with 1x105 spirochetes carrying
each luciferase fusion construct and evaluated for luminescence using IVIS. Three
of the six Bbive sequences, Bbive277, 158, and 252, displayed detectable luciferase
activity at days 7 and 10 post infection (Figure 2–11B and data not shown),
suggesting that these promoters are active during murine infection, albeit at a
levels lower than that of the flaB and ospC promoters at these time points of
infection. None of the tested Bbive sequences were found to be specifically active
in the mammalian host, as Bbive 277, 158, and 252 demonstrated promoter activity
in culture (Figure 2–11A). However, these Bbive sequences appear to represent
promoters for novel un-annotated RNA transcripts. Bbive158 is located internal to
the annotated pseudo gene BB_K02a on lp36. Bbive252 lies antisense to the
hypothetical protein coding gene BB_F14 on lp28-1. Bbive277 maps internal to
chromosomal gene BB_0319, which encodes a riboflavin binding protein that may
be a component of a riboflavin ABC transporter (200).
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Figure 2–11. Novel B. burgdorferi RNA transcripts expressed during murine
infection.
(A) A subset of Bbives which lack or have low read count associated TSSs
demonstrate low promoter activity in culture. Bbive sequences were fused to
luciferase in pJSB161 and measured for luciferase activity, as described in Figure
2–8 legend. Data represent the mean ±SD from three biological replicates shown
in log scale and were analyzed relative to pJSB161 using the two-tailed Student’s
t-test. Unless otherwise indicated all fusion constructs demonstrated significantly
greater RLUs than the promoterless control, pJSB161, (p ≤ 0.01). n.s., not
significantly greater RLU relative to pJSB161. (B) Bioluminescence of Bbive
sequences in the murine host. C3H/HeN mice infected intraperitoneally with 1x105
B. burgdorferi containing controls and specific Bbive luciferase fusions, analyzed by
IVIS as described in Figure 2–10 legend. Symbols indicate specific controls for each
time point. Data is representative of two biological replicates. Note that the same
color spectrum scale is used between figures.
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Future studies are focused on elucidation of the functions of these transcripts in B.
burgdorferi biology. For the sequences that demonstrated no detectable promoter
activity in this assay, further analysis is required to distinguish between the
possibility that these Bbive sequences lack promoter activity completely or that the
amount of transcription driven by these sequences falls below the threshold of
sensitivity by IVIS. In sum, our data provide the first evidence of B. burgdorferi
expression of antisense and intragenic transcripts in the mammalian host
environment.

Discussion
A global understanding of the transcriptome of a pathogen in environments of
interest can provide key insight into patterns of gene expression and possible
modes of gene regulation, which are critical for elucidating molecular mechanisms
of pathogenesis. B. burgdorferi requires coordinated mechanisms of gene
regulation to survive throughout its enzootic life cycle (76); however, the
molecular events that contribute to this process, particularly during mammalian
infection have remained largely unknown. Clearly the mechanisms of B.
burgdorferi adaptation for survival in the tick vector are critical for environmental
persistence as well as pathogenesis of the spirochete. Nonetheless, the work

109

presented herein focused on elucidation of B. burgdorferi transcripts expressed in
the mammalian host using a mouse model of infection. We overcame the
challenges of the paucity of spirochetes present in infected mouse tissues to direct
transcriptome analysis through BbIVET (117). BbIVET identified 233 unique
putative promoter sequences, a majority of which mapped to un-annotated
antisense and intragenic positions in the genome. The BbIVET library likely did
not provide complete coverage of the B. burgdorferi genome. However, there were
several instances where we recovered the same Bbive from multiple mice and
multiple, unique Bbives were recovered from the same mouse (117). Therefore, we
are confident that BbIVET allowed discovery of unique and novel promoter
regions across the chromosome and plasmid replicons, which could potentially
contribute to Lyme disease pathogenesis. To gain further insight into the
significance of the Bbive sequences we applied a genome-wide 5’ end RNA-seq
approach using B. burgdorferi grown in culture. Transcriptome complexity and
experimental technicalities pose additional challenges to the direct measurement
of strand-specific RNA transcripts by conventional methods such as RT-qPCR.
Therefore, we utilized luciferase transcriptional fusions, which provided a unique
approach to evaluate promoter activity of novel B. burgdorferi transcripts during
an active infection. Comparative analysis of BbIVET and 5’RNA-seq has validated
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5’ ends, characterized a variety of categories of RNA transcripts, and discovered
novel transcripts that contribute to the B. burgdorferi transcriptome during
mammalian infection.
5’RNA-seq has been shown to be a valuable transcript discovery tool for a
variety of organisms, and the differential application of TAP, or similar enzymes,
to globally define TSSs and processed 5’ ends has been comprehensively validated
through many independent studies (124, 130, 159, 188). Although 5’ ends may be
inferred from total RNA-seq data (201), unlike 5’RNA-seq, these studies are unable
to distinguish between TSSs and processed 5’ ends and therefore only provide
estimations of transcript boundaries (124). Our application of 5’RNA-seq provides
a snap shot of 6042 unique, potential TSSs across the B. burgdorferi genome during
log phase growth in culture. Our 5’ end identification method was designed to
exclude excessive sequencing background noise, but still report the 5’ ends for a
variety of transcripts in 5’RNA-seq that have low expression in culture, such as the
mammalian-induced ospC gene. We acknowledge that bias in the library
preparation at either the 5’ linker ligation or the amplification steps, or
unintentional 5’ phosphate loss during manipulation of the RNA prior to
sequencing could potentially lead to inaccuracies in the classification of 5’ ends,
particularly for sequences with TAP+:TAP- ratios close to the two-fold enrichment
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cut off. Degradation of RNA during manipulations for 5’ end library preparations
likely contributed, at least in some subset, to the high number of processed 5’ ends
reported herein. It is also possible that in some instances a TSS was not captured
in our libraries due to a high rate of mRNA turnover. Here we provided several
means of validation of 5’ end identification in B. burgdorferi. Initial comparison of
the 5’RNA-seq data to published 5’ RACE- or primer extension-defined TSSs
demonstrated high correlation in the data. This is consistent with the 87%
correlation reported for a similar comparison performed in Helicobacter pylori (124).
It is possible that highly structured regions of the transcriptome may pose
technical challenges to 5’ RACE and primer extension as well as 5’RNA-seq, which
may contribute to the differences between the published TSSs and the 5’RNA-seq
data. Additionally, some 5’ RACE and primer extension approaches are unable to
distinguish between TSSs and stable processed transcripts. Therefore, we
provided bioinformatics evidence of conserved promoter elements upstream of
the 5’RNA-seq identified TSSs as well as used promoter fusions and Northern
blotting to further validate the 5’RNA-seq data.
As many 5’RNA-seq datasets have revealed in recent years, bacterial
transcriptomes are rich in un-annotated sequences (196). 5’RNA-seq in B.
burgdorferi led to the discovery of initiation sites for transcripts that span across,
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between, antisense, and internal to annotated ORFs. Although TSS validation by
Northern blot analysis may be obscured by transcriptional complexity, we have
used multiple Northern blot probes targeting regions of interest to more
confidently validate the presence of a transcript downstream of 5’ ends.
Furthermore, our results indicate that transcriptional complexity may confound
transcript boundary analysis techniques such as reverse transcriptase-PCR (RTPCR) that is used to amplify across annotated gene gaps for evidence of operons.
For example, the 5’RNA-seq data identified additional putative primary TSSs
within the recently described operons, BB_0360-BB_0364 (179), BB_0215-BB_0218
(202) and BB_0404-BB_0406 (203). These findings do not rule out the possibility
that these gene clusters are co-transcribed, but suggest that multiple transcripts
initiate within these loci that may not be detected by traditional methods. Indeed,
sorting out exact transcript maps, particularly in complex annotated regions,
proves complicated. Even more challenging, is definitive determination of the
origin of transcription for the identified processed 5’ ends. In these cases, we did
not attempt to classify processed 5’ ends based on location and rather only
reported specific nucleotide positions of all instances. Future targeted
experimental approaches are required to determine the TSS for each processed 5’
end.
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Principally 5’RNA-seq in B. burgdorferi was conducted to better understand
and distinguish mammalian specific promoters discovered through BbIVET.
However, in establishing this TSS map we discovered numerous novelties of B.
burgdorferi transcription. Of most note was the observation that adenine and
cytosine demonstrated equivalent frequencies of occurrence as the initiating
nucleotide for transcription at internal TSSs. It has been recognized that nucleoside
triphosphate (NTP) concentrations within the cell can dictate initiation of
transcription based on the +1 nucleotide availability, as was first shown for
ribosomal RNA (204). B. burgdorferi lacks the enzymes for de novo purine
biosynthesis, and in turn must salvage these molecules from the host environment
for nucleotide synthesis (24, 205, 206). Considering the concentrations of available
nucleotides and nucleotide precursors likely differ depending on the spirochete’s
immediate environment (24, 175, 182), nucleotide availability may serve as one
fundamental mechanism of transcriptional regulation. Indeed, the identity of the
transcription start site nucleotide and changes in intracellular ATP and GTP levels
have been shown to critically alter gene expression during starvation in Bacillus
subtilis (207).
We have demonstrated strong conservation of the classical Pribnow box
among the promoter regions of the primary, secondary, and antisense TSSs.
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Collectively the internal TSSs lacked a conserved promoter sequence, similar to
what has been documented for Hfx. volcanii (208), but in contrast to findings in
other bacterial species (124, 130). However, the analysis of 7.5% of internal TSS
promoter elements with TAP+ read counts of greater than 500, demonstrated
41.0% with a conserved Pribnow box. These data raise the possibility that
expression of the majority of the B. burgdorferi intragenic transcripts may be
controlled by mechanisms that differ from known means of sigma 70-dependent
regulation. Alternatively, it is possible that in some instances the spirochete RNA
polymerase initiates off-target, in what has been referred to as pervasive
transcription. However, this does not diminish the biological relevance of these
events, as evolutionary pressures could result in the functional roles of such
transcripts (209).
We identified eighty-five leaderless mRNAs, having a UTR length of less
than 10 nts. Typically leaderless transcripts in bacteria are thought to be translated
at low efficiency due to the absence of a canonical ribosome binding site (210).
However, in E. coli under certain stress conditions specialized ribosomes, lacking
the anti-Shine-Dalgarno sequence, have been shown to proficiently translate
leaderless mRNAs (211). An abundance of leaderless transcripts have recently
been discovered in the genomes of Mycobacterium smegmatis and Mycobacterium
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tuberculosis (128, 162), which have been found to be translated as efficiently as
leadered transcripts (162). While the majority of B. burgdorferi leaderless
transcripts are annotated as hypothetical proteins, it is feasible that these
sequences may be involved in stress adaptation or that ribosome recognition of
leaderless mRNA targets in B. burgdorferi may occur by a yet-to-be described
mechanism, as proposed for mycobacterial species (162). It is also possible that
mis-annotation of an ORF and/or the presence of an alternative start codon could
have resulted in inaccurate identification of a transcript as leaderless.
Cis-regulatory RNA elements, such as riboswitches and attenuators present
in 5’ UTRs, may control mRNA transcription and/or translation (212, 213). To date,
the only functionally characterized example of 5’ mRNA regulation in B.
burgdorferi is the mechanism of post-transcriptional regulation of the alternative
sigma factor rpoS by the temperature induced trans-acting sRNA dsrA (138). No
riboswitch mediated gene regulation mechanisms have been discovered in B.
burgdorferi, and among all spirochetes only one example of a riboswitch has been
described, a thiamine sensor in Treponema denticola (214). Several studies have
investigated the contribution of cyclic-di-GMP, the second messenger and
common riboswitch ligand, in B. burgdorferi environmental sensing (101, 215).
Recent data demonstrate that the four-gene (BB_0240-BB_0243) glp operon,
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involved in glycerol transport and metabolism (61, 101, 105), is regulated by cyclicdi-GMP (c-di-GMP) (101, 215, 216). By Northern blotting we validate the presence
of a long UTR in the glp operon. Additionally, the UTR probe alone revealed a ~200
nt transcript. These data suggest the presence of a terminated transcript within the
5’ UTR of the glp operon, which may indicate a cis-regulatory RNA element (193)
and provide support for the notion that long 5’ UTR sequences in B. burgdorferi
may harbor additional regulatory information.
Of the 233 total unique Bbive sequences, 119 associated with 5’RNA-seq
identified TSSs. This group is comprised of transcripts expressed both in culture
and the mammalian host, some of which may be B. burgdorferi mammalian
infection-induced and/or infection-essential RNA species. Among these
transcripts, there are at least five genes which have been previously shown to be
required for B. burgdorferi pathogenesis through a signature-tagged mutagenesis
screen, including BB_0145 (157). Herein, we demonstrated that the Bbive203-TSS
promoter associated with infection-relevant BB_0145 is active both in culture and
during infection. These data highlight the importance of further analysis of these
transcripts despite the finding that their expression is not limited to the
mammalian host environment. Only one Bbive-TSS, Bbive74, failed to
demonstration promoter activity during infection. This TSS was located only 29
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nts downstream the 5’ end of the 125 bp Bbive74 sequence. Based on the cloning
strategy of promoter fusions for Bbive-TSSs, 96 bp of Bbive74 were not tested for
promoter activity and could conceivably contain an infection-specific promoter
and TSS. Alternatively, the activity of this transcript in the mouse could fall below
the level of detection by IVIS.
A subset of Bbives are associated with low-coverage TSSs, as determined
by 5’RNA-seq. In fact, 53 Bbive-TSSs displayed an average TAP+ read count less
than 50. Herein we demonstrate that Bbive277, which has an average TAP+ read
count of 44.5 and just above the threshold cutoff of calling TSSs in 5’RNA-seq, is
active during infection. Some portion of these in culture lowly expressed Bbives
may be induced in the mammalian host. For instance, the primary TSS for the
mammalian infection specific ospC mRNA had an average TAP+ read count of 37.5
in culture, and demonstrated low promoter activity in culture, but strong
promoter activity during murine infection. Notably, exact quantifications of these
instances cannot be empirically determined by the in vivo imaging approaches
reported herein.
Comparative analysis of the BbIVET and 5’RNA-seq data sets identified
114 Bbives that did not associate with culture-expressed TSSs. However, none of
these tested putative mammalian-specific Bbives had activity specific to
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mammalian infection by luciferase transcriptional fusion. Bbive36 and 252 showed
low levels of luciferase activity in culture despite having no associated TSSs by
5’RNA-seq. This could reflect the possible low stability of the transcripts in culture
leading to their absence from the 5’RNA-seq libraries and/or differences in
sensitivity among the techniques. This does not, however, rule out the possibility
that of the 114 Bbives in this category, some are primarily active during mammalian
infection. Indeed Bbive161 and 175 had no detectable promoter activity in culture
and no TSS detected by 5’RNA-seq. However, these sequences were sufficiently
active during murine infection to drive expression of pncA through BbIVET.
Likely, we did not observe luciferase activity for these sequences by IVIS due to
the sensitivity of the currently available IVIS machine. Indeed, even with our
strongest promoter (flaBp) we only detect robust luciferase activity at days 7 and
10 post infection by IVIS. Furthermore, unlike what has recently been shown for
detection of ospCp activity by IVIS (217), using our experimental system we did
not detect ospCp activity above background until 7 days post infection.
Importantly, transcript levels do not necessarily correlate to biological relevance.
Indeed, our group has recently demonstrated by quantitative RT-PCR analysis of
B. burgdorferi infected mouse tissues at 10 days post infection that the transcript
level

of

the

BbIVET-identified

and
119

infection-essential

gene

bb0318

is

approximately 40 fold lower than that of the ospC transcript ((176) and
unpublished data, P.P.A. and M.W.J.). Together, our findings indicate the
sensitivity of BbIVET to identify low activity promoters and the potential for
discovering B. burgdorferi infection-essential transcripts through BbIVET. These
data demonstrate, for the first time, the expression of various types of previously
un-annotated RNAs during B. burgdorferi infection of mice, including antisense
and internal transcripts. Together our findings provide a framework for future
studies focused on defining the contributions of these novel transcripts to the
molecular mechanisms of B. burgdorferi pathogenesis.
Conclusions
The datasets described herein provide a significant resource for the spirochete
community and others interested in bacterial transcriptomes. 5’RNA-seq data has
been

uploaded

to

an

interactive

browser,

available

for

viewing

at

www.ucf.edu/research/interactive-genomics/lyme-disease. This work provides
the first examples of B. burgdorferi expression of non-annotated RNAs during
mammalian infection and lays the foundation for mechanistic studies focused on
elucidation of the contributions of RNA-based regulation to B. burgdorferi
pathogenesis. With the continued advancement of high throughput sequencing
methods and publication of ever increasing numbers of 5’ end deep sequencing
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datasets, the bottleneck in research innovation becomes validation and
prioritization of novel transcripts of interest. This is particularly important for
bacterial pathogens and understanding the biological significance of genetically
intractable transcripts such as antisense and internal RNAs. We have used a
unique synergistic approach of combining 5’RNA-seq and In vivo Expression
Technology, along with luciferase promoter fusions, to validate the expression of
primary, antisense, and internal transcripts during an active infection. This work
encompasses the first application of 5’RNA-seq to validate a global promoteractivity based screen. The infection-model discovery and validation approach that
we present is broadly applicable to any pathogen of interest providing 1) strand
specific validation of novel transcripts expressed during infection, 2) identification
of transcripts of interest for mechanistic studies and 3) transcriptional analysis in
pathogens that do not achieve high loads during infection. In sum, this work
contributes significant insight into the transcriptome of B. burgdorferi and provides
an innovative approach for analysis of 5’ end RNA-seq data from medically
relevant pathogens.
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CHAPTER 3:
DISSECTING CIS-REGULATORY MECHANISMS OF ANTISENSE SRNAS
IN B. BURGDORFERI

Preface
This chapter was composed entirely by P.P.A. Comments from M.W.J. were
incorporated into the final version presented here.
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Abstract
Antisense transcription has remained an abundant, yet a functionally debated
phenomena in prokaryotic transcriptomes. The onset of RNA sequencing
approaches to characterize bacterial gene expression has identified numerous
antisense RNAs, transcribed from the opposing DNA strand to annotated open
reading frames (ORFs). However, there is a surprisingly low number of
documented instances of functional roles for these RNAs, despite their exact
complementarity to mRNA sequences. This study investigates antisense
transcription in B. burgdorferi, the causative agent of Lyme disease. A previous
transcriptional start site (TSS) mapping, RNA sequencing approach (5’RNA-seq)
by our laboratory identified 750 antisense TSSs in B. burgdorferi. Northern blotting
and transcriptional fusions to luciferase validate a variety of antisense RNA
transcripts in the Lyme disease spirochete in culture and during murine infection.
However, directed dissections of the antisense RNA, appO2, adjacently transcribed
from the oligopeptide peptide permease oppAIV, fail to distinguish any cisregulatory mechanism of appO2 against oppAIV. This work continues the ongoing
debate of regulatory mechanisms for antisense transcription in bacteria.
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Introduction
The advent of bacterial transcriptomic applications has pioneered the discovery of
novel RNA transcripts among prokaryotes, revealing previously un-annotated
internal, intergenic, and antisense transcripts. The widespread instances of these
RNAs among both pathogens and model organisms (123, 124, 129, 130, 188), has
sparked much debate into their functionality (209). In particular, antisense RNAs,
those transcribed on the opposing DNA strand from annotated-open reading
frames (ORFs), are the least characterized, despite their high production (123, 218).
Antisense transcription can fluctuate among cyanobacteria, gram-negative, and
gram-positive from ~2-46% occurrence at annotated-ORFs (124, 130, 188, 195, 219,
220). Multiple antisense RNAs per ORF have also been reported, and can even
result in such transcripts dominating the transcriptome. Noteworthy high
incidences of antisense transcription include E. coli at 37% (130), Helicobacter pylori
at 41% (124), Campylobacter jejuni at 44-47% (161) and Vibrio cholerae at 47% (129) .
Considering, it seems surprising that such few functional characterizations of
these transcripts have been reported.
Recently, the transcriptome of B. burgdorferi has been sequenced by 5’ end
mapping and thus revealed 13% of transcriptional start sites (TSSs) to be classified
as antisense to annotated ORFs (221). As the etiological agent of Lyme disease, the
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foremost vector-borne bacterial infection in the world (32), B. burgdorferi fulfills a
unique niche in bacterial pathogens. Propagation of the pathogen in the
environment relies on the maintenance of a mammalian reservoir through infected
Ixodes scapularis ticks (5). Unlike most prokaryotes, its genome is mostly retained
on linear fragments and highly segmented with one chromosome and up to 21
plasmids. Further, B. burgdorferi lacks an array of metabolic genes thereby
depending on host environments for nutrient acquisition and contains an usually
large percentage of unique genomic sequences specific to Borrelia (Borreliella)
species (61, 64). There is currently no functional characterization of antisense
transcripts in B. burgdorferi. Limited transcriptional factors, DNA binding proteins,
two-component systems and other stress response mechanisms have been
identified (76). Because of the disparate environmental niches the Lyme disease
pathogen inhabits, its likely that unexplored regulatory processes are present.
RNA-based mechanisms of gene regulation have only characterized one sRNA in
B. burgdorferi (138). However, with the discovery of the RNA chaperone, Hfq,
additional sRNA interactions have been suggested (137). Recent RNA-seq
approaches have confirmed the abundance of internal, intergenic, and antisense
transcripts in B. burgdorferi (201, 221, 222). Evidence also suggests that antisense
transcripts are transcribed during mammalian infection, as putative antisense
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promoters have been identified through in vivo expression technology for B.
burgdorferi (BbIVET) (117). Of the putative murine-active promoters identified in
this screen ~25% were located antisense to annotated ORFs and luciferase fusions
for a subset of these promoters confirmed their activity in a mammalian model of
Lyme disease (221).
Herein, we dissect the contribution of B. burgdorferi antisense transcripts to
their corresponding ORF. The molecular mechanisms of antisense RNA (asRNA)
regulation, or cis-acting RNAs, include transcriptional interference, transcriptional
attenuation, altered transcript stability, and translation promotion or attenuation
(133, 223). Ultimately, protein production for a target of cis-antisense RNAs is
altered via physical RNA-RNA interactions of the sense (target RNA) and
antisense (cis-RNA) transcripts, excluding the mechanism of transcriptional
interference whereby transcription is occluded via proximal promoters and
inhibition of transcriptional complexes (224). Considering that antisense
transcripts have perfect complementarity to the mRNAs which they are oppositely
transcribed to, they would seemingly influence those mRNAs, if they held
regulatory roles in the cell. However, there are some examples of asRNAs acting
in trans (trans-antisense RNAs) (225-228).
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This study provides examines 3 genomic loci, providing evidence for the
existence of novel B. burgdorferi asRNAs and demonstrates that these transcripts
are expressed during mammalian infection using Northern blotting and promoter
fusion analyses in the murine host. Overexpression and removal of a mammalianexpressed asRNA show no difference in the protein production of the
corresponding sense ORF. Collectively these data support the notion that asRNAs
may not directly regulate complementary mRNA targets and continues the
ongoing debate for the functional role of antisense transcripts in bacterial
pathogens.
Materials and Methods
Bacterial Strains and Growth Conditions
Borrelia (Borreliella) burgdorferi clones used in this study were derived from strain
B31 A3, lacking cp9, herein referred to as wild type. Some B. burgdorferi genetic
manipulations used infectious low-passage clone A3-68Δbbe02, which lacks cp9,
lp56, and gene bbe02 on lp25 (164). Table 3–1 lists all B. burgdorferi clones used in
the study. Spirochetes were cultivated in liquid Barbour-Stoenner-Kelly (BSK) II
medium supplemented with gelatin and 6% rabbit serum (72) and plated in solid
BSK medium as previously described (166). B. burgdorferi cultures were grown at
35°C supplemented with 2.5% CO2 in the presence of 50 µg/ml streptomycin, 200
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µg/ml kanamycin and/or 40 µg/ml gentamycin when applicable. DH5α E. coli were
grown in LB broth or on LB agar plates containing 300 µg/ml spectinomycin, 50
µg/ml kanamycin and/or 15 µg/ml gentamycin when appropriate.

Table 3–1. List of B. burgdorferi clones used in this study.
Clone Number

Description

Reference

1311

B31 A3

(163)

691

1311 lp56- Δbbe02::flgBp-kan

(164)

1970

1311 Δbba34::flaBp-aadA

this study

2000

1311 Δbbb16::flgB-aph[3′]-IIIa

this study

2001

1970 Δbbb16::flgB-aph[3′]-IIIa

this study

2093

691 +pJSB161 (promoterless-flucBb)

(174)

2094

691 +pJSB175 (flaBp-flucBb)

(174)

1802

691 +pJSB161 (appO1p-flucBb)

this study

1943

691 +pJSB161 (appO1p_P.B.-flucBb)

this study

2066

691 +pJSB161 (appO2p-flucBb)

this study

2152

691 +pJSB161 (appO2p_P.B.-flucBb)

this study

2148

691 +pJSB161 (appO3p-flucBb)

this study

2180

691 +pJSB161 (appO3p_P.B.-flucBb)

this study

2178

691 bbb16::bbb16-3xFLAG-flaBp-aadA

this study

2260

2178 +pBSV2G appO1-3 Over Expression

this study

2227

2178 +pBSV2G appO2 Over Expression

this study

2288

2178 +pBSV2G appO1+3 Over Expression

this study

2205

691 Δbbb16::flaBp-aadA

this study

2284

2205 +pBSV2G bb16-3xFLAG

this study

2285

2205 +pBSV2G bbb16-3xFLAG-appO2_P.B.

this study

Genetic Manipulations of B. burgdorferi
All transformants resulting from genetic manipulations in this study were verified
by PCR, restriction enzyme digestion, and Sanger sequencing. All engineered B.
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burgdorferi clones (Table 3–1) were confirmed to contain all native plasmids using
a panel of primers (163, 175) and single clones selected for further experiments.
Vectors pJSB161 and pJSB175 carrying a promoterless or flaBp-driven B.
burgdorferi codon optimized Photinus pyralis firefly luciferease gene (luc),
respectively, were generously provided by Dr. Jon Blevins (174). Generation of the
asRNA promoter fusions to luciferase were constructed by digesting pJSB161 with
BlgII and ligating PCR generated DNA fragments. The -1 nucleotide of all asRNAs,
as determined from 5’RNA-seq (221), to the 5’ end of a BbIVET sequence was PCR
amplified using Phusion High-fidelity DNA polymerase (NEB) from B31 A3
genomic DNA with primer pairs that introduces a BlgII site at the 3’ and 5’ ends
(Table 3–2). All plasmid constructs were confirmed by PCR and sequence analysis
and transformed into B. burgdorferi A3-68ΔBBE02 as previously described (165).
Knockout constructs for removal of genes bbb16 (oppAIV) and bba34 (oppAV)
were designed as follows. Spectinomycin/streptomycin (aadA) or kanamycin
(aph[3′]-IIIa) resistant cassettes driven by the flagellar (flaB) and/or flagellar basal
body rod protein (flgB) promoters, were Phusion-PCR amplified from previously
characterized B. burgdorferi shuttle vectors (205, 229) using primer pairs 1255+1256
and 1789+1833 respectively (Table 3–2). Allelic exchange deletion constructs were
engineered via a PCR-based overlap extension strategy as previously described
131

(117) using primers 1834, 1835, 1836, 1837 for bbb16::flgB-aph[3′]-IIIa; 2141, 2142,
1836, 1837 for bbb16::flaBp-aadA; and 1829, 1830,1831, 1832 for bba34:: flaBp-aadA
(Table 3–2). Allelic exchange cassettes were ligated into pCR-BLUNT vector using
a Zero Blunt PCR Cloning Kit (Thermo Fisher Scientific) according the
manufacturer’s

instructions.

pCR-BLUNT-bbb16::flgB-aph[3′]-IIIa

and

pCR-

BLUNT-bba34:: flaBp-aadA were transformed into wild type B. burgdorferi, whereas
pCR-BLUNT bbb16::flaBp-aadA was transformed into B. burgdorferi A3-68Δbbe02 as
described (165). Double Δbbb16 and Δbba34 B. burgdorferi was created by
transforming the characterized Δbba34 clone with pCR-BLUNT-bbb16::flgB-aph[3′]IIIa.
Similarly, the native bbb16 gene was 3xflag tagged at the C-terminus, in the
genome, using allelic exchange and PCR-based overlap extension strategy with
primers 2127, 2128, 2129, 2130 (Table 3–2). This created pCR-BLUNT bbb16::bbb163xflag-flaBp-aadA which was transformed into B. burgdorferi A3-68Δbbe02 resulting
in BBB16-3xFLAG and insertion of flaBp-aadA downstream bbb16. This clone was
transformed with a variety of vectors overexpressing the asRNAs in bbb16.
Overexpression of asRNAs utilized B. burgdorferi shuttle vector pBSV2G with the
flagellar promoter (flaBp) cloned into restriction sites KpnI and BamHI (182).
asRNA appO2 was Phusion-PCR amplified from B. burgdorferi A3 genomic DNA,
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with primers 1918+2140 (Table 3–2) adding restriction sites for BamHI and SalI
respectively, and cloned into pBSV2G-flaBp using T4 DNA ligase (NEB). The
overexpression of asRNAs appO1 and appO3 were created using the flaB or flgB
promoters and a Gibson cloning strategy. DNA fragments were Phusion-PCR
amplified from B. burgdorferi A3 genomic DNA using primer pairs 2188+2196,
2197+2198, 2199+2200, 2201+2202 (Table 3–2). Products were purified using a PCR
purification kit (Qiagen) and ligated together using Gibson Assembly® Master
Mix (NEB) and 1 µl of each PCR fragment by incubating the reaction at 50°C for
one hour. 1 µl of assembled product was Phusion-PCR amplified using primers
2188+2202, cut with SalI and PstI restriction enzymes and the DNA fragment gel
extracted using the QIAquick Gel Extraction kit (Qiagen). T4 DNA ligase was
subsequently used to clone flaBp-appO1 and flgB-appO3 into SalI/PstI cut pBSV2GflaBp-appO2 or pBSV2G.
Removal of asRNA appO2 was performed by altering the nucleotide
sequence of its native promoter. Δbbb16 in B. burgdorferi A3-68Δbbe02 was used for
these genetic manipulations. Complementation of bbb16 to this clone either
restored bbb16 with a promoter-bashed appO2 or native appO2 promoter, with a
bbb16-3xflag under its native promoter on pBSV2G. Primer pair 1930+2187 (Table
3–2) was used to Phusion-PCR amplify the bbb16-3xflag from the B. burgdorferi
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clone #2178 (Table 3–1), as described above. The PCR product was cut with KpnI
and SalI restriction enzymes and T4 DNA ligated into SalI/KpnI cut pBSV2G. For
the creation of promoter-bashed appO2, a Gibson cloning approach was used.
Primers 2186+2012 and 2055+1930 were Phusion-PCR amplified from B. burgdorferi
A3 genomic DNA. Following PCR purification (Qiagen), products were ligated
using Gibson Assembly® Master Mix (NEB) and Phusion-PCR amplified using
primers 2186+1930. Product was cut with SalI and KpnI restriction enzymes, gel
extracted using the QIAquick Gel Extraction kit (Qiagen) and ligated to SalI/KpnI
cut pBSV2G using T4 DNA ligase.
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Table 3–2. Oligonucleotides used in this study.
Number

Sequence (5’-3’)

Use

Luciferase Fusions on pJSB161
asRNA upstream 5’RNA-seq BB_0649
BlgII

1660

GAAGATCTGCAAAAAAGATTACAACAAAAGAAG

1661

GAAGATCTAATTAATAAAGGTTTATTTGTCCCTAAA

5' end of Bbive 231 BB_0649 BlgII

1658

GAAGATCTATTCATATAATAAACTTCAAAGAATTAAAAGATC

asRNA upstream 5'RNA-seq BB_0401
BlgII

1659

GAAGATCTTTTATTGTTCATCTAAAGCTAAATATTTTG

5' end of Bbive 283 BB_0401 BlgII

1657

GAAGATCTTTAAGAAATACAGCCGGAAAATC

5' end of Bbive 100 BB_B16 BlgII

1656

GAAGATCTTCTTAATGATAGTTCTATTCCTACAAG

1801

GAAGATCTTCTTAACGATAGCTCCATCCCTACAAGAAGAGCTACTCCAGACTATATCG
ATTACTCTTATAA

asRNA appO1 upstream 5'RNA-seq
BB_B16 BlgII
asRNA appO1 upstream 5'RNA-seq
Promoter Bash BB_B16 BlgII Tm=65°

1802

GAAGATCTTTAAGAAATACAGCCGGAAAATCTCTTTCAATTATTATTGCTTCTGC

5' end of Bbive 100 BB_B16 BlgII Tm=65°

1917

GAAGATCTAATAAATATTATAATTCCAAAGATGTTGTTC

2004

GAAGATCTAACAAGTACTACAACTCCAAAGATGTTGTTCTTGACAGT

2049

GAAGATCTAAGAAAATCTTATCTTAGAATTTTAGATAAAG

2074

GAAGATCTAAGAAAGTCATACCTAAGAATCTTAGATAAAGAAACCGGCT

asRNA appO2 upstream 5'RNA-seq
BB_B16 BlgII
asRNA appO2 upstream 5'RNA-seq
Promoter Bash BB_B16 BlgII
asRNA appO3 upstream 5'RNA-seq
BB_B16 BlgII
asRNA appO3 upstream 5'RNA-seq
Promoter Bash BB_B16 BlgII

Knockout BB_B16 and BB_A34 Constructs
1834
1835

CCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATTTAAGTA
AAAATGGTTTATAG
GTTCAACCTTAATAGGAAATCTTCCTTGAAGCTCGGGTATTAACAAGCATCCTTACAA
GTTT

2141

CACAAGAGGCGACAGACAACAAGCATCCTTACAAGTTT

2142

CACCAAGGTAGTCGGCAAATAATTTAAGTAAAAATGGTTTATAG
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BB_B16 OppAIV KO aph[3′]-IIIa 3'
BB_B16 OppAIV KOaph[3′]-IIIa 5'
BBB16 OppAIV KO aadA 5'
BBB16 OppAIV KO aadA 3'

Number

Sequence (5’-3’)

Use

1836

TTATTAGATCATTGCAAACAATTTT

BB_B16 OppAIV KO -500

1837

CTCCAAATCAAGATATTTTCAAC

BB_B16 OppAIV KO +500

1829

CCGGAAGCCACAAGAGGCGACAGACAATCCTTATGACCTTCCTTTAG

BB_A34 OppAV KO aadA 5'

1830

GGCGAGATCACCAAGGTAGTCGGCAAATAACTGATTTTTAAACTTTTTCACAAATAG

BB_A34 OppAV KO aadA 3'

1831

CTGGTATGAAAGAAAATAACTGTAATA

BB_A34 OppAV KO -500

1832

CATTAATAAAATACTTATCCTTTGCATC

BB_A34 OppAV KO +500

2127

GTTCTATTCCTACAAGAAGAGCA

BB_B16 OppAIV KO +500 from TGA

2128

GCCACAAGAGGCGACAGACATCATTTATCATCATCATCTTTATAATCTTTATCATCATC
ATCTTTATAATCTTTATCATCATCATCTTTATAATCTTTAATTGGTTTTATTTCAGATAAA
TTAAATCT

BBB16 OppAIV 3xFLAG aadA 5'

2129

ATCACCAAGGTAGTCGGCAAATAATTTAAGTAAAAATGGTTTATAGCTAGATCT

BBB16 OppAIV 3xFLAG aadA 3'

2130

GCTCCAAATCAAGATATTTTCAA

BB_B16 OppAIV KO -500 from TGA

1789

TAATACCCGAGCTTCAAGGAAGATTTCCTATTAAGGTTGAAC

flgBp-aph[3′]-IIIa 5'

1833

TTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGG

aph[3′]-IIIa 3'

1255

TGTCTGTCGCCTCTTGTG

flaBp-aadA 5'

1256

TTATTTGCCGACTACCTTGGTG

aadA 3'

1918

CGGGATCCATTCTTTTCAAGAACAACCTTTTCATTTAA

asRNA appO2 BamHI 5'

2140

CGGGATCCGGCTCATCTTTTGTTAACATGAT

asRNA appO2 SalI 3'

2188

ACGCGTCGACTAATACCCGAGCTTCAAGGA

flgBp 5' SalI

2196

CCATTACTGCCGAAGGAATATGGAAACCTCCCTCATT

flgBp 3' asRNA appO1 5' Gibson Overlay

2197

AATGAGGGAGGTTTCCATATTCCTTCGGCAGTAATGG

asRNA appO1 5' Gibson Overlay flgBp 3'

2198

CACAAGAGGCGACAGACAGTGAGCCTGCTACTTTAGAT

asRNA appO1 3' Gibson Overlay flaBp 5'

2199

ATCTAAAGTAGCAGGCTCACTGTCTGTCGCCTCTTGTG

flaBp 5' Gibson Overlay asRNA appO1 3'

2200

AACCTTAACAGAGAGCGTGATTGATAATCATATATCATTCCTCC

flaBp 3' Gibson Overlay asRNA appO3 5'

2201

GATATATGATTATCAATCACGCTCTCTGTTAAGGTTTTTCT

asRNA appO3 5' Gibson Overlay flaBp 3'

2202

AACTGCAGGATAATAGCATTACAGCTTATAATATG

asRNA appO3 PstI 3'

Over Expression of asRNAs on pBSV2G
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Number

Sequence (5’-3’)

Use

Complementation of BB_B16 on pBSV2G
2187

GGGGTACCTCATTTATCATCATCATCTTTATAATCTTTATC

BB_B16 OppAIV COMP 3' 3xFLAG
KpnI

2186

GGGGTACCTCATTTATCATCATCATCTTTATAATCTTTATCATCATCATCTTTATAATCT
TTATCATCATCATCTTTATAATCTTTAATTGGTTTTATTTCAGATAAATTAAATCT

BB_B16 OppAIV COMP 3' 3xFLAG
KpnI

2012

AACAAGTACTACAACTCCAAAGATGTTGTTCTTGACAGT

asRNA appO2 Promoter Bash 5'

2055

GGAGTTGTAGTACTTGTTATTCTTTTCAAGAACAACCTTTTC

asRNA appO2 Promoter Bash Gibson
Overlay 3'

1930

ACGCGTCGACCGTTTAAGGAAGTGCAAGATATTAATAA

BB_B16 OppAIV COMP 5' SalI

Northern Probes
5

GACTGACGAATTTTCTCAGCAGCCAAATTTACAGCGTGATCTATTC

Sense to BB_0649

6

GAATAGATCACGCTGTAAATTTGGCTGCTGAGAAAATTCGTCAGTC

Antisense to BB_0649

14

CAAAGTCGATTAGTAAAGCCAAAGAGATTAATATCGGCAGC

Sense to BB_0401

13

GCTGCCGATATTAATCTCTTTGGCTTTACTAATCGACTTTG

Antisense to BB_0401

22

AAGGCGCTGTCTTTTGCTATTGATAGAAAAACCTTAACAGAG

Sense to asRNA appO1

65

TTGTTAGTGGTCCTTTCAAATTAAAATCTAGAGTTTTAAATG

Sense to asRNA appO2

72

CTGATGACGGAGTAGTTTATACGTTTCATTTAAGAGATAATC

Sense to asRNA appO3
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RNA Isolation and Northern Blots
Forty-five milliliters of a log phase (3-7x107 cells/ml) B. burgdorferi was pelleted at
3210 x g for 15 min, supernatant decanted, and snap frozen in liquid N2. Total RNA
was extracted using a hot phenol protocol and DNase treated as described
previously (104). Formaldehyde-agarose Northern blots were performed as
described (221). Briefly, 10 µg of DNase treated total RNA was denatured in 1X
MOPS (20mM MOPS, 5mM NaOAC, 1mM EDTA, pH 7.0), 3.7% formaldehyde,
and 1X RNA loading dye (ThermoScientific) at 70°C for 10 min, and incubated on
ice for 3 min prior to separating on a 1% agarose, 1X MOPS, 5.5% formaldehyde
gel at 150V at 4°C. RNA was transferred to Hybond XL membranes (Amersham
Pharmacia Biotech) via capillary action overnight and UV crosslinked.
Oligonucleotide probes (Table 3–2) were end-labeled with ATP [γ-32P] and
hybridized overnight at 42°C prior to phosphor screen exposure and imaging with
a Typhoon Trio+ (GE).
Ethics Statement
The University of Central Florida is accredited by the International Association for
Assessment and Accreditation of Laboratory Animal Care. Protocols for all animal
experiments were prepared according to the guidelines of the National Institutes
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of Health and were reviewed and approved by the University of Central Florida
Institutional Animal Care and Use Committee.
Luciferase Assays
For in vitro derived culture analyses, B. burgdorferi clones harboring the luciferase
fusion constructs were grown to logarithmic phase (4-7x107 spirochetes/ml) in BSK
II medium and pelleted at 3210 x g for 10min. Cells were washed twice with PBS
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) and
resuspended to approximately 2-3x109 spirochetes/ml. A BioTek Synergy 4 was
used to measure OD600 readings with 100 µl of each sample while 92.5 µl was
loaded into a black, solid bottom 96-well plate (Corning) and combined with 750
µM D-luciferin (Regis) in PBS. The relative luciferase activity (RLA) was
determined by measuring photon emission in each well for 1 second, 10 times
using the EnVision 2104 Multilabel Reader (PerkinElmer). RLA for each sample
was averaged, subtracted from the PBS control, and normalized to the OD600
reading for that clone, providing the relative luciferase units (RLU) for each
promoter fusion. Experiments were conducted in biological triplicate and
analyzed by one-tailed Student’s t-test relative to pJSB161 using Prism Graphpad.
Luciferase assays during mammalian infection were performed as
described (221). Briefly, 6-8 week old female C3H/HeN mice (Envigo) were
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depilated ventrally and treated with 5 mg/ml streptomycin and 1 mg/ml Equal in
their water one week prior to injection with 105 spirochetes intraperitoneally. Mice
were intraperitoneally injected with 150 mg/kg body weight sterile D-luciferin in
PBS, 15 min prior to imaging on the IVISTM 50 Imaging System (Xenogen Imaging
Technologies). Background luciferase signals detected in the mice inoculated with
B. burgdorferi carrying the promoterless luciferase gene were subtracted out of the
readings. Infectious doses were verified to contain all expected B. burgdorferi
plasmids and confirmed by plating for colony-forming units plated in solid BSK
medium. Immediately following the final IVIS reading time point, mice were
confirmed infection positive by reisolation of spirochetes from ear and bladder
tissues (221)
Western Blots
B. burgdorferi were grown to log phase in BSKII, spun at 3210 x g for 10min, washed
twice with cold HN buffer (50 mM Hepes, 50 mM NaCl, pH 7.5), and resuspended
in equal parts HN and 2X Laemmli Sample Buffer (Bio-Rad) with 5% ßMercaptoethanol. Samples were boiled for 5 mins at 100ºC and 1 x 107 cells loaded
per well of a 10 well, 4-15% Mini-PROTEAN TGX Precast Protein Gel (Bio-Rad).
Following separation, gels were transferred to PVDF membranes (Bio-Rad) and
blocked with equal parts Odyssey Blocking Buffer in TBS (Licor) and TBS (25mM
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Tris, 150mM NaCl). Monoclonal mouse-anti-FlaB H9724 (230) (1:200) and rabbitanti-DYKDDDDK(FLAG)-tag pAb (Genscript) (1 µg/ml) detected FlaB and BBB16FLAG respectively. IRDye® 800CW Goat anti-Rabbit (Licor) (1:25,000) and
IRDye® 680LT Goat anti-Mouse (Licor) (1:30,000) were used as secondary
antibodies. All antibody incubations were performed with equal parts Odyssey
Blocking Buffer in TBS (Licor) and TBS-T (TBS with 0.5% Tween). For the
incubation of IRDye® 700 Goat anti-Mouse 0.2 % SDS was added to reduce
background. Membranes were washed between incubations with TBS-T and
imaged on the Licor Odyssey. Image Studio v. 3.1 was used to quantify western
signals and analyzed with GraphPad Prism version 7.02. All experiments were
performed in biological triplicate.
Results and Discussion
B. burgdorferi Antisense RNAs are expressed in Culture and during
Murine Infection
Previously, we identified numerous instances of antisense transcription both
through 5’ end mapping of the B. burgdorferi transcriptome (5’RNA-seq) (221) and
via in vivo expression technology for B. burgdorferi (BbIVET) (117). Given the
prevalence, yet controversial functional role, of antisense transcripts in bacterial
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species (209, 231), we selected several examples of B. burgdorferi antisense
transcription for analysis in vitro and during mammalian infection.
BB_0649 is annotated as the heat shock chaperon, GroEL, and a
transcriptional start site (TSS) (green arrow) for this mRNA was detected by
5’RNA-seq (Figure 3–1). Additionally, 5’RNA-seq captured an antisense transcript
beginning at chromosomal position 688,888 on the minus strand (purple arrow).
Northern blot analysis using an oligo probe (black box) complementary to the
sense strand revealed the ~2000 nt groL mRNA and the reverse complement to this
probe validated an ~200 nt asRNA (Figure 3–1B). BB_0401 is annotated as a
glutamate transporter (GluT). 5’RNA-seq captured both its TSS (green arrow) and
a novel antisense TSS (purple arrow) at chromosomal position 414,264 (Figure 3–
1C). A Northern blot oligo probe (black box) complementary to the gluT mRNA
confirmed the ~1500 nt transcript. The reverse complement to this probe, revealed
several antisense transcripts in this region (Figure 3–1D). Due to the proximity,
direction, size of BB_0402 and BB_403, and the lack of an identified TSS for
BB_0402 we hypothesize that BB_0402 and BB_403 are co-transcribed as an operon,
and that a lack of tight transcriptional termination may result in the observed
~2000 nt antisense transcript. The sRNA identified by 5’RNA-seq is likely
represented by the ~750 nt and/or 400 nt transcripts detected in the Northern blot
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(Figure 3–1D). However, we cannot disregard the possibility that the 2 kb
transcript originates from the antisense TSS, or that the observed northern blot
bands correlate to upstream processing events. Such observations represent the
complexity in dissecting transcription in B. burgdorferi, and bacteria in general
(221).

Figure 3–1. Antisense RNA transcription in B. burgdorferi.
(A) Screenshot of the 5’RNA-seq data for an antisense TSS in BB_0649. Only the
sequenced 5’ nucleotide, of overlaid biological replicates treated with (TAP+) and
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without (TAP−) tobacco acid pyrophosphatase, is displayed where the positive
strand is indicated in gray and the negative strand in orange. Read count ranges
are shown in the upper left of each frame. The chromosome nucleotide
coordinates, relative orientation of the BB_0649 ORF (wide black bar), bb0649 TSS
(green bent arrow), antisense TSS (purple bent arrow), putative transcripts (broken
line arrows, ; predicted asRNA, ‡; predicted mRNA transcript), northern probe
locations (black boxes), are indicated. (B) Northern blot analyses of BB_0649
mRNA and asRNA. Total RNA was extracted from mid-log phase spirochetes and
separated by a denaturing formaldehyde–agarose gel, blotted to nylon
membranes and probed with 32P-labeled oligonucleotide probes specific for the
mRNA, and the reverse complement of that same sequence specific for the asRNA
(black box). Symbols indicate the predicted transcripts. Transcript nucleotide sizes
are indicated to the left of the blots. (C) Screenshot of the Bb5’RNA-seq data for an
antisense TSS in BB_0401, labeled as described above, with processed 5’ ends
indicated (scissors). (D) Northern blot analyses of BB_0401 mRNA and asRNA, as
described above. (E) BB_0649 and BB_0401 asRNA promoters are active in culture.
B. burgdorferi clones harboring promoter fusions were grown to mid-log phase,
and incubated with 750 µM D-luciferin. Relative luciferase units (RLU) were
normalized to cell density by OD600. Data represent the mean ±SD from three
biological replicates and were analyzed relative to pJSB161 (promoterless
luciferase control) using the two-tailed Student’s t-test (Prism Graphpad) pJSB175
which contains a flaBp transcriptional fusion to luciferase served as the positive
control. Both asRNA promoter fusions demonstrated significantly greater RLUs
than the promoterless control, pJSB161 (p ≤ 0.01). (F) B. burgdorferi asRNAs
promoters are active during murine infection. C3H/HeN mice were infected
intraperitoneally with 105 B. burgdorferi containing controls and asRNA promoter
fusions. At days 7 and 10 post infection mice were injected intraperitoneally with
150 mg/kg D-luciferin imaged on an IVISTM 50 Imaging System (IVIS) using a 5
min exposure. Images were normalized to the same p/s range of 1.73e4 to 1.128e5
and displayed on the same color spectrum scale (right). Data are representative of
two biological replicates.
BbIVET identified putative promoter sequences expressed during murine
infection, termed Bbives (117). The combined comparison of these findings with
5’RNA-seq demonstrated a variety of Bbives contain associated TSSs, suggesting
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these transcripts are expressed during murine infection. Although the TSSs for
these asRNAs fell beyond the parameters we established for Bbive-TSS
associations (221), Bbive231 was located 237 nts upstream of the antisense TSS in
BB_0649 and Bbive283 mapped 45 nts upstream of the antisense TSS in BB_0401.
To confirm promoter activities in these genomic regions, the promoter sequences
for the antisense TSSs including the upstream Bbives were fused to luciferase.
Detection of significant relative luciferase activity levels for both antisense
transcript promoters confirmed their expression in culture (Figure 3–1E). 105
spirochetes harboring these promoter fusions were inoculated into mice and
surveyed for luminescence over the course of 10 days. The antisense sRNA
promoters in BB_0649 and BB_0401 were both found to be active during infection
(Figure 3–1F).
Elucidation of cis-regulatory mechanisms for a
BbIVET-associated asRNA
The oligo peptide permease OppAIV encoded on B. burgdorferi circular plasmid
cp26 position BB_B16, is an environmentally regulated transcript (232). Because B.
burgdorferi lacks the enzymes for de novo synthesis of amino acids (61) it relies on
the scavenging of peptides from the environment for protein synthesis, mediated
by oligo peptide permeases. This system is also present in other bacteria, as an
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alternative to de novo synthesis, however unique to B. burgdorferi is that five
periplasmic substrate binding proteins are annotated (oppAI-oppAV) compared to
classically one (233). Further, two are located distantly from the other genes in the
oligo peptide transporter, oppAIV on cp26 and oppAV on lp54. Of interest, three
antisense RNAs, one of which is associated to Bbive100 (221) were discovered by
5’RNA-seq to transcribe opposing oppAIV (Figure 3–2A). Bbive-associations were
defined as the sequencing of a TSS, by 5’RNA-seq, within 6 nts downstream of the
3’ end of a Bbive sequence through 20 nts downstream the 5’ end of a Bbive
sequence (221). The primary TSS for oppAIV was determined at cp26 location 11858
(green arrow) with a secondary TSS at 11973. The TSSs for these antisense RNAs
(purple arrows) were mapped to nucleotides 12981, 12691, and 12351 on cp26 and
given the names appO1, appO2, and appO3 respectively, regarding their reverse
transcription to oppAIV and numbered numerically from Bbive100. The TSS for
appO1 directly follows the infection-active putative promoter Bbive100. Northern
blots probing the oppAIV mRNA and each asRNA (black boxes) demonstrated the
expected ~2000 nt transcript for oppAIV and three antisense transcripts of less than
~200 nts in length (Figure 2B). The complemented oligonucleotide for appO2 was
used for detection of the oppAIV mRNA. Because the asRNA Northern blots
resulted in relatively weak detection of all three transcripts, we verified the
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oligonucleotide probes used were specific for their target sequences. B. burgdorferi
clones lacking bbb16 or both bbb16 and bba34 (oppAV) were used for this
confirmation. RNA isolated from these clones and probed for the asRNA targets
demonstrate the absence of the asRNA transcripts, thus validating the specificity
of the Northern probes. The finding that these RNAs were relatively low in
detection compared to the oppAIV mRNA, also corroborated the 5’RNA-seq data
(Figure 3–2A).
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Figure 3–2. Three antisense RNAs are transcribed in BB_B16.
(A) Screenshot of the 5’RNA-seq data for antisense TSSs for appO1, appO2, appO3
in BB_B16, as described in the Figure 3–1 legend. The bbb16 TSS (green bent arrow),
antisense TSSs (purple bent arrows), Bbive100 (thin black arrow), putative
transcripts (broken line arrows, ‡; predicted mRNA transcript), northern probe
locations (black boxes), and upstream asRNA promoter sequences and nucleotide
substitutions (red letters) in promoter bash (P.B.) constructs are indicated. (B)
Northern blot analyses of BB_B16 mRNA (oppAIV) and asRNAs, performed as in
the Figure 3–1 legend. Symbols indicate the predicted transcripts. Transcript
nucleotide sizes are indicated to the left of the blots. (C) BB_B16 asRNA promoters
are active in culture. Luciferase assay performed as described in the Figure 3–1
legend. Data represent the mean ±SD from three biological replicates and were
analyzed relative to pJSB161 using the two-tailed Student’s t-test (Prism
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Graphpad). Unless indicated, means were not significantly greater from the
pJSB161 control. Significant differences are indicated with asterisks (p ≤ 0.01; ***,
p ≤ 0.001; ****, p ≤ 0.0001). (D) BB_B16 asRNAs promoter appO2 is active during
murine infection. C3H/HeN mice were infected intraperitoneally with 105 B.
burgdorferi containing controls and asRNA promoter fusions and analyzed using
the IVIS system as detailed in the legend of Figure 3–1. Note that the same color
spectrum scale is used between figures.
As before, we were interested in determining the expression of these
transcripts during mammalian infection, especially considering the association of
Bbive100 to the appO1 TSS. Therefore, promoter fusions for each asRNA to
luciferase were generated. As a means to further validate the upstream regions of
each asRNA as promoters, nucleotide substitutions between the -1 and -48
positions were also executed in promoter fusion constructs (Figure 3–2A). These
exchanges were designed to maintain the integrity of the OppAIV protein, which
would only alter the third nucleotide of OppAIV codons, resulting in no changes
to amino acid composition. Further, these base changes recognized the codon
usage of B. burgdorferi (Codon Usage Database, NCBI-GenBank) and did not cause
the addition of an extremely rare codon. While these considerations are arguably
negligible for promoter fusion analysis, the implementation of these parameters
here will allow future experiments using these altered sequences, where OppAIV
integrity matters. All asRNA promoter fusions exhibited significant activity above
the pJSB161 promoterless control (Figure 3–2C). Nucleotide substitutions in the
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promoter regions, termed promoter bashes (P.B.), for all asRNAs, effectively shut
down activity of the luciferase fusions. The design of these promoter fusions
includes sequence through the 5’ end of Bbive100 for each asRNA. Therefore, the
appO3 promoter fusion contains the promoters of appO2 and appO3 as well.
However, the P.B. constructs demonstrated that there was no read through
transcription from these upstream promoters, as there was no detectable luciferase
signal for the appO3 P.B. construct. This suggests that the promoters for these
asRNAs are independently expressed, each containing specific RNA polymerase
binding sites for transcription. However, there may also be important regulatory
sequences upstream of these promoters, including Bbive100, which could amplify
expression of these asRNAs. These promoter fusions were designed to include
Bbive100, but do not test the contribution of Bbive100 for each TSS. Promoter
fusions could be re-engineered and limited to just -10 and -35 regions upstream of
these asRNAs to test the contribution of Bbive100 for bbb16 asRNAs transcription.
The activities of the putative promoters for these sRNAs were examined during
mammalian infection, and revealed that only appO2 achieved detectable luciferase
signals at days 7 and 10 post inoculation (Figure 3–2D). It is possible that of appO1
and appO3 are transcribed during B. burgdorferi infection of mice, but their
promoter activities fall below the limit of detection by this assay. Additionally,
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further upstream sequence could be needed, that is lacking in the current promoter
fusion, to achieve detectable signals for these two asRNA promoters. However,
appO2 has the highest transcript expression by 5’RNA-seq (Figure 3–2A) and in
vitro promoter activity (Figure 3–2C) compared to the other asRNAs. Spirochetes
carrying the appO2 P.B. construct were also examined during mammalian
infection, which confirmed the results of the in vitro assay luciferase assay, ceasing
transcription of the luciferase reporter though alterations in the appO2 promoter.
Because of the repetition of the oppA genes in the B. burgdorferi genome the
expression and contribution of these transcripts during the spirochete’s infectious
life cycle has been of great interest. Previous studies document fluctuations in the
expression of the oppA transcripts during B. burgdorferi acquisition of the tick,
persistence during the tick molting process, and transmission and colonization of
the mammalian host (87, 232). It has been hypothesized that these proteins
uniquely transport specific peptides, depending on the spirochete’s immediate
environment and their availability (234). However, the regulatory processes which
control the expression of the oppA genes has yet to be fully characterized. Only
oppAV is regulated by the mammalian-specific alternative sigma factor, RpoS, and
the transcription factor BosR/Fur homologue has been suggested to interact with
the oppAIV promoter (235). With the abundance of asRNAs opposing and
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complementary to oppAIV, we hypothesized these transcripts could modulate and
fine tune the transcript expression and protein production of OppAIV. Given that
appO2 promoter activity was detectable during a B. burgdorferi infection, we
pursued mechanistic approaches to examine possible cis-regulation of appO2 and
oppAIV.
To begin dissecting the regulatory roles, if any, of appO2, a B. burgdorferi
clone was created which produced a 3xFLAG-tagged OppAIV. Theoretically,
protein stability is a final readout of sRNA regulation for a specific target as any
changes in transcription, transcript stability, or translation of the target would be
represented. Therefore, we performed quantitative Western blot analysis of
OppAIV-3xFLAG while modifying the expression of appO2. Utilization of an
epitope tagged OppAIV ensures specificity of only quantifying the target protein,
which was especially important for OppAIV as it shares some sequence homology
with the other OppA proteins (61, 233). Anti-FLAG antibodies against B.
burgdorferi lysates revealed an expected ~60 kDa OppAIV band only present in the
B. burgdorferi producing OppAIV-3xFLAG samples, compared to the parent A368Δbbe02 lysates (Figure 3–3A). We next tested the production of OppAIV3xFLAG while overexpressing appO2 in trans on the B. burgdorferi shuttle vector
pBSV2G and under control of the strong promoter flaBp. There was no observed
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difference in OppAIV-3xFLAG, normalized to the protein loading control FlaB
(Figure 3–3B). This was also true for overexpression of appO1 and appO3
simultaneously or all three asRNAs. Because these manipulations occurred in
trans, it is possible that the asRNA targets were inefficient at encountering oppAIV
mRNA, compared to when these sequences are transcribed in cis relative to the
OppAIV ORF. To further examine appO2 regulation without the hindrance of
expression in trans, we used the P.B. sequence for appO2 characterized above to
knockout appO2. To achieve this, a ΔoppAIV B. burgdorferi was either
complemented with native oppAIV-3xflag or oppAIV-3xflag-appO2 P.B. on shuttle
vector pBSV2G. Quantitative Western blots again demonstrated that even with the
removal of appO2, there was no difference in OppAIV-3xFLAG production (Figure
3–3).
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Figure 3–3. Overexpression and removal of appO2 result in no observable
difference in OppAIV protein production.
(A) Western blot analysis of overexpression and appO2 knockout B. burgdorferi
lysates. B. burgdorferi were either genomically tagged at the 3’ end of the oppAIV
mRNA with a 3xflag and transformed with overexpression constructs of the three
antisense RNAs or removed of oppAIV mRNA entirely and complemented with
the addition of 3’ 3xflag or with a 3’ 3xflag and promoter bash (P.B.) of appO2.
Spirochetes were gown to mid-logarithmic phase, lysed, and loaded at 1 x 107
cells/well in an SDS denaturing gradient gel, and transferred to a PDVF
membrane. Anti-FLAG and anti-FlaB antibodies detected protein production of
OppAIV (green bands) and FlaB (constitutive control, red bands), respectively.
Experiments were performed with biological triplicate samples, and one
representative western blot is depicted. (B) Quantitation of western blot. OppAIV3xFLAG bands were selected, quantified, and normalized to FlaB bands of the
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same lysate using Image Studio v. 3.1. Values were normalized to oppAIV-3xFLAG
control for overexpression samples and normalized to Δbbb16+bbb16-FLAG for
appO2 P.B. sample. Data represent the mean normalized, quantitated values of
each OppAIV band ±SD from three biological replicates. Means were analyzed
using the two-tailed Student’s t-test (Prism Graphpad). No significant differences
were observed.
Future studies are aimed at continued molecular experiments to analyze
the contribution of these asRNAs to gene regulation. RNAprediator, a software
which predicts targets for regulatory RNAs, finds oppA1 and oppA2 in the top five
hits for appO2 putative targets (using 148 nts from the 5’RNA-seq TSS of appO2 as
bait) on the B. burgdorferi chromosome (236). Possibilities of the asRNAs in oppAIV
regulating these and other genes in trans is under current investigation.
Alternatively, these asRNAs could result from non-functional pervasive
transcription. Also referred to as spurious or promiscuous transcription, this
concept recognizes that the abundance of internal, intergenic, and antisense may
result from transcriptional “noise” (209). For antisense transcription in particular,
evidence to support this includes the lack of functional asRNAs reported in the
literature despite their abundance (130, 218) and a lack of conservation of antisense
sequences among bacteria (231). Others argue however that because asRNAs form
double-stranded complexes (237) and bind Hfq (238) they play larger unknown
roles in bacterial gene regulation. Collectively these data demonstrate that while
asRNAs are expressed by B. burgdorferi both during in vitro cultivation and murine
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infection, their specific regulatory roles, if any, are challenging to dissect and may
not always occur via a cis-mediated mechanism.
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CHAPTER 4:
A DUAL LUCIFERASE REPORTER SYSTEM FOR B. BURGDORFERI
MEASURES TRANSCRIPTIONAL ACTIVITY DURING TICK-PATHOGEN
INTERACTIONS
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Abstract
Knowledge of the transcriptional responses of vector-borne pathogens at the
vector-pathogen interface is critical for understanding disease transmission.
Borrelia (Borreliella) burgdorferi, the causative agent of Lyme disease in the United
States, is transmitted by the bite of infected Ixodes sp. ticks. It is known that B.
burgdorferi has altered patterns of gene expression during tick acquisition,
persistence and transmission. Recently, we and others have discovered in vitro
expression of RNAs found internal, overlapping, and antisense to annotated open
reading frames in the B. burgdorferi genome. However, there is a lack of molecular
genetic tools for B. burgdorferi for quantitative, strand-specific, comparative
analysis of these transcripts in distinct environments such as the arthropod vector.
To address this need, we have developed a dual luciferase reporter system to
quantify B. burgdorferi promoter activities in a strand-specific manner. We
demonstrate that constitutive expression of a B. burgdorferi codon-optimized
Renilla reniformis luciferase gene (rlucBb) allows normalization of the activity of a
promoter of interest when fused to the B. burgdorferi codon-optimized Photinus
pyralis luciferase gene (flucBb) on the same plasmid. Using the well characterized,
differentially regulated, promoters for flagellin (flaBp), outer surface protein A
(ospAp) and outer surface protein C (ospCp), we document the efficacy of the dual
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luciferase system for quantitation of promoter activities during in vitro growth and
in infected ticks. Cumulatively, the dual luciferase method outlined herein is the
first dual reporter system for B. burgdorferi, providing a novel and highly versatile
approach for strand-specific molecular genetic analyses.

Introduction
Vector-borne illnesses account for 17% of worldwide infectious diseases,
amounting to over one billion cases yearly (239). Ticks are notorious for delivering
a diversity of infectious agents to their hosts during the blood meal. Of these
pathogens the Borrelia burgdorferi sensu lato complex or Borreliella genus (17), the
spirochete group that causes Lyme disease, contributes the highest incidence of
arthropod-transmitted bacterial infection worldwide (32). Particular to the United
States, Borrelia (Borreliella) burgdorferi interaction with and colonization of Ixodes
species is highly specific (240), with no other natural arthropod vector identified
to date.
Newly hatched larval ticks are not colonized with B. burgdorferi, as there is
currently no evidence to support transovarial transmission of the pathogen (23).
Rather, larvae can become infected by feeding on one of the numerous small
vertebrates that serve as reservoirs for B. burgdorferi in nature, such as the white159

footed mouse Peromyscus leucopus. Larval ticks then undergo an approximate
month-long morphogenesis process and molt into nymphs. All the while, B.
burgdorferi reside in the tick midgut. Like the larvae, the infected nymphs take a
single blood meal from a vertebrate followed by morphogenesis to adults. During
nymph feeding, B. burgdorferi migrate from the midgut to the tick salivary glands
and are transmitted to the vertebrate host, maintaining the spirochete in its
enzootic cycle (5). Therefore, it has been proposed that B. burgdorferi undergoes
three major tick-related events that require complex genetic regulation:
acquisition, persistence, and transmission (87, 241).
Survival of B. burgdorferi in the tick requires that the spirochete overcome a
number of environmental stress conditions, such as starvation and assault from
tick immune factors (5, 241). Recently, open reading frame-based microarray
analysis has provided insight into the gene expression changes that occur in the B.
burgdorferi transcriptome in fed larvae, fed nymphs and under mammalian hostlike conditions in dialysis membrane chambers (87). The unusual structure of B.
burgdorferi’s genome and its scarcity of characterized transcription factors, further
contribute to interest in understanding the mechanisms of stress adaptation and
gene regulation that the spirochete employs during its interaction with the tick
vector. The B. burgdorferi segmented genome, in characterized type strain B31, is
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composed of an approximate 900 kb linear chromosome and 21 plasmids of size
ranges 5 to 56 kb that include many annotated open reading frames (ORFs) of
unknown function (61, 64). A recent global examination and 5’ end mapping of the
B. burgdorferi transcriptome by our laboratory has revealed that the spirochete is
rich with “overlapping transcripts” where 63% of total RNA species are
transcribed internal and 13% antisense to annotated open reading frames (221).
Other recent RNA-seq based applications have also described the presence of these
transcripts in B. burgdorferi (201, 222). These findings are supported by similar
analyses in other bacteria, which have revealed complex transcriptomes that
include a variety of antisense, intragenic, intergenic and orphan transcripts, which
in some cases represent the majority of transcript types as opposed to mRNAs for
annotated open reading frames (124, 130, 188). These discoveries drive the need
for the development of new molecular genetic tools for investigating the
expression patterns and functional roles of novel RNA transcripts in a strandspecific manner.
For over three decades, researchers have been isolating, expressing, and
adapting bioluminescence genes for biomedical applications (242, 243). These
techniques are based on the enzymatic (i.e., luciferase) oxidation of a substrate (i.e.,
luciferin) to generate light. Transcriptional reporters using bioluminescence read161

outs have proven to be robust and sensitive molecular tools for investigating
transcript expression (244). Infectious disease-based research has resulted in the
development of multiple luciferase systems for a variety of pathogens, and
demonstrated that relative

luciferase

units of constitutively

expressed

bioluminescence reporters correlate to bacterial numbers (244). Advanced and
high-throughput adaptations for transcriptional reporters utilize multiple
luciferase enzymes with unique substrates, which are compatible within the same
experimental setup. In this manner, one luciferase serves as an experimental
readout of promoter activity and the other as the normalization control for cell
number (245, 246). A previously engineered B. burgdorferi codon-optimized
Photinus pyralis (firefly) luciferase gene (174), when fused to a constitutive
promoter, has been successful for in vivo live imaging of B. burgdorferi
dissemination during mouse infection (247, 248). Furthermore, this luciferase
reporter has been used to characterize the promoters for a variety of annotated
ORFs and novel RNAs during in vitro cultivation, in vivo mouse infection, and in
infected mouse tissues ex vivo (217, 221). However, this reporter plasmid is limited
in that it does not contain a constitutive control reporter to allow normalization
and quantitation of the data. In order to expand the utility of this approach, we
engineered a dual luciferase plasmid that carries both a constitutively expressed
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B. burgdorferi codon-optimized Renilla reniformis (sea pansy) luciferase gene and
the B. burgdorferi codon-optimized Photinus pyralis (firefly) luciferase gene driven
by a promoter of interest. Luciferin, the substrate of Photinus pyralis luciferase,
emits yellow-green photons (550-570 nm) of light (249), whereas coelenterazine,
the substrate of Renilla reniformis luciferase, produces light in the blue spectrum
(470 nm) (250). Functioning on the premise that each luciferase enzyme requires
unique substrates for bioluminescence readout, this approach provides a method
for quantitative measurement of strand-specific transcription, in an environment
of interest. It has been previously demonstrated that coelenterazine-based
luciferase reporters are ineffective for in vivo live imaging detection of bacterial
pathogens during murine infection (251), despite successful in vivo applications
for mammalian tumor systems (252). Herein, our studies demonstrate the efficacy
of the B. burgdorferi dual luciferase system for genetic studies during in vitro
cultivation of spirochetes and analysis of transcriptional activity that occurs at the
tick-pathogen interface, which is critical for understanding the interactions of B.
burgdorferi with the tick vector for the development of novel therapeutic strategies
for Lyme disease.
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Materials and Methods
Bacterial Strains and Growth Conditions
B. burgdorferi clones used in this study were derived from strain B31. For genetic
manipulations infectious low-passage clone A3-68Δbbe02 was utilized, which
lacks cp9, lp56, and gene bbe02 on lp25 (164), and herein referred to as wild type.
Spirochetes were cultivated in liquid Barbour-Stoenner-Kelly (BSK) II medium
supplemented with gelatin and 6% rabbit serum (72) and grown at 35°C with 2.5%
CO2. Luciferase plasmids were engineered in DH5α E. coli, grown in LB broth or
on LB agar plates containing 300 µg/ml spectinomycin when appropriate, and
transformed into B. burgdorferi as previously described (165). Transformants were
selected by plating in solid BSKII medium as previously described (166), in the
presence of 50 µg/ml streptomycin and/or 200 µg/ml kanamycin, when applicable.
All transformants were verified by PCR to contain the plasmid content of the
parent clone (163, 175).
Construction of the Dual Luciferase Plasmids
The Renilla reniformis luciferase gene (243) was codon-optimized for B. burgdorferi
(rlucBb) with the OptimumGeneTM algorithm, synthesized and cloned into the E.
coli vector pUC18 (Genscript) (Genebank accession number MF043582). All primer
sequences are listed in Table 4–1. The rlucBb gene was PCR amplified from pUC18164

rlucBb plasmid DNA using Phusion High-fidelity DNA polymerase (NEB) and
primer pair 1732 and 1733. This also resulted in the addition of 27 bp of DNA from
the 3’ of the flaB promoter to the 5’ of rlucBb. Concurrently, a DNA fragment
containing the flaB promoter sequence with a 24 bp overhang from the 5’ of the
rlucBb gene was Phusion-PCR amplified using B31 A3 genomic DNA and primer
pair 1730 and 1731. The PCR fragments were ligated together by combining
Gibson Assembly® Master Mix (NEB) and 0.16 pmol of each PCR fragment and
incubating the reaction at 50°C for one hour. 1 µl of assembled product (flaBprlucBb) was Phusion-PCR amplified using primers 1730 and 1733 and the DNA
fragment gel extracted using the QIAquick Gel Extraction kit (Qiagen), and cloned
into pCR-Blunt using the Zero Blunt PCR cloning kit (Invitrogen) according to the
manufacturer’s instructions. The sequence of the flaBp-rlucBb cassette was verified
by Sanger sequencing.
The flaBp-rlucBb cassette was Phusion-PCR amplified from the pCR-Blunt
flaBp-rlucBb plasmid using primer pair: 1850 and 1910, introducing BamHI and
KpnI restriction sites. B. burgdorferi shuttle vectors containing the promoterless B.
burgdorferi optimized Photinus pyralis luciferase gene (flucBb), flaBp-flucBb, ospApflucBb or ospCp-flucBb (174, 221) were digested with BamHI and KpnI high fidelity
enzymes (NEB), gel extracted using the QIAquick Gel Extraction kit (Qiagen), and
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ligated to the BamHI/KpnI-digested flaBp-rlucBb cassette using T4 DNA ligase
(NEB), generating plasmids pCFA701, pCFA801, pCFA802 and pCFA803. All
plasmid constructs were confirmed by PCR, restriction digest, and Sanger
sequencing.
Table 4–1. Oligonucleotide primers used in this study.
Number

Name

Sequence (5’-3’)

1730

flaBp 5'

TGTCTGTCGCCTCTTGTG

1731

flaBp 3', 24bp overlay rlucBb 5'

1732

rlucBb 5', 27bp overlay flaBp 3'

1733

rlucBb 3'

AGGATCATAAACTTTACTTGTCATGATTGATAATCAT
ATATCATTCCTCCA
TGGAGGAATGATATATGATTATCAATCATGACAAGT
AAAGTTTATGATCCT
TTATTGTTCATTTTTCAATACTCGT

1850

rlucBb 3' KpnI

CTAAGGTACCTTATTGTTCATTTTTCAATACTCGTTC

1910

flaBp 5' BamHI

TGGCCGGATCCTGTCTGTCGCCTCTTGTGGC

In Vitro Dual Luciferase Assay
B. burgdorferi clones were grown to logarithmic phase (3-7 x 107 spirochetes/ml) or
stationary phase (1-1.2 x 108 spirochetes/ml) in 15 ml of BSKII medium and pelleted
at 3210 x g for 10 min. Cells were washed with phosphate buffered saline (PBS)
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) and
resuspended in 300 µl of PBS. 80 µl of each sample was used to measure the optical
density at 600 nm (OD600) using a BioTek Synergy 4. This resulted in an average
OD600 value of ~0.25 for logarithmic phase spirochetes and ~0.36 for stationary
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phase spirochetes. 100 µl of each sample was loaded into a black, solid bottom 96well plate (Corning) and combined with 700 µM D-luciferin (Regis) in PBS or 3.5
mM water soluble native coelenterazine (NanoLight Technology) in PBS. For
samples containing coelenterazine, one well was left empty, in all directions
around each sample, to decrease signal overlap between samples. For determining
B burgdorferi Photinus luciferase (FlucBb) and Renilla luciferase (RlucBb) sensitivity,
spirochetes containing pCFA801 were grown to logarithmic phase in 15 ml of
BSKII medium, cell density determined using a Petroff Hauser counting chamber,
washed with PBS, and resuspended in PBS to a density of 2 x 106 cells/µl. Samples
were serial diluted 10-fold and 100 µl of each dilution was loaded into a black,
solid bottom 96-well plate (Corning) and combined with 700 µM D-luciferin or 3.5
mM coelenterazine. The relative luciferase units (RLUs) for FlucBb and RlucBb were
determined by measuring photon emission in each well for 1 second, 10 times
using the EnVision 2104 Multilabel Reader (PerkinElmer), following the addition
of luciferin or coelenterazine substrate, respectively. Background relative FlucBb or
RlucBb units, the average RLUs of the PBS control for either substrate, was
subtracted from all experimental measurements, as appropriate. Backgroundsubtracted relative FlucBb units were then normalized to the OD600 value or 108
background-subtracted relative RlucBb units of the same sample, when applicable
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(e.g. 4 x 104 FlucBb units / 0.1 OD600 value = 4 x 105 relative FlucBb units / OD600; 4 x
104 FlucBb units / 0.06 108 RlucBb units = 6.4 x 105 relative FlucBb units / 108 RlucBb
units). The limit of detection (LoD) and quantification (LoQ) for Fluc Bb and RlucBb
were established as the average RLUs for PBS alone plus 3 or 10 standard
deviations, respectively. All experiments were conducted in biological triplicate.
Ethics Statement
The University of Central Florida is accredited by the International Association for
Assessment and Accreditation of Laboratory Animal Care. Protocols for all animal
experiments were prepared according to the guidelines of the National Institutes
of Health and were reviewed and approved by the University of Central Florida
Institutional Animal Care and Use Committee.
B. burgdorferi Infection of Ticks
One week prior to inoculation, and throughout the duration of the study, mice
were treated with 5 mg/ml streptomycin and 1 mg/ml Equal® sweetener in their
water to maintain selection for the luciferase plasmid in the B. burgdorferi clones.
Using B. burgdorferi carrying pJSB175, pCFA701, pCFA801, pCFA802 or pCFA803,
groups of two 6-8 week old female C3H/HeN mice (Envigo) per clone were
inoculated with 1x105 spirochetes per mouse 80% intraperitoneally and 20%
subcutaneously. The inoculum doses were verified by colony forming unit (CFU)
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counts in solid BSKII medium. All inoculum were PCR verified to contain the
endogenous B. burgdorferi plasmids of the parent clone as previously described
(163, 175). Three weeks post inoculation mouse infection was confirmed by
positive seroreactivity against B. burgdorferi protein lysate as previously described
(175, 253). Groups of approximately 200 naïve Ixodes scapularis larvae each (Centers
for Disease Control, BEI resources) were fed to repletion on the B. burgdorferi
infected mice (24). Mice were further confirmed for infection by reisolation of
spirochetes from bladder and joint tissues, as described (176). Larvae were
analyzed for infection (24, 254). Briefly, ticks were individually surface sterilized
by sequential washes in 100 µl of 3% H2O2, 70% ethanol, and sterile H2O. Subsets
of larvae were analyzed for infection by reisolation of spirochetes in BSKII
medium containing RPA cocktail (60 µM rifampicin, 110 µM phosphomycin, and
2.7 µM amphotericin B), immediately post feeding to repletion. Approximately
two weeks following feeding, additional subsets of larvae were crushed and
plated in solid BSKII containing RPA cocktail and 50 µg/ml streptomycin to
determine CFU counts/larva. The remaining larvae were maintained and allowed
to molt into nymphs. Two groups of 10-18 infected nymphs per B. burgdorferi clone
were fed to repletion on naïve 6-8 week old female C3H/HeN mice (Envigo). These
mice were treated with 5 mg/ml streptomycin and 1 mg/ml Equal® sweetener in
169

their water one week prior to the feeding, to help sustain the luciferase plasmids
in B. burgdorferi within the feeding nymphs. Throughout the duration of the study,
ticks were stored in glass desiccation jars containing saturated potassium sulfate
to maintain appropriate humidity.
In Vivo Tick Dual Luciferase Assay
Approximately two weeks post feeding to repletion triplicate groups of 24 fed
larvae or 8 fed nymphs per B. burgdorferi clone were crushed with a sterile pestle
in 250 µl of PBS to generate tick extracts. For tick extracts, which were also plated
for CFU counts, the ticks were first surface sterilized as described above, with a
final wash in sterile PBS instead of H2O. Tick debris was allowed to settle and 100
µl of sample was removed and incubated with 700 µM D-luciferin (Regis) in PBS
or 3.5 mM water soluble native coelenterazine (NanoLight Technology) in PBS.
RLUs were measured as described for in vitro grown spirochetes. The limit of
quantification (LoQ) for FlucBb was established as the average relative FlucBb units
for PBS alone plus 10 standard deviations. The LoQ for RlucBb was established as
the average relative RlucBb units for infected tick extracts with spirochetes
containing pJSB175, which lacks the rlucBb gene, plus 10 standard deviations.
Samples with relative FlucBb units below the LoQ were given a value of zero;
whereas, samples with relative RlucBb units below the LoQ were removed from the
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analysis. Relative FlucBb units were normalized to 108 relative RlucBb units for each
sample. 1 µl of each fed nymph extract was also plated for CFUs in solid BSKII
containing RPA cocktail and 50 µg/ml streptomycin.
Statistical Analysis
GraphPad Prism version 7.02 was used for all statistical analyses. One-way
ANOVA was used for analysis of all luciferase assays. For statistical comparison
of the relative FlucBb units normalized to OD600 or 108 relative RlucBb units, which
had an extremely wide distribution (~101-107), all values were first square root
transformed prior to statistical analysis. Following ANOVA, all samples were
compared to the B. burgdorferi clones carrying the promoterless flucBb control
plasmid pJSB161 or pCFA701 using Dunnett’s multiple comparison test. To
compare two groups (i.e. the same clone in logarithmic versus stationary phase)
following ANOVA, Bonferroni’s multiple comparison test was applied to
determine significance. For association analysis, Pearson correlation coefficient (r)
was determined. p ≤ 0.05 was considered statistically significant for all statistical
tests.
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Results
Generation of the B. burgdorferi Dual Luciferase Plasmid
The B. burgdorferi shuttle vector pJSB161 (174) contains a promoterless B.
burgdorferi codon-optimized Photinus pyralis luciferase gene (flucBb) with a BlgII
restriction site upstream of a ribosome binding site (RBS) for flucBb (Figure 4–1A).
This reporter plasmid allows a cloned promoter of interest to be analyzed for
activity in a strand-specific manner via a bioluminescence detection method (174,
217, 221). However, this approach does not allow for quantitative comparative
analysis of promoter activity in different environments or between multiple
promoters in the same environment due to the lack of an endogenous means to
control for spirochete number across samples and conditions. Therefore to
improve upon this technique for quantitative applications, we engineered a dual
luciferase reporter system to constitutively express Renilla reniformis luciferase
(rluc) (243), while maintaining flucBb for quantifying the activity of a promoter of
interest. Codon usage in B. burgdorferi is biased (61, 255), as the A/T nucleotide
frequency is at 71.8% across the genome (61, 221). Codon optimization has been
shown to improve production and activity of non-B. burgdorferi proteins expressed
in B. burgdorferi (174, 256). Therefore to prevent rare codons interfering with the
Renilla luciferase reporter, the OptimumGeneTM algorithm (GenScript) was used
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to refine the codon adaption index (CAI) of rluc (243) for B. burgdorferi from 0.64 to
0.85 (where a CAI value of 1.0 indicates the highest proportion of the most
abundant codons) and synthesized (GenScript). This codon-optimized rluc gene
(rlucBb) (Genebank accession number MF043582) was cloned into pJSB161 (174), for
use in the dual luciferase reporter system under control of the constitutive
promoter flaBp and corresponding ribosome binding site, generating pCFA701
(Figure 4–1B).

Figure 4–1. B. burgdorferi luciferase plasmids.
All of the B. burgdorferi luciferase shuttle vectors were derived from pJSB161,
which contains a Rho-independent transcription terminator sequence
(terminator); ORFs 1, 2, and 3 of the B. burgdorferi cp9 replication machinery (cp9
ori); E. coli origin of replication (ColE1 ori); and the spectinomycin/streptomycin
resistance cassette (flg-aadA) (174). (A) The B. burgdorferi shuttle vector pJSB161
features a promoterless, B. burgdorferi codon optimized Photinus pyralis luciferase
(flucBb), an upstream ribosome binding site (RBS) and a unique BlgII restriction site
(174). The plasmid pJSB175 was generated by addition of the flaBp promoter
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upstream of flucBb in pJSB161 (174). (B) The B. burgdorferi codon optimized Renilla
reniformis luciferase (rlucBb) gene under the control of the flaB promoter (flaBprlucBb) was added to pJSB161, generating the B. burgdorferi dual luciferase shuttle
vector, pCFA701. Plasmids, pCFA801, pCFA802, and pCFA803, harbor the flaB,
ospA, and ospC promoters, respectively, upstream of flucBb. (C) The density of B.
burgdorferi clone A3-68Δbbe02 (wild type) alone or harboring various B. burgdorferi
luciferase plasmids was assessed over a period of 144 hours using a Petroff Hauser
counting chamber and dark-field microscopy. The data are presented as the mean
spirochete density (spirochetes/ml) ± standard deviation over time (hours).
B. burgdorferi survival in the tick vector is essential for maintenance of the
pathogen in its enzootic cycle. The spirochete is known to change its
transcriptional profile at different stages of tick colonization including:
acquisition, persistence during the molt, and transmission to the mammalian host
(87, 241). Because of our interest in applying the dual luciferase reporter system to
quantitative analysis of B. burgdorferi promoter activities in the tick, we selected
three well characterized promoters with distinct patterns of expression in the tick
environment for proof of principle analysis. The flagellar protein promoter, flaBp,
is constitutively active (257). The promoter for outer surface protein A (ospAp) is
active during in vitro culture and in the tick during acquisition and persistence. In
contrast, the promoter for outer surface protein C (ospCp) is active in the feeding
tick during transmission and the mammalian host during the early stages of
infection (99, 146, 147, 149). The flaBp-rlucBb cassette was cloned into three
previously constructed plasmids, each containing one of these promoters driving
174

the expression of flucBb (174, 221), generating plasmids pCFA801, pCFA802, and
pCFA803, respectively (Figure 1B). Spirochetes carrying pCFA701, pCFA801,
pCFA802, or pCFA803 had no observed in vitro growth defect in BSKII medium
compared to the wild type or B. burgdorferi carrying flaBp-flucBb alone (+pJSB175)
(174) (Figure 4–1C).
RlucBb Selectivity and Limit of Quantification
Photinus pyralis luciferase (Fluc) and Renilla reniformis luciferase (Rluc) are
compatible for a dual reporter due to the specificity of each enzyme for distinct
substrates (245, 252). Therefore, we verified the selectivity of the FlucBb and RlucBb
enzymes to recognize luciferin and coelenterazine, respectively. Based on our
previous work using the flaBp-flucBb reporter (221), we performed these analyses
with approximately 3 x 108 spirochetes harvested during log phase growth. As
expected, the negative control, spirochetes not expressing flucBb or rlucBb
(+pJSB161), demonstrated no significant relative luciferase units for either
substrate compared to wild type. Spirochetes expressing flucBb alone (+pJSB175)
demonstrated robust activity when incubated with luciferin, but no significant
activity above the background of B. burgdorferi carrying pJSB161 when exposed to
coelenterazine (Figure 4–2A). Conversely, spirochetes expressing rlucBb alone
(+pCFA701) demonstrated strong activity when incubated with coelenterazine,
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but no significant activity above the negative control background when exposed
to luciferin (Figure 4–2A). Spirochetes which express both flucBb and rlucBb
(+pCFA801) demonstrated significant relative luciferase units compared to
spirochetes containing pJSB161 for both luciferin and coelenterazine. The
background relative luciferase units for wild type and negative control spirochetes
exposed to coelenterazine were found to be approximately 10-fold higher than
those of the same spirochetes incubated with luciferin.
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Figure 4–2. Selectivity and sensitivity of the dual luciferase assay in B.
burgdorferi.
(A) B. burgdorferi clones were grown to mid-logarithmic phase, and the in vitro
luciferase assay performed with 700 µM D-luciferin or 3.5 mM coelenterazine.
Relative luciferase units were normalized to optical density at 600 nm (OD600) and
presented as the mean relative luciferase units/OD600 ± standard deviation for
biological triplicate samples. The data were square root transformed and analyzed
with a one-way ANOVA followed by Dunnett’s multiple comparison test
compared to B. burgdorferi containing the promoterless flucBb (+pJSB161) for each
substrate. Unless indicated, means were not significantly different from the
control. Significant differences are indicated with asterisks (****, p ≤ 0.0001). (B)
Mid-logarithmic phase grown B. burgdorferi expressing both flaBp-rlucBb and flaBp177

flucBb (+pCFA801) were serial diluted from 2 x 108 to 2 x 100 spirochetes, and
incubated with 3.5 mM coelenterazine. The limit of detection (LoD) was
established as the mean relative luciferase units for PBS alone plus 3 standard
deviations (gray dotted line). The limit of quantitation (LoQ) was established as
the mean relative luciferase units for PBS alone plus 10 standard deviations (red
dotted line). Data are presented as the mean relative luciferase units ± standard
deviation for biological triplicate samples.
Collectively, these data validated the ability of the codon-optimized RlucBb
enzyme to effectively oxidize coelenterazine and confirmed the specificity of the
FlucBb and RlucBb enzymes for their respective substrates.
The utility of the dual luciferase reporter system not only depends on the
substrate specificity of FlucBb and RlucBb, but also the sensitivity of detecting and
quantifying spirochetes expressing rlucBb. The limit of detection (LoD) and limit of
quantification (LoQ) were established as the number of spirochetes required to
achieve relative RlucBb units greater than that of phosphate-buffered saline (PBS)
alone plus three standard deviations and ten standard deviations, respectively.
Analysis of triplicate samples of 10-fold serially diluted spirochetes, 2 x 108 to 2 x
100, harvested during log phase growth and incubated with coelenterazine,
demonstrated 2 x 103 spirochetes to be the lowest detectable number of flaBp-rlucBb
expressing spirochetes in the assay (Figure 4–2B). However, the LoQ fell between
2 x 103 to 2 x 104 spirochetes. Saturation of the bioluminescence signal was never
reached under the conditions examined, with a linear increase in relative Rluc Bb
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units from 2 x 103 to 2 x 108 spirochetes (y = 0.0404x; R2 = 0.9997). Extrapolating
from this linear equation, the LoQ was calculated to be 4.8 x 103 spirochetes. These
data indicate that a minimum of ~ 1 x 104 flaBp-rlucBb expressing spirochetes are
needed to achieve quantifiable relative RlucBb units in the assay. Similar to what
has been reported previously (247), 2 x 103 spirochetes was also found to be the
lowest detectable number of flaBp-flucBb expressing spirochetes (data not shown).
The flaBp-rlucBb Reporter is a Robust Constitutive Control for Measuring
B. burgdorferi Promoter Activities during in vitro Growth.
Previously, we reported quantification of in vitro active B. burgdorferi promoters by
normalizing relative luciferase units (RLUs) from flucBb expressing cells to the
optical density of the bacterial sample measured at 600 nm (OD600) (221). In this
manner, the OD600 measurement reflects the number of spirochetes in the sample
allowing normalization of RLUs across samples and assay conditions. To establish
the flaBp-rlucBb reporter as an effective alternative for OD600 readings in our assay,
first, relative RlucBb units were measured for all rlucBb-expressing B. burgdorferi
clones and normalized to the number of spirochetes in the assay by OD600 (Figure
4–3A). All clones demonstrated consistent, robust relative RlucBb units, ranging
from 5 x 107 to 1.68 x 108. There was no significant difference among clones except
for B. burgdorferi carrying pCFA802, which demonstrated higher relative RlucBb
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units/OD600 compared to all other clones as well as a difference between
logarithmic and stationary phase growth. The same rlucBb-expressing clones, were
also incubated with luciferin and relative FlucBb units were determined by
normalizing to OD600 (Figure 4–3B). All flucBb promoter fusions displayed the
expected relative FlucBb units/OD600, given the known expression patterns of their
corresponding mRNA during logarithmic and stationary phase growth (201). Both
the flaB (+pCFA801) and ospA (+pCFA802) promoters demonstrated significant
activity above the promoterless flucBb control (+pCFA701) for both logarithmic and
stationary phase growth. The activity of the ospC promoter (+pCFA803) during
logarithmic phase growth was no different than the promoterless flucBb control
(+pCFA701). Whereas, the ospC promoter activity underwent significant induction
from logarithmic to stationary phase growth (Figure 4–3B). Normalization of the
relative FlucBb units to 108 relative RlucBb units for each clone demonstrated no
difference in the trend of the data resulting from this method of analysis compared
to the data resulting from FlucBb units normalized to OD600 (Figure 4–3B).
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Figure 4–3. Dual luciferase assay with in vitro grown B. burgdorferi.
Spirochetes were grown to either mid-logarithmic or stationary phase and the in
vitro luciferase assay performed with 700 µM D-luciferin or 3.5 mM coelenterazine.
All data are presented as mean normalized relative luciferase units ± standard
deviation for biological triplicate samples. (A) Relative RlucBb units normalized to
OD600. The data set for each growth condition was analyzed with a one-way
ANOVA followed by Dunnett’s multiple comparison test compared to B.
burgdorferi expressing flaBp-rlucBb (+pCFA701) and Bonferroni’s multiple
comparison test to compare the same clone in the two growth phases. (B) Relative
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FlucBb units normalized to OD600 or 108 relative RlucBb units of the same sample.
Each data set was square root transformed and analyzed with a one-way ANOVA
followed by Dunnett’s multiple comparison test compared to B. burgdorferi
expressing flaBp-rlucBb (+pCFA701). Unless indicated, means were not significantly
different from the control. Significant differences are indicated with asterisks (*, p
≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001).
Together these findings establish flaBp-rlucBb as an effective constitutive control
reporter, whose quantitation is reflective of spirochete number and is a robust
means to normalize data obtained from flucBb promoter fusions using the dual
luciferase reporter system.
The Dual Luciferase Reporter System Quantifies Promoter Activities during TickSpirochete Interactions.
Having established the dual luciferase reporter system for use with in vitro grown
spirochetes, we examined the efficacy of the reporter system for measuring B.
burgdorferi promoter activities in the tick vector. Naïve Ixodes scapularis larval ticks
were infected with B. burgdorferi carrying the dual luciferase reporter plasmids or
flaBp-flucBb, lacking rlucBb (+pJSB175) by feeding on groups of mice infected with
the reporter clones via needle inoculation. Immediately following feeding to
repletion, the percent of infected larvae per experimental group was determined
by spirochete reisolation in BSKII medium. This analysis revealed that 60-90% of
each experimental group of larvae successfully acquired B. burgdorferi upon
feeding on infected mice. As an additional means to determine the percentage of
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infected larvae and to quantitate the number of spirochetes per tick, individual fed
larvae were crushed and plated in solid medium for colony forming units (CFUs).
Similar to the spirochete reisolation analysis, the groups of fed larvae were found
by CFU analysis to be 66-100% infected. Moreover, although a broad range of
spirochetes per tick was detected, there was no statistical difference between the
average spirochete load per tick for each of the B. burgdorferi clones (Figure 4–4).
These data suggest that all of the clones were able to colonize the ticks with the
same efficiency.

Figure 4–4. The dual luciferase plasmids do not affect B. burgdorferi acquisition
efficiency.
Groups of ~200 naïve Ixodes scapularis larvae were fed to repletion on mice infected
with B. burgdorferi containing distinct luciferase plasmids. Subsets of individual
fed larvae per B. burgdorferi clone were surface sterilized, crushed, and plated in
solid BSKII containing RPA cocktail and 50 µg/ml streptomycin. Data points
represent the number of colony forming units (CFUs) per individual fed larva.
Uninfected larvae (CFU = 0) are represented as data points on the X-axis. No
significant differences were detected across the data as determined with a oneway ANOVA.
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Based on our quantitation of the average number of spirochetes per tick
(Figure 4–4), we estimated that pools of 24 fed larvae would equate to
approximately 104 spirochetes per sample, suggesting that the RlucBb activity
would be quantifiable by our assay (Figure 4–2B). Therefore, two weeks following
the blood meal, 24 fed larvae per experimental group, in triplicate, were crushed
in PBS and relative FlucBb and RlucBb units measured using the luciferin and
coelenterazine substrates, respectively (Table 4–2). The remaining fed larvae were
reserved and allowed to molt into nymphs. The unfed, infected nymphs were then
fed to repletion on naïve mice. Approximately two weeks post feeding, groups of
eight fed nymphs were crushed in PBS, in triplicate, and assessed for relative
FlucBb and RlucBb units (Table 4–2). Under the assumption that the spirochete load
per fed nymph is increased approximately 10-fold compared to that of fed larvae
(24, 175), we estimated the average spirochete load per fed nymph to be
approximately 104. Therefore, a pool of eight fed nymphs was estimated to equate
to approximately 8 x 104 spirochetes, which is above both the LoD and LoQ of the
in vitro assay (Figure 4–2B).
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Table 4–2. In vivo tick dual luciferase assay.
Tick
Life
Stage

Plasmid

Luciferase
Cassette(s)

PBS
pJSB175

Relative RlucBb Units Biological/Replicatea
1

2

3

n/ac

85.2

89.6

92.8

flaBp-flucBb

37.6

36.4

34.4

Relative FlucBb Units Biological/Replicateb
1

2

3

20.0

24.8

24.4

137.6

245.6

138

LoQ = 52.3

LoQ = 49.7

d

Fed
Larvaee

Fed
Nymphf

pCFA701

flaBp-rlucBb

185.6

108.8

208.0

22.4*

24.0*

24.0*

pCFA801

flaBp-rlucBb; flaBp-flucBb

603.6

1,502.4

1,187.6

56.0

136.0

100.8

pCFA802

flaBp-rlucBb; ospAp-flucBb

144.4

153.2

176.0

26.0*

25.2*

24.0*

pCFA803

flaBp-rlucBb; ospCp-flucBb

346.8

341.2

234.8

22.4*

23.6*

19.6*

PBS

n/a

82.4

93.2

83.2

19.6

20.4

18.8

pJSB175

flaBp-flucBb

31.6

31.6

30.0

504.8

1,700.8

881.6

41.6
2,416.8
1,001.2
1,500.8

LoQ = 40.3
29.6*
2,560.0
2,257.6
1,239.6

18.0*
956
107.6
21.2*

LoQ = 27.6
19.6*
552.8
262
32.8

18.0*
388
36
16.4*

pCFA701
pCFA801
pCFA802
pCFA803

flaBp-rlucBb
flaBp-rlucBb; flaBp-flucBb
flaBp-rlucBb; ospAp-flucBb
flaBp-rlucBb; ospCp-flucBb

296.0
780.4
338.4
34.8*

Relative RlucBb units from three independent tick extracts incubated with 3.5 mM coelenterazine.
Relative FlucBb units from three independent tick extracts incubated with 700 µM luciferin.
cNot applicable.
dLimit of Quantification (LoQ) defined as the average background signal for each assay plus ten standard deviations.
eExtract from groups of 24 fed larvae crushed in PBS.
fExtract from groups of 8 fed nymphs crushed in PBS.
*Samples that fell below their respective LoQ.
a

b
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The actual LoQ for the in vivo tick assay was established using the average RlucBb
units plus ten standard deviations for tick extracts from fed ticks infected with B.
burgdorferi lacking rlucBb but expressing flaBp-flucBb, (+pJSB175), rather than PBS
alone. This is due to the observation that this tick extract negative control resulted
in lower background relative RlucBb units compared to PBS alone (Table 4–2). In
contrast, there was no observed difference in the background relative Fluc Bb units
between PBS and the tick samples containing B. burgdorferi with a promoterless
flucBb and expressing flaBp-rlucBb (+pCFA701) in the luciferin assay. Therefore, the
LoQ for FlucBb in the in vivo tick assay was determined using the average relative
FlucBb units for PBS plus ten standard deviations. Samples that fell below the LoQ
threshold for either luciferase enzyme were considered no different than
background (Table 4–2). As expected, we detected quantifiable relative RlucBb
units for all fed larvae samples, and all but two fed nymph samples (Table 4–2),
indicating that sufficient spirochetes were present in the samples for the assay. In
the pools of fed larvae, only samples containing B. burgdorferi carrying flaBp-flucBb
(+pCFA801) demonstrated quantifiable relative FlucBb units. The activities of ospAp
and ospCp were below the LoQ for FlucBb (Table 4–2). In contrast, all three
promoters produced quantifiable relative FlucBb units in the fed nymphs.
Although one of the extracts from the fed nymphs infected with B. burgdorferi
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carrying ospCp-flucBb (+pCFA803) did not result in quantifiable relative FlucBb units,
this sample also failed to achieve quantifiable relative RlucBb units (Table 4–2),
indicating that the number of spirochetes in the sample was insufficient for the
assay. The promoter activities of the spirochetes in the fed nymph samples were
analyzed by subtracting the average relative FlucBb units of PBS from the relative
FlucBb units of each sample and the average relative RlucBb units of the infected tick
extracts containing the negative control plasmid (+pJSB175) from the relative
RlucBb units of each sample. Background-subtracted FlucBb units were then
normalized to the respective background-subtracted relative RlucBb units, for all
quantifiable values. The RlucBb-normalized promoter activities reflected the
expected corresponding B. burgdorferi transcript expression pattern during the fed
nymph life stage (Figure 4–5A) (87).
As an additional means to validate the method as well as to demonstrate
that relative RlucBb units are directly reflective of spirochete numbers in the
infected tick samples, a portion of each sample from the fed infected nymphs used
for RlucBb and FlucBb quantitation (Table 4–2 and Figure 4–5A), was plated in solid
BSKII medium for determination of B. burgdorferi CFUs. The average CFUs per 100
µl of tick extract, the same volume used for the dual luciferase assay, across all
clones, was found to be 3.72 x 105 spirochetes. These data support our
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rationalization for the use of 8 fed nymphs in the assay. Raw relative RlucBb units
(Table 4–2) for these samples plotted against their corresponding CFU counts
demonstrated a significant positive correlation (Figure 4–5B). Furthermore, this
analysis indicated that 1.2 x 103 spirochetes are sufficient to generate relative RlucBb
units above the LoQ for the in vivo tick assay, which is similar to the sensitivity we
observed for the in vitro assay.
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Figure 4–5. The dual luciferase assay quantitates known patterns of B.
burgdorferi transcript expression in nymphs.
(A) Groups of eight fed nymphs per B. burgdorferi clone were surface sterilized and
crushed in 250 µl of PBS and the in vivo tick luciferase assay performed with 100
µl of tick extract and 700 µM D-luciferin or 3.5 mM coelenterazine. The data are
presented as the mean relative FlucBb units per 108 relative RlucBb units ± standard
deviation (n = 3; B. burgdorferi carrying pCFA803 n = 2). (B) Relative RlucBb
luciferase activity is reflective of spirochete numbers in extracts from fed infected
nymphs. 1 µl of fed nymph extract was plated for CFUs in solid BSKII containing
RPA cocktail and 50 µg/ml streptomycin. The number of CFUs/100 µl of tick
extract (CFUs) was plotted against the relative RlucBb units for the same extract.
The red dotted line indicates the established LoQ for relative RlucBb units. Black
symbols represent extracts with quantifiable relative RlucBb units and red symbols
represent extracts with non-quantifiable RlucBb units. A nymph extract with no
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detectable CFU (CFU = 0) is represented as the data point on the Y-axis. A
significant positive correlation was detected between CFU and relative Rluc Bb
units (Pearson coefficient, r = 0.8022, p = 0.0017).
Collectively, we have described a valuable new method to determine the activity
of B. burgdorferi promoters of interest under in vitro growth conditions and in
infected ticks. This is the first application of a dual reporter system for B.
burgdorferi and, to the best of our knowledge, the first quantification of spirochete
promoter activities in the tick vector.

Discussion
Promoter fusion reporter systems are elegant, simple, and powerful tools to
quantitate bacterial promoter activities in environments of interest. Herein we
have established a new dual luciferase reporter method using the Renilla (sea
pansy) and Photinus (firefly) luciferase enzymes for measurement of B. burgdorferi
promoter activities in vitro and in the feeding tick during spirochete acquisition
from an infected vertebrate host and transmission to a naïve vertebrate host. We
demonstrate that constitutive expression of the B. burgdorferi codon-optimized
Renilla luciferase gene (rlucBb) is a specific and sensitive measurement of spirochete
numbers for normalization of Photinus luciferase gene (flucBb) expression under the
control of a promoter of interest.
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Several reporter genes have been applied to B. burgdorferi including
chloramphenicol acetyl transferase (cat) (258), genes encoding a variety of
fluorescent proteins (259-261), the Photinus pyralis luciferase gene (flucBb) (174), and
lacZ encoding β-galactosidase (lacZBb) (256). Here we describe the first use of a dual
reporter system for B. burgdorferi. The combined application of the Renilla and
Photinus luciferase genes has several advantages compared to other B. burgdorferi
reporter systems as well as other methods of gene expression quantitation such as
RT-qPCR. No sample extraction or purification is required to achieve detectable
bioluminescence signals, allowing for rapid assay read out with little sample
manipulation. Our data indicate that the rlucBb gene under the control of the strong,
constitutive flaB promoter results in relative RlucBb units reflective of the number
of live spirochetes. This allows relative RlucBb units to serve as the endogenous
control against which the relative luciferase units of promoter fusions to flucBb on
the same plasmid, in the same sample, can be normalized. It is even possible to
measure FlucBb and RlucBb signals back-to-back in the same assay well using firefly
luciferase quenching reagents, such as Stop & Glo by Promega (245) and therefore
little sample material is required. Use of optical density at 600 nm (OD 600) to
quantitate sample turbidity as a measure of cell number does not distinguish
between live and dead cells in the sample and therefore may not accurately reflect
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the number of live cells that contribute to the bioluminescence signal.
Furthermore, OD600 cannot be used for complex biological samples such as extracts
from fed ticks. We demonstrate a significant positive correlation between relative
RlucBb units and numbers of live spirochetes both in vitro and in ticks. The B.
burgdorferi clone containing pCFA802 exhibited statistically different relative
RlucBb units in vitro when normalized to OD600 compared to the other clones.
However, the relative FlucBb units/108 relative RlucBb units for this clone followed
the expected pattern of ospA expression in vitro and in nymphs. Furthermore, the
relative RlucBb units for spirochetes carrying pCFA802 correlated to the number of
live spirochetes in fed nymph extracts from this clone, suggesting that the
observed difference may not result in a biologically significant effect. Utilizing
flaBp-rlucBb as an endogenous constitutive control provides new opportunities for
the development of novel high-throughput genetic screening approaches. DNA
libraries engineered to drive expression of flucBb could be effectively screened for
active promoters in various growth conditions of interest and relative FlucBb units
normalized to relative RlucBb units. Further, the dual luciferase reporter plasmid
can be manipulated to engineer FlucBb translational fusions to quantitate protein
production and stability in growth conditions of interest. An additional important
benefit of the dual luciferase reporter assay is the ability to quantitate the promoter
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activity of a transcript in a strand-specific manner. We and others have recently
reported recognition of novel RNA transcripts in the B. burgdorferi genome (201,
221, 222). Through global 5’ end mapping of the B. burgdorferi transcriptome, we
have predicted promoter sequences for previously unannotated RNAs, including
antisense and intragenic transcripts, and validated their activities in a variety of
environments (221). Application of the dual luciferase reporter system now
provides a robust means for quantitative comparative analysis of strand-specific
B. burgdorferi transcription in complex regions of the genome at the tick-pathogen
interface.
For the correct interpretation of molecular techniques it is important to
define the lowest level of a measurement, in this case relative luciferase units,
which can be reliably analyzed. The limit of detection (LoD) is the lowest amount
of measurable signal above background and the limit of quantification (LoQ)
signifies the lowest interpretable signal above background. Effective use of LoD
and LoQ are based off the standard deviation (SD) of background readings and
assume at least 95% of analyzed values are true measurements in the biological
assay (262). We have stringently defined LoD as the meanbackground RLUs + 3SD and
LoQ as the meanbackground RLUs + 10SD. Thereby LoQ should be calculated for each
luciferase substrate and each independent application of the B. burgdorferi dual
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luciferase assay to best distinguish low but quantifiable bioluminescence signals
from background. It is also important to define the appropriate background
controls in the context of the assay. Indeed, our studies have demonstrated that
background relative RlucBb units were ~60% decreased in fed tick extracts
compared to PBS alone. Therefore, extracts from fed ticks infected with B.
burgdorferi lacking rlucBb expression (+pJSB175) served as the background control
to calculate the LoQ for RlucBb in ticks. Conversely, this was not observed for the
background relative FlucBb units for fed tick extracts and PBS alone served as the
negative control for these measurements. We hypothesize that the biological
matrix of the fed tick extracts contributes, in part, to alteration of the RlucBb signal
by inhibiting non-specific activation of the coelenterazine substrate.
We found that not all samples with quantifiable relative RlucBb units, also
had quantifiable relative FlucBb units. In some cases, the finding that a promoter
fusion has non-quantifiable relative FlucBb units may accurately reflect the weak to
no biological activity of that promoter in a particular environment and/or nonquantifiable relative FlucBb units may result from low numbers of spirochetes,
albeit quantifiable relative RlucBb units. These challenges may be overcome by
increasing the number of spirochetes used in the assay. This is evident in the data
we present for the in vivo tick assay, in which the fed larvae samples for all B.
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burgdorferi clones achieved quantifiable relative RlucBb units; however, the clone
containing flaBp-flucBb (+pCFA801), but not the clones containing ospAp-flucBb
(+pCFA802) or the ospCp-flucBb (+pCFA803), produced quantifiable relative FlucBb
units. This finding was not surprising for the ospC promoter, given that the ospC
transcript is known to have weak to no activity in fed larvae following B.
burgdorferi acquisition from infected mice. This finding was, however, unexpected
for the ospA promoter, whose transcript is known to have strong activity in this
environment (215). Yet, the average number of spirochetes in the ospAp-flucBb
(+pCFA802) and ospCp-flucBb (+pCFA803) containing clone extracts, as reflected by
the average relative RlucBb units (1.6 x 102 and 3.1 x 102, respectively), were
approximately 10-fold and 4-fold less than that of the flaBp-flucBb (+pCFA801)
containing clone (1.1 x 103), suggesting that spirochete number may contribute, in
part, to the non-quantifiable relative FlucBb units for these spirochetes. In contrast,
the fed nymph extracts contained comparable average numbers of spirochetes
regardless of the clone, as reflected by both the average relative RlucBb units (1.5 x
103 ± 380) and CFU counts (4.4 x 105 ± 2.2 x 105) and all flucBb promoter fusions
achieved quantifiable relative FlucBb units. Furthermore, while it was one of our
goals to measure promoter activities for spirochetes in unfed-flat nymphs postmolt, we found the luciferase signals for these samples to be below the limit of
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quantification of our assay. We again hypothesize that the spirochete loads in the
ticks at this point in the infectious cycle may be below the number of spirochetes
necessary for the assay. To examine this possibility we crushed and plated for CFU
a subset of individual unfed nymphs infected with spirochetes carrying both flaBprlucBb and flaBp-flucBb (+pCFA801). The average spirochete load was determined to
be ~27 spirochetes/unfed nymph. This was approximately 10-fold lower than the
average spirochete load in the fed larval ticks for the same clone (~4.4 x 10 2
spirochetes/fed larvae) and approximately 10,000-fold lower than that of fed
nymphs (~1.6 x 105 spirochetes/fed nymph). Considering that pools of 24 fed larvae
and 8 fed nymphs, and therefore ~104 and ~106 spirochetes carrying pCFA801,
respectively, were used for the luciferase assays, nearly 400 up to 40,000 unfed
nymphs would be required to achieve equivalent relative luciferase units. The
difficulties of studying B. burgdorferi transcription in unfed nymphs was also
shown by a recent microarray study, where even with an amplification step,
transcript analysis in this tick life-stage was precluded (87). RT-qPCR does remain
an alternative approach for gene expression analysis in unfed nymphs, having
several documented successes in determining B. burgdorferi transcript levels (176,
232, 263), albeit lacking strand specificity. It should be noted that the endogenous
copies of the flaB, ospA, and ospC genes and their promoters are present in the
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genetic background of all of the B. burgdorferi clones that were analyzed. This raises
the possibility that a reduction in FlucBb or RlucBb signals could have occurred due
to titration of transcription factors away from the promoter fusions by the
endogenous promoters. However, expression of flaB, ospA, and ospC are essential
for survival of B. burgdorferi throughout its infectious cycle (76, 264) and thus these
experiments could not be conducted in the absence of these genes.
While dual fluc and rluc reporter systems have been used successfully for
live imaging and quantitation of eukaryotic tumor cells in mice (252), the use of
Renilla luciferase and the coelenterazine substrate for live imaging of microbial
infections in mice has proven challenging (244) and few publications report
exploration of the use of dual Renilla and Photinus luciferase reporters in the
context of infectious disease applications. There is great interest in applying a
luciferase dual reporter system to quantification of B. burgdorferi promoter
activities during an active mammalian infection. We and others have
demonstrated the power of the flucBb reporter for tracking B. burgdorferi
dissemination and qualitative detection of promoter activities over time in live
mice (221, 247, 265). By extension we investigated the efficacy of the dual luciferase
reporter system for live imaging applications with B. burgdorferi in infected mice.
Exhaustive examination of available coelenterazine substrates including: h197

Coelenterazine-SOL in vivo (NanoLight), Inject-A-Lume h-Coelenterazine
(NanoLight), ViviRenTM in vivo Renilla Luciferase Substrate (Promega), and
XenoLight RediJect Coelenterazine h (PerkinElmer) as well as various substrate
concentrations, substrate injection methods and imaging times, resulted in no
significant RlucBb signals above background (data not shown). Unlike for
applications for solid cancers, use of luciferase substrates for in vivo detection of
microbial pathogens relies on the substrates to be available in excess, systemically
throughout the animal. Luciferin has been documented to rapidly distribute
throughout the mouse (266), but the bioavailability of coelenterazine may be more
limited (267). In addition, we found coelenterazine to have an extraordinary high
background signal. Indeed, RlucBb signals following coelenterazine delivery were
observed for mice infected with spirochetes lacking rlucBb entirely, which were not
able to be overcome in mice infected with spirochetes expressing flaBp-rlucBb (data
not shown). These findings are consistent with what has been reported for
attempted in vivo imaging applications using coelenterazine and Mycobacterium
smegmatis expressing Gaussia luciferase (251). Rather, alternative methods of
normalization may be used, such as determining spirochete loads of infected
tissues immediately following FlucBb imaging (217), in instances where
quantification of promoter activity during murine infection is warranted.
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B. burgdorferi has been shown to colonize Ixodes scapularis via a biphasic
mode of dissemination which is believed to involve complex interactions between
the pathogen and the arthropod vector (268). We are still discovering many of the
mechanisms B. burgdorferi employs to survive throughout its enzootic cycle.
Additionally, the recently sequenced Ixodes scapularis genome opens new areas of
study for host-pathogen interactions (269). Successful and reliable techniques for
analysis of spirochete biology in the tick are critical to drive understanding of these
interactions. The dual luciferase system presented here is a simple and powerful
approach for measuring transcript expression, which can be easily modified to
meet the needs of the researcher and adds to the ever growing molecular genetic
toolbox for investigation of B. burgdorferi transcription and gene regulation.
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CHAPTER 5:
GENE BB0562 ENCODES A MEMBRANE-ASSOCIATED
PROTEIN CRITICAL FOR B. BURDORFERI MAMMALIAN
INFECTION
Preface
This chapter was composed entirely by P.P.A. Comments from M.W.J. were
incorporated into the final version presented here.
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Abstract
In vivo expression technology in the Lyme disease spirochete, B. burgdorferi
(BbIVET), discovered a variety of novel transcripts expressed during murine
infection. BbIVET-identified gene bb0562 encodes a hypothetical protein that
contains a conserved domain of unknown function, DUF3996. Herein we
demonstrate that bb0562 is constitutively expressed throughout B. burgdorferi’s
tick-mouse enzootic cycle and encodes a membrane-associated protein. Targeted
deletion of bb0562 revealed its requirement for efficient colony formation in solid
medium but not for normal growth in liquid medium. Further, bb0562 was found
to

be

critical

for

mouse

infectivity

by

needle

inoculation

in

both

immunocompetent and immunocompromised mice as well as by tick bite
transmission. In contrast, bb0562 was dispensable for spirochete replication and
persistence in the tick. Collectively, this work provides the first experimental
evidence for the importance of gene bb0562 in infection and highlights the power
of BbIVET to discover novel genetic factors critical for B. burgdorferi pathogenesis.
Introduction
Lyme disease, caused by the spirochete Borrelia (Borreliella) burgdorferi, is the
leading vector-borne bacterial illness in the world (32, 33). B. burgdorferi is
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naturally maintained in an enzootic cycle between an arthropod vector, Ixodes sp.
ticks, and diverse small vertebrate reservoir hosts (5). Humans acquire B.
burgdorferi infections through the bite of an infected tick (1). If left untreated, B.
burgdorferi disseminate from the bite site, transiently through the blood, to distal
tissues leading to the debilitating clinical manifestations of Lyme disease such as
arthritis, carditis, facial nerve palsy and encephalopathy (270).
For B. burgdorferi to achieve a disseminated infection the pathogen must
adapt to physical conditions of the host environment, overcome host innate and
adaptive immune defenses, and interact with key host cell molecules to effectively
move through and colonize distal tissues (271, 272). Broad research efforts in the
field have resulted in identification of numerous B. burgdorferi proteins important
for spirochete dissemination (271, 273). Largely, these studies have been primarily
guided by hypotheses based on protein sequence identity and conserved domain
analyses. However, B. burgdorferi harbors a reduced genome lacking many
canonical metabolic, virulence, and host defense evasion functions. Furthermore,
a large number of B. burgdorferi genes encode hypothetical proteins of unknown
function which are uniquely conserved among Borrelia (Borreliella) species (61,
169). Together this suggests that B. burgdorferi has evolved unique mechanisms to
survive in the host.
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In order to elucidate novel factors important for B. burgdorferi survival and
pathogenesis we previously sought to identify transcripts expressed by the
pathogen during an active mammalian infection through application of in vivo
expression technology (BbIVET) (117). This in vivo genetic screen identified 233
infection-active putative promoter sequences, referred to as B. burgdorferi in vivo
expressed sequences (Bbives). Ninety-one Bbives mapped within 300 nts upstream
of annotated start codons for open reading frames (ORFs) (117, 221), suggesting
that these sequences serve as promoters for proximal genes during infection.
Approximately 33% of the 91 Bbives mapped upstream of genes annotated to
encode hypothetical proteins of unknown function. Many of these genes have yet
to be investigated for their contributions to B. burgdorferi pathogenesis. Of these,
we targeted novel gene bb0562 for deletion and examination during the B.
burgdorferi infectious cycle. Herein, we demonstrate that gene bb0562, is expressed
throughout the tick-mouse infectious cycle and encodes a membrane-associated
protein that is dispensable for survival in the tick vector but critical for infection
of the mammalian host.
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Materials and Methods
Bacterial Strains and Growth Conditions
Borrelia (Borreliella) burgdorferi clones used in this study were derived from clone
B31 A3 and genetic manipulations used infectious low-passage clone A3-68Δbbe02,
herein referred to as wild type (WT) (164). B. burgdorferi cultures were grown at
35°C supplemented with 2.5% CO2 in the presence of 50 µg/ml streptomycin, 200
µg/ml kanamycin and/or 40 µg/ml gentamycin when applicable. Spirochetes were
cultivated in liquid Barbour-Stoenner-Kelly (BSK) II medium supplemented with
gelatin and 6% rabbit serum (72) and plated in solid BSKII medium as previously
described (166). DH5α E. coli were grown in LB broth or on LB agar plates
containing 300 µg/ml spectinomycin, 50 µg/ml kanamycin and/or 15 µg/ml
gentamycin when appropriate.
B. burgdorferi Genetic Manipulations
The flag epitope sequence (274) was added in triplicate to the C-terminus of bb0562
via Phusion-PCR using B. burgdorferi A3 genomic DNA and primer pair 1650+1764
(Table 5–1). The KpnI/ SalI digested-PCR product was ligated into pBSV2G (275)
and cloned in E. coli. The pBSV2G bb0562-3Xflag plasmid was verified by PCR,
restriction enzyme digest, and Sanger sequencing prior to transformation into WT
B. burgdorferi, as described (165).
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Targeted deletion and cis complementation of bb0562 was carried out via
allelic exchange on the B. burgdorferi chromosome. Spectinomycin/streptomycin
(flaBp-aadA) and gentamycin (flgBp-aacC1) resistant cassettes were Phusion-PCR
amplified from B. burgdorferi shuttle vectors (205, 229, 275) using primer pairs
1255+1256 and 1789+1790, respectively (Table 5–1). Allelic exchange constructs
were engineered via a PCR-based overlap extension strategy (117) using PhusionPCR and primers 1340, 1341, 1342, 1343 for Δbb0562 (bb0562::flaBp-aadA) or 1340,
1791, 1788, 1343 for clones bb0562-flgBp-aacC1 (bb0562+ and WT-gent)
(Supplementary Table 1), ligated into pCR-BLUNT and transformed into WT B.
burgdorferi or spirochetes lacking bb0562, as described (165). All clones were
verified by PCR using external primers to the lesion (1343+1340), internal primers
to bb0562 (1718+1715), and internal primers to flaBp-aadA (1826+1825) or flgBpaacC1 (1789+1790) (Table 5–1). All clones were verified to contain the endogenous
plasmid content of the parent (163, 175).
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Table 5–1. Oligonucleotides used in this study.
Number

Name

Sequence (5’-3’)

Primers:
1123

recA qPCR 5'

AATAAGGATGAGGATTGGTG

1124

recA qPCR 3'

GAACCTCAAGTCTAAGAGATG

1875

flaB qPCR 5'

GCATTAATCTTACCAGAAACTCC

1876

flaB qPCR 3'

GCATTAACGCTGCTAATCTTAG

2138

ospA qPCR 5'

CGATCTAGGTCAAACCACA

2139

ospA qPCR 3'

GTTCCGTCTGCTCTTGT

2203

ospC qPCR 5'

ACGGATTCTAATGCGGTTTTACCT

2204

ospC qPCR 3'

CAATAGCTTTAGCAGCAATTTCATCT

1715

bb0562 qPCR 5'

GGTGGTAGTAATGGAATAAATCTATC

1716

bb0562 qPCR 3'

ATATGCTTATATTTCCTCCTATTCC

2179

bb0563 qPCR 5'

GGTCTTTACAGCGGAGTAA

2180

bb0563 qPCR 3'

CTGCCTCCAAATCTTGAAA

2263

bb0564 qPCR 5'

GCTCAGATTTAACAAATGTTTCT

2264

bb0564 qPCR 3'

GTTAGGCATTTGGCCA

1650

bb0562 5' +145 nt upstream TSS, KpnI

GGGGTACCATAATAAAATTCTTTTTTAAAAAGTTTTAAAAAAGAAC

1764

bb0562 3' + 3Xflag, SalI

GCGTCGACTTATTTATCATCATCATCTTTATAATCTTTATCATCATCATCTTTATAATCTT
TATCATCATCATCTTTATAATCAAAGATATAGTACTTAGCAAATATTCC

1255

flaBp-aadA 5'

TGTCTGTCGCCTCTTGTG

1256

flapBp-aadA 3'

TTATTTGCCGACTACCTTGGTG

1789

flgBp-aacC1 5'

TAATACCCGAGCTTCAAGGAAGATTTCCTATTAAGGTTGAAC

1790

flgBp-aacC1 3'

TTAGGTGGCGGTACTTGGGTCGATATCAAAGTGCATC

1340

bb0562 + ~500 bp 5'

CTTGACATTGGTCTTTACAGCG

1341

bb0562 + ~500 bp 3' flaBp overlap

CGGAAGCCACAAGAGGCGACAGACACGTTGTCTCCCAAATTTTGTC

1342

bb0562 + ~500 bp 5' aadA overlap

GGCGAGATCACCAAGGTAGTCGGCAAATAAGCTGGGGGAATATTTGCTAAG

1343

bb0562 + ~500 bp 3'

TGAGTTTGAGCTTAGTGATTGG

1788

bb0562 + ~500 bp 3' flgB overlap

GTTCAACCTTAATAGGAAATCTTCCTTGAAGCTCGGGTATTATTATTGCCAAGCGCTAT
GAAAAAAT
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Number

Name

Sequence (5’-3’)

1791

bb0562 3' aacC1 overlap

1715

bb0562 internal 5'

GATGCACTTTGATATCGACCCAAGTACCGCCACCTAAATTTAATAAATTAGAATGAAT
TGGTGTTAAAAGAT
GGTGGTAGTAATGGAATAAATCTATC

1718

bb0562 internal 3'

GCAAAGTTTGATTTTATGCCC

1825

aadA internal 5'

ATGAGGGAAGCGGTGATCGCCGAAG

1826

aadA internal 3'

TTATTTGCCGACTACCTTGGTGATCTCGCCTT

1137

flaB-TaqMan-FWD

TCTTTTCTCTGGTGAGGGAGCT

1138

flaB-TaqMan-REV

TCCTTCCTGTTGAACACCCTCT

1140

nid-TaqMan-FWD

CACCCAGCTTCGGCTCAGTA

1141

nid-TaqMan-REV

TCCCCAGGCCATCGGT

1139

flaB-TaqMan-Probe

6-FAM-AAACTGCTCAGGCTGCACCGGTTC-TAMRA

1142

nid-TaqMan-Probe

6-FAM-CGCCTTTCCTGGCTGACTTGGACA-TAMRA

Probes: a

6-FAM, 6-carboxyfluorescein; TAMARA, 6-carboxytetramethylrhod

a
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BB0562 Localization and Western Blot Analysis
Fractionation of B. burgdorferi lysates were prepared as described (276). Briefly,
spirochetes were grown to log phase in BSKII, spun at 3210 x g for 10min, washed
twice with cold HN buffer (50 mM Hepes, 50 mM NaCl, pH 7.5), and resuspended
in 1 ml HN and 100 µl Halt Protease Inhibitor Cocktail (Thermo Scientific).
Spirochetes were lysed via sonication and spun at 125,000 x g to collect soluble and
membrane components of the lysate.
Proteinase K digestions were performed as described (73, 233). Briefly, 1 x
109 spirochetes of log phase grown (3x107 cells/ml) B. burgdorferi were resuspended
in PBS-Mg2+ (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 5mM
MgCl2 pH 7.4) with or without 200 µg/ml proteinase K and incubated at 20°C for
1 hr. Simultaneously, the same conditions were performed with the addition of
0.1% SDS during the incubation. 1 mg/ml phenylmethylsulfonyl fluoride was
added to samples, which were pelleted by centrifugation at 2000 xg.
Protein samples were combined with equal parts HN and 2X Laemmli
Sample Buffer (Bio-Rad) with 5% ß-Mercaptoethanol, boiled for 5 mins at 100ºC
and separated on a 12.5% SDS denaturing gel. Gels were subsequently transferred
to nitrocellulose membranes (Bio-Rad) and blocked with 5% skim milk in TBS-T
(25mM Tris, 150mM NaCl, 0.5% Tween). Antibodies, monoclonal mouse-anti-FlaB
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H9724 (230) (1:200), polyclonal mouse anti-SodA NIH754 (277) (1:1000), polyclonal
rabbit anti-VlsE (Rockland Immunochemicals) (1:1000), and DYKDDDDK(FLAG)tag mAb (Genscript) (0.1 µg/ml) detected FlaB, SodA, OspB, and BB0562-3XFLAG
respectively. HRP-conjugated goat anti-mouse or –rabbit (EMD Millipore)
(1:10,000) was used as the secondary antibody. Membranes were washed between
incubations

with

TBS-T,

developed

using

Supersignal

West

Pico

Chemiluminescent Substrate (Thermo Scientific), and exposed to x-ray film.
Ethics Statement
The University of Central Florida is accredited by the International Association for
Assessment and Accreditation of Laboratory Animal Care. Protocols for all animal
experiments were prepared according to the guidelines of the National Institutes
of Health and were reviewed and approved by the University of Central Florida
Institutional Animal Care and Use Committee.
RNA Extractions and RT-qPCR Analysis
Isolation of RNA from in vitro cultivated spirochetes, was performed using a hot
phenol protocol as described (104). All extractions used 45 ml of log phase (3-7x107
cells/ml) B. burgdorferi in BSKII medium, as determined using a Petroff-Hausser
counting chamber under dark field microscopy. Up to 50 µg of total extracted RNA
was treated for the removal of any DNA by incubating with 10 U DNase I (Roche)
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and 80 U rRNasin (Promega) at 37°C for 15 min. Purification of RNA samples were
as described (104). DNase treatments were performed twice to ensure the removal
of DNA.
For isolation of RNA from infected ticks, 6-8 week old female C3H/HeN
mice (Envigo) were needle inoculated with B. burgdorferi B31 A3, at a dose of 105
spirochetes and infection confirmed via positive seroreactivity to B. burgdorferi
lysate, as previously described (175, 253). Three weeks post inoculation,
approximately 200 naïve ~5 month old Ixodes scapularis (Centers for Disease
Control, BEI resources) per mouse were fed to repletion as previously described
(24). Approximately one week following feeding to repletion, triplicate groups of
25-50 fed larvae and 13-15 fed nymphs, or five weeks following feeding to
repletion, triplicate groups of 25 unfed nymphs, were snap frozen in liquid
nitrogen. Ticks were homogenized in ~1 ml TE buffer (10 mM Tris, 1 mM EDTA,
pH 8.0) containing 0.5 mg/ml lysozyme in gentleMACSTM M tubes using a
gentleMACSTM Dissociator, setting RNA 2 (Miltenyi Biotech). For RNA
purifications from infected animals, mice were needle inoculated as described
above and 10 days following animals were sacrificed and bladder tissues
harvested. In triplicate groups of 3 bladders per RNA preparation, bladders were
snap frozen in liquid nitrogen and homogenized as described for infected ticks.
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Mice and tick samples were transferred to 1.5 ml safe-lock Eppendorf tubes, in 1%
SDS and incubated at 64°C for 2 mins, followed by the addition of NaAOc pH 5.2
at a final concentration of 0.1 M. RNA extraction continued using a hot phenol
protocol as described previously (104). Up to 50 µg RNA was treated with 10 U
DNase I (Roche) and 80 U rRNasin (Promega) at 37°C for 15 mins. The RNA
samples were purified as described (104). The DNase treatment and purification
was repeated twice to ensure DNA removal from samples.
The concentrations of the in vitro and in vivo-derived samples, were
measured using a nanodrop spectrophotometer, and 1 µg was converted to cDNA
using the iScript Select cDNA synthesis kit and random primers (Bio-Rad),
according to the manufacturer’s instructions. Parallel reactions without reverse
transcriptase for each sample were also performed. One microliter of neat cDNA
was used as template for qPCR. The following primers: 1123+1124 (recA),
1875+1776 (flaB), 2138+2139 (ospA), 2203+2204 (ospC), 1715+1716 (bb0562),
2179+2180 (bb0563), and 2263+2264 (bb0564) (Table 5–1) at a final concentration of
60 nM each and iQ SYBR green super mix (Bio-Rad) amplified selected mRNA
targets using the CFX Connect Real-Time System (Bio-Rad) with the following
program specifications: Step 1: 95°C 5 min, Step 2: 95°C 10 sec; 55°C 30 sec – Repeat
Step 2 for 40 cycles, Step 3: melt curve increasing from 55°C – 95°C in 5 sec
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intervals, with an initial denaturation step at 95°C for 15 sec. Amounts of mRNA
transcripts were determined using a B. burgdorferi genomic DNA standard curve
(107-104 genome copies) for each gene target. cDNA samples were represented in
technical and biological triplicates. All minus reverse transcriptase samples were
verified to contain no significant amplification and were represented in technical
duplicates for each sample. mRNA copy numbers for flaB, ospA, ospC, bb0562,
bb0563, and bb0564 were normalized to recA copies.
Murine Infection of B. burgdorferi by Needle Inoculation
All B. burgdorferi clones were grown to stationary phase (~108/ml) and diluted to
the desired inoculum density. Six-to-eight-week-old female C3H/HeN mice were
purchased (Envigo) and six-week male NOD-scid IL2Rgammanull (NSG) mice were
bred at the UCF vivarium from purchased breeding pairs (The Jackson
Laboratory). Groups of 6 mice each were needle inoculated with 104 or 107 B.
burgdorferi clones 80% intraperitoneally and 20% subcutaneously. Inoculum
densities were confirmed by plating for individuals in solid BSKII or in liquid
BSKII in 96-well plates, as described above. All inoculum cultures were verified to
contain the expected endogenous plasmids (163, 175) and individuals from the
Δbb0562 and bb0562+ inoculums were analyzed for the presence of virulence
plasmids lp25, lp28-1 and lp36 (24). Mouse infection was determined by serology
213

and spirochete reisolation from tissues 3 weeks post inoculation (24). The
spirochete loads in the tissues of infected mice were quantified using a B.
burgdorferi genomic DNA standard curve (108-104 genome copies) and mouse nid
gene standard curve (5.5 x 107 – 5.5 x 104 nid copies) (175). The DNA from each
tissue was analyzed in technical triplicate, and the data are reported as flaB copies
per 105 nid copies. Data were analyzed using a two-tailed student t-test (GraphPad
Prism, version 7.02).
Artificial B. burgdorferi Infection of I. scapularis Ticks
Approximately 4-month-old Ixodes scapularis naïve larval ticks (CDC, BEI
resources) were dehydrated by exposure to saturated ammonium sulfate for ~45
hr. B. burgdorferi clones (3.5 x 107 – 1.65 x 108 cells/ml) were diluted to 2 x 107
cells/ml in BSKII. 500 µl of spirochetes were incubated with dehydrated ticks at
35°C for ~1.5 hrs and washed twice with PBS (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4) (278). The inoculum cultures were verified to
contain the expected endogenous plasmids (163, 175). Infectious plasmids lp25,
lp28-1 and lp36 were present in 80-100% of individuals in the Δbb0562 and bb0562+
inoculum cultures. Groups of ~20 artificially infected larvae were fed to repletion
on groups of 3 naïve C3H/HeN mice (Envigo). Twelve days following the artificial
infection, groups of ~10 unfed larvae were surface sterilized and plated in solid or
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liquid BSKII containing RPA cocktail (60 µM rifampicin, 110 µM phosphomycin,
and 2.7 µM amphotericin B) for individuals, as previously described (24, 279).
Similarly, individual fed larva were analyzed for B. burgdorferi burden 14-18 days
post feeding to repletion. A subset of fed larvae were allowed to molt into nymphs
and 10 weeks following, individually assessed for B. burgdorferi infection and fed
using four naïve C3H/HeN mice (Envigo) per B. burgdorferi clone, excluding WT
where 3 mice were used. Four infected flat nymphs were fed per mouse.
Individual fed nymphs were analyzed for B. burgdorferi burden 14-18 days post
feeding to repletion. Mice were assayed for B. burgdorferi infection via serology
and tissue reisolation (24).
Results
BbIVET-Associated Gene bb0562 is Constitutively Expressed throughout the
B. burgdorferi Infectious Cycle and Encodes a Membrane-Associated Protein
In vivo expression technology for B. burgdorferi (BbIVET) identified an infectionactive putative promoter sequence immediately upstream from gene bb0562 (117,
221), suggesting that bb0562 is expressed during mammalian infection.
Furthermore, using global 5’ end RNA-seq analysis we detected a transcription
start site (TSS) for bb0562 located at the 3’ end of the BbIVET-identified sequence
(221). Together these data suggested that bb0562 is expressed during mammalian
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infection, driven by a promoter directly upstream of its annotated ORF. To gain a
more complete understanding of the expression pattern of bb0562 we quantified
bb0562 transcription throughout the B. burgdorferi infectious cycle (Figure 5–1A).
RNA isolated from B. burgdorferi infected ticks and mouse tissue were probed for
expression of target gene bb0562 as well as the constitutive flagellar gene (flaB),
and the differentially expressed outer surface protein A (ospA) and outer surface
protein C (ospC) genes (76). Gene bb0562 was found to be expressed at a low, but
constitutive level across all stages of the infectious cycle (Figure 5–1A).
Gene bb0562 is annotated to encode a 180 amino acid (aa) hypothetical
protein of unknown function and to contain the conserved domain of unknown
function DUF3996 (pfam13161) (280). DUF3996 is also found within adjacent
encoded proteins BB0563 (172 aa) and BB0564 (201 aa) as well as BB0405 (203 aa)
and BB0406 (203 aa) (203, 281-283). BB0405 and BB0406 have recently been shown
to be immunogenic outer membrane proteins (281, 282) and BB0405 but not
BB0406 is required for B. burgdorferi infection (203, 283). Consensus Constrained
TOPology prediction (CCTOP) suggests that BB0562 harbors two transmembrane
domains at amino acids 29-46 and 75-92 (284). Furthermore, proteomic analysis of
spirochete membranes has suggested that BB0562 is membrane associated in B.
burgdorferi (strain B31), B. afzelii (strain K78), and B. garinii (strain PBi) (285). To
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experimentally validate BB0562 protein production and localization in the
spirochete, the sequence for a triple flag epitope (3Xflag) was added to the Cterminus of bb0562. Western blot analysis of total protein lysate from the bb05623Xflag clone using anti-FLAG antibodies specifically detected a ~20 kDa protein,
the predicted molecular mass of BB0562 (Figure 5–1B). Further BB0562-3XFLAG,
like membrane-associated FlaB, was found to be restricted to the spirochete
membrane fraction (Figure 5–1B). Proteinase K treatment of intact bb0562-3Xflag
spirochetes did not affect the amount or size of BB0562-3XFLAG (Figure 5–1C).
Similarly, the periplasmic FlaB protein was unaffected by proteinase K treatment;
whereas, this treatment resulted in complete loss of the surface exposed outer
membrane protein VlsE. In contrast, proteinase K treatment of SDS-exposed
bb0562-3Xflag resulted in the loss of BB0562 (Figure 5–1C).
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Figure 5–1. B. burgdorferi gene bb0562 is constitutively expressed throughout the
spirochetes infectious cycle and encodes a membrane-associated protein.
(A) Reverse transcription (RT)-qPCR analysis of infected tick and mouse tissue
samples. Naïve, Ixodes scapularis larval ticks acquired B. burgdorferi strain B31 A3
by feeding on infected mice. Fed larvae were molted into nymphs, which were
then fed on naïve mice. Approximately one week following feeding to repletion,
triplicate groups of 25-50 fed larvae or 13-15 fed nymphs were snap frozen in
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liquid nitrogen, homogenized, and RNA extracted. Five weeks following larval
feeding, triplicate groups of 25 unfed nymphs were similarly processed. For
mouse samples, RNA was isolated from the bladders of triplicate groups of 3 mice
infected by needle inoculation with B. burgdorferi strain B31 A3. RT-qPCR using
gene specific primers and a B. burgdorferi genomic standard curve was used to
quantify the amount of each target mRNA transcript. Copy numbers for each gene
target were normalized to recA mRNA copies. Data are presented as the average
of biological triplicate samples ± standard deviation. There was no significant
difference in bb0562 expression level across samples, one-way ANOVA GraphPad
Prism 7.02. The expression patterns of control targets, flaB, ospA and ospC were as
expected (87). (B) BB0562 protein localization analysis. Total protein lysate (T) of
wild type (WT) or B. burgdorferi producing BB0562-3XFLAG (bb0562-3Xflag) were
fractionated into the soluble (S) and membrane (M) components using
ultracentrifugation. Protein fractions from equivalent numbers of spirochetes were
subjected to SDS-PAGE and analyzed by immunoblot with FLAG (BB0562),
periplasmic-associated FlaB, or cytoplasmic-associated SodA antibodies. (C)
Proteinase K susceptibility of BB0562. Equal numbers of B. burgdorferi producing
BB0562-3XFLAG were either treated with or without 200 µg/ml Proteinase K (PK)
in the presence or absence of 0.1% SDS. Samples were subjected to SDS-PAGE and
analyzed by immunoblot with FLAG (BB0562), periplasmic-associated FlaB, or
outer surface associated VlsE antibodies. Protein standards in kilodaltons (kDa)
are indicated.
Two recombinant peptides (aa 52-106, aa 107-161), which covered ~61% of the
predicted BB0562 coding region, lacked detectable immunogenicity against
pooled-immune sera from WT B. burgdorferi infected mice (data not shown).
Collectively, these data suggest that BB0562 is membrane associated and is not
surface exposed.
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The Δbb0562 Mutant is Defective for Colony Formation in Solid Medium
In order to assess the contributions of bb0562 to B. burgdorferi biology, targeted
deletion of bb0562 was carried out by allelic exchange (Δbb0562) and
complementation of completed in cis, restoring bb0562 on the chromosome
(bb0562+). As a control for the cis-complementation strategy, a gentamycin marked
WT clone (WT-gent) was generated in a similar manner (Figure 5–2A). All clones
were verified by end-point PCR (Figure 5–2B). RT-qPCR analysis demonstrated
no bb0562 expression in Δbb0562 and restoration of expression in bb0562+. The
expression of proximal genes bb0563 and bb0564 was unaltered in these clones,
with less than a two-fold difference across all genetic backgrounds (Figure 5–2C).
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Figure 5–2. Genetic deletion of B. burgdorferi bb0562.
(A) Schematic representation of the bb0562 gene locus on the B. burgdorferi
chromosome (Chr). The bb0562 open reading frame was replaced with the flaBpaadA antibiotic resistance cassette in wild type B. burgdorferi (WT) by allelic
exchange. Complementation of the Δbb0562 mutant (Δbb0562) was performed in
cis on the chromosome using the flgBp-aacC1 antibiotic cassette, resulting in clone
bb0562+. To control for any polar effects resulting from the addition of the flgBpaacC1 cassette to this genomic location, allelic exchange using this same construct
was performed in WT B. burgdorferi (WT-gent). The infection-active promoter,
identified via BbIVET (Bbive67), and primary and secondary transcription start
sites, identified by 5’RNA-seq (pTSS and sTSS, respectively), for gene bb0562 (221)
are indicated. Dashed lines mark allelic exchange boundaries. Numbers and small
arrows indicate approximate locations and orientation of the primers used for
clone verification. (B) PCR analysis of the B. burgdorferi bb0562-related clones.
Genomic DNA was isolated from all clones and used as template in PCR reactions,
as indicated above the image. A no template control (NTC) served as the negative
control. The primer pairs used to amplify target DNA sequences, given
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underneath the image, correspond to the labels in panel A. Target DNA sequences
are separated by a DNA ladder and fragment sizes, in base pairs (bp), are indicated
to the left of the image. (C) RT-qPCR analysis of bb0562 and adjacent genes. RNA
was extracted from logarithmic phase spirochetes in biological triplicates.
Expression of recA, bb0562, bb0563, and bb0564 were quantified by RT-qPCR using
gene specific primers and a B. burgdorferi genomic DNA standard curve. Data are
presented as the average number of target mRNA copies per recA mRNA copies ±
standard deviation.
No defect was detected for Δbb0562 during growth in liquid medium
(Figure 5–3A) nor obvious morphological alterations or motility defects observed
under routine dark field microscopy. However, analysis of aliquots of spirochetes
at distinct points revealed a significant deficiency in colony formation in solid
medium. At all time points there were significantly fewer Δbb0562 recovered in
solid medium compared to bb0562+, which achieved the expected 100% (Figure 5–
3B&C). In contrast, Δbb0562 demonstrated 100% recovery by single-cell liquid
plating at all growth stages, as did bb0562+, indicating that the reduced recovery of
Δbb0562 in solid medium was not due to altered viability of the spirochetes. The
colony formation defect of Δbb0562 was statistically more pronounced for
stationary phase spirochetes, which averaged only 1.5% recovery in solid medium,
compared to logarithmic phase spirochetes, which averaged 18% recovery (Figure
5–3B). Furthermore, the colonies that resulted from Δbb0562 varied in size and
morphology (Figure 5–3C).
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Figure 5–3. Δbb0562 spirochetes have no growth defect in liquid medium but
inefficiently form colonies in solid medium in a growth phase dependent
manner.
(A) Analysis of the growth of WT, Δbb0562, bb0562+, and WT-gent spirochetes in
liquid medium. Clones were diluted to 1 x 105 bacteria in biological triplicate 5 ml
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cultures and enumerated by dark-field microscopy approximately every 24 hr for
a period of 196 hr. (B) Δbb0562 spirochetes inefficiently form colonies in solid
media. Δbb0562 and bb0562+ were grown in liquid medium in biological triplicate
and aliquots removed at various time points. The aliquots were plated for an
expected 100 colonies in solid medium and an expected 25 individuals per 96-well
cell culture plate in liquid medium. Data represent the average percent of
spirochetes recovered by either method relative to the number expected. Data
were analyzed with a one-way ANOVA followed by Tukey’s multiple comparison
test, GraphPad Prism 7.02, across clones at a single time point (*) or the same clone
across all time points ($). Relevant significant differences are indicated (*, p ≤ 0.05;
$, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; n.s., not significant). (C) Representative images
of Δbb0562 and bb0562+ colonies in solid medium. Aliquots of the B. burgdorferi
cultures removed at the 52 hr and 73 hr time points (panel B) were plated in solid
medium for an expected 104 colonies per plate. Plates were maintained at 35ºC
with 2.5% CO2 for 10 days (52 hour samples) and 16 days (73 hr samples) prior to
imaging.
Selection of a variety of individual Δbb0562 colonies for growth in liquid medium,
and subsequent re-plating in solid medium resulted in the same colony formation
deficiency (data not shown), suggesting that the visible colonies are likely not the
result of selection of second site suppressor mutations.

Δbb0562 Spirochetes are Attenuated for Mouse Infection by Needle Inoculation
To examine the role of bb0562 during mammalian infection, mice were needle
inoculated with 104 or 107 of each B. burgdorferi clone and assessed for infection
after 3 weeks. At the dose of 104 spirochetes only 3 out of 12 Δbb0562 inoculated
mice resulted in infection; whereas, all mice inoculated with clones containing
bb0562 became infected (Table 5–2). In contrast, 1000-fold increase in the inoculum
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dose resulted in infection of all mice, independent of the presence or absence of
bb0562 (Table 5–2).
Table 5–2. B. burgdorferi lacking bb0562 are attenuated for infection in
immunocompetent and immunodeficient mice a dose of 104 spirochetes.
No. of positive mice/no. of mice analyzed as
determined by:

Mouse
Strain

Inoculum

104
C3H/HeN
107
NSG

104

B. burgdorferi
Clone
WT

Serologya

Reisolation of spirochetes from
tissuesb
Ear

Bladder

Joint

12/12

12/12

12/12

12/12

3/12

3/12

3/12

3/12

12/12

12/12

12/12

12/12

WT-gent

12/12

12/12

12/12

12/12

Δbb0562

6/6

6/6

6/6

6/6

bb0562+

6/6

6/6

6/6

6/6

c

2/6

2/6

2/6

n/a

6/6

6/6

6/6

Δbb0562
bb0562

+

Δbb0562
bb0562

n/a

+

aDetermined

3 weeks postinoculation by sera reactivity against B. burgdorferi B31 lysate via Western blot
analysis, where 5 bands were required to be considered positive.
b3

weeks postinoculation mouse tissues were cultured in BSKII medium for 7-10 days and examined under
dark-field microscopy for presence of spirochetes.
cNot applicable

Further, the bacterial burdens in the tissues of these mice were measured as
a means to identify any bb0562-dependent quantitative differences in infectivity.
No statistical differences were detected between the bacterial loads of Δbb0562 and
bb0562+ infected ear or joint tissues (Figure 5–4). However, Δbb0562 spirochetes
were found to be below the level of detection in heart tissues (Figure 5–4).
Together, these data demonstrate that spirochetes lacking gene bb0562 are
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attenuated for infection of mice at a dose of 104 spirochetes and that this defect
cannot be completely overcome by increasing the inoculum dose 1000-fold.

Figure 5–4. Spirochetes lacking gene bb0562 exhibit reduced loads in heart
tissues at an inoculum dose of 107 per mouse.
Total DNA was isolated from the ear, heart, and joint tissues of Δbb0562 (▲) and
bb0562+ (■) B. burgdorferi infected C3H/HeN mice 3 weeks post needle-inoculation
with 107 spirochetes. qPCR was used to quantify B. burgdorferi flaB copies and
mouse nid copies. Data are presented as flaB copies / 105 nid copies. Symbols
represent individual mice and horizontal lines indicate the mean. Data sets were
compared across clones using a two-tailed Student’s t-test, GraphPad Prism 7.02.
No significant differences were observed unless indicated (***, p ≤ 0.0001).
To gain further insight into the potential barriers to Δbb0562 infectivity, we
examined the ability of the mutant to infect immunodeficient mice. NOD-scid
IL2Rgammanull (NSG) mice lack key components of innate immunity and the entire
adaptive immune system (286). Only 2 out of 6 NSG mice inoculated with 104
Δbb0562 B. burgdorferi became infected (Table 5–2), similar to the phenotype of the
mutant in immunocompetent C3H/HeN mice. All NSG mice inoculated with
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bb0562+ spirochetes were positive for infection (Table 5–2). These data indicate that
the immunocompromised state of the NSG mice was not sufficient to rescue the
infectivity defect of Δbb0562 spirochetes.
Gene bb0562 is Critical for Murine Infection by Tick Bite
Due to the attenuation of Δbb0562 infection of both immunocompetent and
immunocompromised mice by needle inoculation, we were interested to
determine the contribution of bb0562 to B. burgdorferi survival throughout the tickmouse infectious cycle. Naïve Ixodes scapularis larvae were artificially infected with
the B. burgdorferi clones. All B. burgdorferi clones were found to colonize the unfed
larvae with the same efficiency (Figure 5–5A). Moreover, no bb0562-dependent
difference in spirochete load was detected at any tick life stage (Figure 5B-D),
indicating that bb0562 is dispensable for B. burgdorferi survival and replication in
the tick.
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Figure 5–5. B. burgdorferi gene bb0562 is dispensable for tick infection.
Naïve Ixodes scapularis larval ticks were artificially infected with B. burgdorferi
clones and assessed for bacterial burden throughout tick development. Ticks were
surface sterilized, crushed, diluted, and plated for individuals in solid medium or,
for Δbb0562 spirochetes, in liquid medium in 96-well cell culture plates. (A) Twothree groups of 10 unfed larvae each were assessed for spirochete burden. Symbols
represent the average number of spirochetes per unfed larva for each group.
Individual ticks from fed larvae (B), unfed nymphs (C), and fed nymphs (D) were
assessed for spirochete burden, where symbols represent individual ticks.
Horizontal lines represent the mean. Data were analyzed with a one-way ANOVA,
GraphPad Prism 7.02 and no significant differences were detected. Any ticks
which were not infected were eliminated from the analysis.
However, bb0562 was found to be important for mouse infection by tick bite.
Δbb0562-infected larvae and -infected nymphs resulted in dramatic reduction in
infectivity of mice, compared to bb0562+-infected ticks (Table 5–3). Surprisingly,
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perhaps due to low numbers of feeding larvae, few WT- and WT-gent-infected
larvae-fed mice became infected; however, 100% of the mice fed on by infected
nymphs of these clones became infected. Collectively, these data indicate a critical
role for bb0562 in B. burgdorferi mammalian infectivity.
Table 5–3. B. burgdorferi lacking bb0562 are attenuated in mice by tick bite.
No. of positive mice/no. of mice analyzed as determined
by:
Reisolation of spirochetes from tissuesc
Infected
Ticka

Larvae

Nymph

B. burgdorferi
Clone
WT
Δbb0562
bb0562+
WT-gent
WT
Δbb0562
bb0562+
WT-gent

Serology

b

Ear

Heart

Bladder

Joint

1/3
0/4
3/4
1/3

1/3
0/4
3/4
1/3

1/3
0/4
3/4
1/3

1/3
0/4
3/4
1/3

1/3
0/4
3/4
1/3

3/3
1/4
4/4
4/4

1/3
1/4
4/4
4/4

2/2
1/4
4/4
4/4

3/3
1/4
4/4
4/4

3/3
1/4
4/4
4/4

Tick developmental life stage which was fed on naïve C3H/HeN mice to repletion. On average ~18 infected
fed larvae and ~3 infected fed nymphs were collected from each mouse.
bDetermined 3 weeks post tick feeding by serum reactivity against B. burgdorferi B31 lysate via Western blot
analysis where 5 bands were required to be considered positive.
c3 weeks post tick feeding mouse tissues were cultured in BSKII medium for 7-10 day and examined under
dark-field microscopy for the presence of spirochetes.
a

Discussion
The progression and devastating clinical manifestations of Lyme disease
result from the human immune response against a B. burgdorferi infection (5).
Therefore, the mechanisms that B. burgdorferi uses to survive and disseminate in
the host are critical for its pathogenesis. Lacking typical virulence and host defense
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evasion factors while encoding a large percentage of unique hypothetical proteins
of unknown function (61, 169), B. burgdorferi likely applies novel mechanisms to
achieve infection. BbIVET identified numerous novel B. burgdorferi genes that are
expressed during mouse infection, including bb0562, which we now demonstrate
plays a critical role in infectivity.
Gene bb0562 was not only expressed during mammalian infection but also
at similar low levels in fed and unfed ticks. These findings are consistent with
previous reports that bb0562 does not demonstrate differential expression under
in vitro growth conditions altered to mimic the two host environments (81, 82, 155).
Gene bb0562 is annotated to encode a hypothetical protein and contain a DUF3996
conserved domain of unknown function unique to Borrelia species (61, 280). This
domain is also present in BB0405, BB0406, BB0563, and BB0564 (280). Nonetheless,
BB0562 shares only 24-29% sequence identity with the other members of this
protein family. HHpred (287) identifies ~87% probable conservation between
BB0562 amino acids 93-143 and E. coli outer membrane protein A (OmpA).
Characterized to play important roles in environmental stress responses, OmpA,
plays versatile roles in Gram-negative pathogens including evasion of
complement, interaction with immune cells, and as a receptor for bacteriocins
(288). We have demonstrated that BB0562 is associated with the spirochete
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membrane. The finding that BB0562-3XFLAG was unaffected by proteinase K
treatment of intact spirochetes, suggests the predicted transmembrane protein is
likely localized to the spirochete’s inner membrane.
Interestingly, deletion of gene bb0562 attenuated the ability of the
spirochete to efficiently form colonies in solid medium, but had no detectable
effect on growth in liquid medium. This phenotype does not universally affect all
of the individuals in the population. Approximately 1-20% of the expected number
of individuals formed colonies in solid medium, with the phenotype strongest for
spirochetes in late stationary phase growth. Moreover, the colonies demonstrated
morphological variation. Independent of their colony size, individuals likely did
not harbor second site suppressor mutations, suggesting the phenotype is
somewhat stochastic in nature. Although the mechanism remains unknown, it is
possible that the defect lies in the ability of the mutant to transition to the metabolic
program required for colony formation, during which the innermost cells are
deprived of essential nutrients. This is unlike spirochetes in liquid culture that are
encased in an even pool of nutrients. Indeed, bb0562 and putative related genes
bb0563 and bb0564 are flanked by ORFs involved in carbohydrate metabolism and
chemotaxis. Alternatively, the removal of BB0562 may affect the resilience of the
spirochete membrane to physical stress posed by growth in solid medium.
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Gene bb0562 is critical for mammalian infectivity but dispensable for B.
burgdorferi survival and replication in ticks. The Δbb0562 mutant was attenuated
for mouse infection by both needle inoculation at a dose of 104 spirochetes and by
tick bite. Consistent with the colony formation phenotype, the infectivity defect
was not absolute with 28% and 12.5% of the mice becoming infected by needle
inoculation and tick bite, respectively. Inoculation of mice with 107 Δbb0562
resulted in 100% infection, but did not recapitulate WT levels of bacterial burden
in heart tissues, suggesting that bb0562 may contribute to pathogen dissemination
and/or tissue tropism. Further, these data likely rule out a direct role for bb0562 in
nutrient acquisition considering previously characterized nutritional mutants fail
to infect at this inoculum (24, 182, 205). To investigate a possible role for bb0562 in
immune invasion, NSG mice were challenged and failed to rescue the Δbb0562
phenotype, eliminating a contribution to avoidance of adaptive immunity
responses. Aspects of innate immune evasion, as well as motility and chemotaxis
defects in Δbb0562 are currently being explored.
This work encompasses the first investigation of bb0562 in B. burgdorferi
infectivity. The contributions of putative related genes bb0405 and bb0563 to
infection have recently been reported (157, 203, 283), supporting the notion that
DUF3996 domain proteins confer key functions critical for B. burgdorferi
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pathogenesis. BbIVET discovered numerous previously unrecognized genes,
many of which are annotated to encode hypothetical proteins unique to Borrelia
species. Elucidation of the contributions of non-conserved proteins of unknown
function, such as BB0562, to B. burgdorferi pathogenesis uncover new opportunities
to gain unique understanding of the biology of B. burgdorferi infections and
perhaps discover novel therapeutic targets for Lyme disease.
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CHAPTER 6:
CONCLUSIONS
Preface

This chapter was composed entirely by P.P.A. Comments from M.W.J. were
incorporated into the final version presented here.
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B. burgdorferi fulfills a distinct niche among bacterial pathogens. Its compact and
segmented genome lacks an array of metabolic genes rendering it solely
dependent on its host for nutrient acquisition. Persisting through a complex
infectious life cycle, B. burgdorferi relies on the maintenance of a mammalian
reservoir via an arthropod vector. Additionally, the low number of bacteria
present during infection and the diversity of unique genomic sequences specific to
Borrelia (Borreliella) species adds to the complexity of the Lyme disease pathogen.
This dissertation provides both global and targeted investigations of the B.
burgdorferi transcriptome, elucidates a novel gene critical for B. burgdorferi
pathogenesis, and delivers valuable insight into the spirochete’s biology
throughout the tick-murine infectious cycle.
BbIVET Ushers A New Frontier of Transcriptome Analysis for the Lyme Disease
Pathogen
Until the application of in vivo expression technology to B. burgdorferi (BbIVET)
(117), there was no direct, global evaluation of sequences expressed by the Lyme
disease spirochete during mammalian infection. This has been mainly attributed
to the low number of bacteria present during infection (80). Therefore, a variety of
studies have attempted to mimic environmental conditions on the bench (81-84),
and while these approaches have been successful in identifying several genes
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important for B. burgdorferi pathogenesis, they likely do not depict the true
transcriptional profile of the pathogen in its natural environments. Microarray
analyses using RNA isolated from infected ticks and mammalian tissues have also
been useful for quantifying gene expression during pathogenesis (85-87, 155), yet
have been restricted to annotated open reading frames (ORFs) and depend on
amplification steps prior to hybridization which can introduce bias. In vivo
expression technology, while a relative dated microbiology technique (111), is
advantageous for B. burgdorferi as it does not rely on recovery of bacterial
nucleotide sequences. Rather, BbIVET is a screening method based on the recovery
of live organisms which survive murine infection due to expression of an essential
biosynthetic gene driven by a putative murine-active promoter sequence.
Following the murine infection, surviving spirochetes can be expanded by
harvesting and culturing infected tissues, for subsequent sequencing and
identification of B. burgdorferi in vivo expressed sequences (Bbives) (117). Thereby,
putative murine-active, B. burgdorferi promoters are identified without the
requirement for amplification steps, regardless of the bacterial numbers during
infection, and that theoretically span the entire genome (i.e. not limited to
annotated ORFs). The findings from BbIVET were somewhat surprising, in that
61% of the sequences discovered mapped to genomic locations internal, antisense
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or intergenic to ORFs (221) (Chapter 2). The importance of this observation was
largely unknown as almost no published investigations had reported the
expression of transcripts other than annotated ORFs and housekeeping RNAs.
Concurrently with the findings of BbIVET, bacterial genetic labs researching other
pathogens began to recognize the overwhelming presence of internal, antisense,
and intergenic transcripts (124, 128-130, 159, 160, 188). Mechanisms for noncoding, regulatory RNAs (classically termed sRNAs due to their tendency for
being transcribed as small transcripts) were at the forefront of novel virulence gene
regulation for pathogens (123); yet, no global sequencing approach had validated
the presence of such transcripts in B. burgdorferi. While some argued the absence
of sRNAs in the Lyme disease spirochete (289), evidence was accruing to suggest
otherwise. The trans-acting sRNA dsrA was shown to be crucial for regulating the
mammalian-induced sigma factor RpoS (138) and an ortholog to Hfq, a critical
RNA chaperone which mediates sRNA interactions with target transcripts, was
identified in B. burgdorferi (137). Given the high percentage of putative promoters
that mapped to non-ORF annotated transcripts through BbIVET, a global
incidence of such transcripts was likely. Therefore, we applied 5’RNA-seq to B.
burgdorferi to globally characterize the transcriptome (221) (Chapter 2). This was
the first genome-wide characterization of transcriptional start sites (TSSs) for B.
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burgdorferi which not only defined a variety of novel transcripts, but also provided
appreciation for initiation of transcription, and when compared to BbIVET
elucidated transcripts expressed during a murine infection of B. burgdorferi.
Novel Insights into the B. burgdorferi Transcriptome
5’RNA-seq application to B. burgdorferi has extensive implications to researchers
in spirochete genetics and pathogenesis. Mapping of the B. burgdorferi
transcriptome indicated that a variety of transcripts originate internal, antisense
and intergenic to annotated-ORFs. The use of tobacco acid pyrophosphatase (TAP)
in our RNA-seq library preparations allowed differential identification of TSSs
from processed 5’ ends. We validated this approach via examination of known
processed transcripts (such as tRNAs) and targeted Northern blotting techniques
(221) (Chapter 2). This information becomes critical in the future exploration of
novel regulatory RNAs, as many have been documented to be processed prior to
acting on targets (290). Collectively we mapped 6042 unique, potential TSSs across
the B. burgdorferi genome and 30716 processed 5’ ends (221) (Chapter 2).
Considering the number of annotated ORFs are at ~815 (64), our work reshapes
ideals concerning B. burgdorferi transcription. The majority of our defined TSSs lie
internal to annotated-ORFs, revealing much complexity within the genome.
Previously researchers have relied on techniques such as RT-qPCR to map the
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boundaries of transcripts and operons (179, 202, 203). However, our data suggest
that these analyses could be confounded by internal, intergenic, and antisense
transcripts. Northern blotting, rather, should be used to better understand regions
of complex transcription in the spirochete, as this method is targeted and strandspecific. Furthermore, a variety of researchers, including our own laboratory,
remove entire mRNA sequences of annotated ORFs for contributional analysis of
specific genes to Lyme disease pathogenesis (145). However, the removal of a
mRNA could also disrupt or remove important regulatory RNA species from the
cell, thus; its becomes increasingly difficult to definitively demonstrate that
phenotypes associated with ORFs are not actually associated with putative
regulatory RNAs in the same genomic region. Cross-referencing our 5’RNA-seq
database in the design of targeted gene deletion constructs can provide awareness
of other local transcripts in genomic regions of interest. Furthermore, by mapping
the TSSs of mRNAs researchers can better estimate the promoter sequences of
transcripts. Promoter alterations of transcripts, could serve as a mechanism to
target the expression of specific transcripts without removing entire mRNA
sequences, and thus may preserve internal or antisense transcripts in regions of
interest. Important regulatory information is also housed in promoter regions,
which can provide insight into new transcriptional factors for B. burgdorferi. For
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expedited use of B. burgdorferi 5’RNA-seq an interactive website has been created
to view the 5’ end transcriptome: http://www.ucf.edu/research/interactivegenomics/lyme-disease.
Similar to the examination of global 5’ ends in other bacteria, our
classification in B. burgdorferi revealed both expected and surprising observations
concerning the spirochete’s transcription. We classified TSSs based on their
proximity to annotated ORFs. Briefly, primary TSSs were those located directly
upstream an ORF with the highest read count, secondary TSSs as those in the same
boundary but with lower read counts than the primary TSS, internal TSSs were
defined as originating within an ORF, antisense TSSs mapped on the opposite
DNA strand to an ORF, and orphan TSSs as those that did not fall into any of the
above categories. We documented 839 possible primary TSSs (221) (Chapter 2),
which also includes housekeeping RNA TSSs, which correlated well to the
predicted number of ~815 ORFs in B. burgdorferi (61, 64). Examination of the
sequences directly upstream of defined TSSs found strong conservation of the
classical Pribnow box sequence for primary, secondary, and antisense TSSs. This
was expected considering that our approach utilized logarithmically grown
spirochetes likely undergoing sigma-70 dependent housekeeping transcription.
However, internal TSSs greatly lacked this characteristic promoter sequence,
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which contrasts with findings in other bacteria (124, 130). This suggests that
internal TSSs may originate from alternative mechanisms of transcription in B.
burgdorferi. Further examination of highly expressed internal TSSs (read counts
over 500) revealed ~41% contained a conserved Pribnow box (221) (Chapter 2).
Perhaps the remaining internal transcripts, the majority of which are expressed at
low levels in logarithmic phase grown cultures, are controlled independently of
sigma-70, and could harbor specific stress response activation sequences. Further
evaluation of these numerous internal transcripts, representing 63% of the total B.
burgdorferi transcripts sequenced by 5’RNA-seq (221) (Chapter 2), is warranted to
dissect their importance to pathogenesis. Notably, Leptospira interrogans, the
pathogenic spirochete responsible for leptospirosis, was also recently sequenced
by 5’ end mapping to discover ~50-60% of transcripts map internal of ORFs (291).
Another obvious difference concerning internal transcription was the observation
that adenine and cytosine demonstrated equivalent frequencies of occurrence as
the initiating nucleotide (221) (Chapter 2). This is in contrast to E. coli which
typically initiates with a purine (A or G) (130), and considerably even stranger for
B. burgdorferi considering that the percentage of combined G+C usage in the
genome is only 28.2% (221) (Chapter 2). Nucleoside triphosphate concentrations
within the cell have been shown to dictate transcription initiation based on the +1
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nucleotide availability, and changes in intercellular ATP and GTP have been
documented to critically alter Bacillus subtilis stress responses during starvation
(204, 207). B. burgdorferi lack the enzymes for de novo biosynthesis of purines and
rely on scavenging these molecules and precursors from the environment (182,
205, 206), of which levels likely fluctuate depending on the immediate
environment of the spirochete (24, 175, 182). Considering the lack of a conserved
conical sigma factor binding sequence for the majority of these transcripts, their
regulation and role in the cell is of great interest. The function of these numerous
and

previously-unannotated

internal

transcripts

is

currently

unknown.

Alternatively, these RNAs may result from pervasive transcription, a highlydebated concept in bacterial genetics, that will be discussed in depth in subsequent
sections.
Riboswitches and sRNAs: New Regulatory Mechanisms for B. burgdorferi?
Regulatory RNAs serve as dynamic mediators of bacterial gene regulation and
adaption to stress responses. While shown to be vital for a variety of pathogenic
organisms (123), their role in B. burgdorferi is just beginning to emerge. 5’RNA-seq
identified numerous instances of internal, antisense, and intergenic TSSs (221)
(Chapter 2). It is likely that at least some of these novel transcripts are unannotated ORFs as B. burgdorferi has been documented to initiate translation from
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unique start codons (274). However, we believe to have identified a variety of new
regulatory features, currently undocumented for B. burgdorferi, which should be
mechanistically explored further. 5’RNA-seq defined the untranslated regions
(UTRs) for mRNAs and found on average this sequence to be ~36 nts (221)
(Chapter 2), similar to other organisms (124, 188, 194). Yet, 17% of identified UTRs
were between 100-293 nts in length (221) (Chapter 2). Numerous regulatory
elements in 5’ UTR sequences, including riboswitches and RNA thermometers, are
dynamic environmental sensors for modifying bacterial gene expression (191,
292). At least 24 types of riboswitches have been characterized in bacteria, with
hundreds or even thousands of examples of these classifications in sequenced
bacterial genomes (293). To date, no such cis-regulatory RNA element has been
characterized in B. burgdorferi. Indeed, very few are described among all
spirochetes: a thiamine sensor in Treponema denticola (214) and a RNA thermometer
in Leptospira interrogans (294). The only example of 5’ mRNA regulation in B.
burgdorferi is mediated by the trans-acting sRNA thermometer dsrA (138). 5’RNAseq provided initial evidence that additional regulatory elements are present in B.
burgdorferi 5’ UTRs. Because transcription is costly, requiring much energy, for the
cell (295) it seems illogical that these sequences are transcribed for naught. We
used Northern blotting to validate a 195 nt UTR upstream the glp operon, which
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also revealed an ~200 nt transcript which we believe correlates to a termination
event of the UTR (221) (Chapter 2). The four-gene (bb0240-bb0243) glp operon,
involved in glycerol transport and metabolism, is critical for survival in the tick
where spirochetes convert glycerol to dihydroxyacetone phosphate for glycolysis
and energy production (105). However, the glp transport system is dispensable for
mammalian infection, as glucose is the predominant carbohydrate in murine
blood (296, 297) which B. burgdorferi utilizes as an energy source (298). Therefore,
the transcription of the operon has been shown to be repressed in murine infection
in a RpoS-dependent manner (105) and also highly regulated by the second
messenger and common riboswitch ligand, cyclic-di-GMP (101, 215). C-di-GMP is
produced by the response regulator and digunaylate cyclase Rrp1, part of a twocomponent system essential for tick midgut colonization (100, 102). A recent
comparative RNA-seq study between wild type and Δrrp1 B. burgdorferi
demonstrated 219 genes that are differentially regulated by c-di-GMP (215).
Intriguingly, several of these genes also contain long UTR sequences as
determined by 5’RNA-seq. Predominantly, the glp operon had the highest
differential regulation by c-di-GMP. Given the historical role of c-di-GMP as a
riboswitch ligand (216), the differential expression of the glp genes, and a
terminated transcript of the glp 5’ UTR suggests additional regulatory features
245

may act to fine tune glp expression throughout B. burgdorferi’s infectious cycle.
Terminated 5’ UTRs are a hallmark of RNA regulation by a riboswitch, trans-acting
sRNA, or attenuation mechanisms (126, 135). Multiple regulatory features can
even occur concurrently, with a terminated riboswitch acting as a trans-RNA to
modulate the expression of another gene in L. monocytogenes (132). Likely other cdi-GMP regulated transcripts, are present in the B. burgdorferi transcriptome. Of
interest, the histidine kinase Hk1, which controls the digunaylate cyclase activity
of Rrp1 (299) was found to have a UTR of 208 nt (221) (Chapter 2).
Given the numerous long UTRs that we identified through 5’RNA-seq (221)
(Chapter 2), we hypothesize that other small molecular riboswitches may play
regulatory roles in the spirochete’s ability to sense and respond to its specific
environmental niche. Especially considering that B. burgdorferi relies on the
scavenging of metabolites for the synthesis of nucleotides, amino acids, fatty acids,
and enzyme cofactors (61, 69), its seems logical that these same metabolites could
serve as ligands for regulating their transport and synthesis based on availability.
For instance, the B. burgdorferi purine transport system gene bbb23 contains an 258
nt UTR (221) (Chapter 2). Guanine-responsive riboswitches have been widely
classified upstream purine transport systems of other bacteria which bind
guanine, hypoxanthine, or xanthine to terminate transcription (300, 301). Novel,
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uncharacterized, riboswitch classifications may also be present within the B.
burgdorferi genome. The well defined nicotinamidase pncA gene is critical for
spirochete mammalian infection, as it converts nicotinamide to nicotinic acid for
nicotinamide adenine dinucleotide (NAD) production (118). 5’RNA-seq identified
a TSS for pncA 294 nts upstream the start codon of pncA (221, 274) (Chapter 2).
Northern blot oligonucleotide probes targeting the 5’ UTR and coding regions of
pncA: UTR: 5’-GGTTTTATAATTATTAATATTAAGATCCGCATTACAATCATT3’; ORF: 5’-GCTTCTTGTAGCATCTGTTATTAGATAAACTCGAAATCCCAA-3’,
validated the long UTR and, similar to what was observed to the glp operon,
indicated a terminated transcript of the same size (Figure 6–1).
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Figure 6–1. The B. burgdorferi pncA gene contains a long 5’ UTR and terminated
transcript.
Total RNA was extracted from mid-log phase spirochetes and separated by a
denaturing formaldehyde–agarose gel, blotted to nylon membranes and probed
with 32P-labeled oligonucleotide probes specific for the pncA 5’ UTR and ORF.
Transcript nucleotide sizes are indicated to the left of the blots.
Currently no NAD riboswitches have been characterized in any bacterial species.
Because riboswitches have been hypothesized to originate from the RNA world
(302, 303) and NAD is ancient, ubiquitous, and important, researchers have
speculated that nicotinamide-based coenzyme riboswitches will eventually be
identified (293).

Contrary to long 5’ UTR sequences, there can also be regulatory features in
having no UTR, or a leaderless mRNA. 5’RNA-seq identified 85 leaderless
transcripts, which we designated as having a UTR length of 10 nts or less (221)
(Chapter 2). Normally these transcripts are translated at low efficiency, as they are
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missing a canonical ribosome binding site (RBS) (210). Yet, E. coli has specialized
ribosomes which lack the anti-Shine-Dalgarno sequence to proficiently translate
these leaderless mRNAs under stress conditions (211). B. burgdorferi could
similarly use leaderless mRNAs as a stress response mechanism. Given that we
only examined spirochetes actively growing in nutrient-rich media, B. burgdorferi
could harbor additional leaderless transcripts under specific stress conditions.
Other 5’RNA-seq applications have indicated that leaderless transcripts can be as
frequent as ~25% (162) and bioinformatics analysis of 953 bacterial and 72 archaeal
genomes revealed widespread presence of leaderless genes (304).
In addition to the proposed 5’ UTR regulatory features, 5’RNA-seq
identified numerous instances of antisense and internal transcription (221)
(Chapter 2). Putative regulatory RNAs, also referred to as small regulatory RNAs
(sRNAs) due to their typically short sequences, are just emerging in the Lyme
disease spirochete. As discussed previously, to date only one sRNA and Hfq, the
RNA chaperone, have been characterized in B. burgdorferi (137, 138). A recent
sRNA targeted RNA-seq approach identified over 1000 sRNAs in B. burgdorferi, of
which 43% were differentially expressed by temperature (222). This vast number
of temperature dependent sRNAs are biologically relevant as ticks are ~23°C,
while mammals maintain body temperatures of ~37°C (305). BbIVET discovered
249

putative promoters for a subset of transcripts expressed during mammalian
infection. There were numerous overlaps between the BbIVET sequences (117),
5’RNA-seq (221) (Chapter 2), and the sRNA transcriptome (222). Specifically, the
Northern blots performed in this dissertation (Chapters 2 and 3) encompass
validated sRNAs spanning all three data sets. Another recent RNA-seq approach
which measured growth phase dependent transcripts also reported widespread
instances of sRNAs in the B. burgdorferi genome (201). Of note, it cannot be simply
assumed that all small RNA sequences are non-coding. Growing evidence
indicates that “miniproteins” in bacteria are largely underappreciated (162, 306).
The notion that a subset of B. burgdorferi’s numerous sRNAs code small proteins
should be further explored. Given their abundance, differential regulation, and
expression during mammalian infection, sRNAs likely play an unrecognized role
in gene regulation of the Lyme disease spirochete.
Pervasive Transcription: The Debate
Transcripts overlapping annotated ORFs are pervasive in bacteria, meaning by
definition that these instances are widespread both within an organism (i.e. occurs
frequently in a particular genome) and across bacterial species (i.e. this high
frequency is conserved). However, the functionality of these internal and antisense
transcripts is highly debated. Therefore, the term “pervasive transcription” has
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also been applied to indicate transcriptional “noise” that results in noncoding,
sometimes antisense, transcripts that are not delineated by gene boundaries, also
called promiscuous or spurious transcription (307-309). Quite detailed arguments
exist concerning the purpose of pervasive transcription (209). In general, targeted
examples of internal transcripts have documented a variety of functional
regulatory roles (123). Comparatively, the cases of functional antisense transcripts
are much fewer (123, 310). This is also true for conservation, where internal
transcription was shown to be more evolutionary conserved over antisense
transcription (311). Yet, antisense RNAs have the unique feature of being 100%
complementary to their adjacent annotated ORF. Seemingly, they could modulate
the expression of these sequences, change the transcript stability, or affect protein
production. Analysis of asRNA interactions with complementary mRNAs
(forming double stranded RNA) was demonstrated in over 300 occasions in E. coli
(237), yet very few, if any, of these have been functionally characterized. We
investigated antisense transcription in B. burgdorferi (Chapter 3). Northern blotting
validated the presences of such transcripts and luciferase fusions of their
promoters demonstrated both culture and mammalian transcription. However,
we have yet to dissect a particular functional role for the asRNA appO2 in the B.
burgdorferi (Chapter 3). While some proclaim that the presence of antisense
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transcripts implies that these RNAs regulate their corresponding mRNA (201), our
data exemplifies that this may not be straight forward. Seemingly many more
molecular examinations of asRNAs would be reported if they simply targeted
antisense ORFs. Herein we took an in-depth approach of both overexpressing and
removing (by creating a defective promoter) an antisense RNA (Chapter 3). We
observed no change in the protein production of the antisense RNA-associated
ORF, although we cannot eliminate the possibility that through an unknown
technical issue or experimental design flaw in our study the correct parameters for
observing a regulatory change was hindered. Assuming this is not the case, and
that the antisense RNA examined (appO2) has no effect on the transcription of
oppAIV, what then is the purpose of the spirochete spending energy to produce
this transcript? Further, this antisense RNA has a conical Pribnow sequence and
promoter. Through 5’RNA-seq we classified 734 unique antisense TSSs in the
Lyme disease spirochete and 89.4% of these have classically conserved promoter
sequences (221) (Chapter 2). How is it then that these promoters were
evolutionarily formed and selected for, albeit having no function? Perhaps a more
complex answer ensues. It is possible that these asRNAs regulate other transcripts
in trans, forming complexes via RNA chaperones, such as HfqBb (137). Other
evidence suggests that genome evolution and pervasive transcription are linked
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(309). Reductions in transcription (i.e. silent regions of the genome) have a higher
suitability for mutations in their immediate genomic loci (312). Given the
proofreading capabilities of RNA polymerase (transcription coupled repair) (313,
314), it may be that the function of pervasive transcription is to uphold the
integrity of the genome. Regardless of one’s stance on the functionality of
pervasive transcription, the complexity of bacterial transcriptomes is apparent,
which demands the development of new techniques to quantify such instances.
New Approaches for Quantitating RNAs in Pathogenic Environments
The strand specific analysis of bacterial transcripts becomes increasingly
important with the nuances of overlapping internal and antisense transcription.
Further, there is significant interest in understanding bacterial transcription
during infection, as this can identify novel mechanisms of pathogenesis as well as
possible therapeutic targets. We took a unique approach to qualitatively examine
internal and antisense transcription during an active murine infection using
promoter fusions to luciferase and in vivo imaging (221) (Chapter 2). Ultimately,
having quantifiable tools to measure these transcriptional events is warranted.
RNA-seq and microarray techniques to determine spirochete RNA expression in
tick and mammalian tissues are limited, in that few spirochetes are present at
points in the infectious cycle of B. burgdorferi (i.e. unfed nymphs and mammalian
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tissues) and therefore these approaches have either not been successful or relied
upon amplification steps of RNA prior to analysis (86, 87). RT-qPCR approaches
have been successful for quantitating B. burgdorferi transcription among all tick
developmental stages and during mammalian infection, yet are not a strand
specific measurement (176, 232, 263) Due to our success in the application of a
murine in vivo approach to visualize B. burgdorferi transcription (221) (Chapter 2),
we designed a dual luciferase reporter which could quantitate promoter activities
at the tick-pathogen interface (279) (Chapter 4). This new genetic tool for B.
burgdorferi has great implications for understanding roles of novel transcripts
regardless of transcriptional complexity.
We transgenically engineered Renilla reniformis (sea pansy) luciferase for B.
burgdorferi by cloning a codon optimized Renilla luciferase (rlucBb) under the
control of the constitutive flagellar protein promoter (flaBp), on the same vector
that contained a codon optimized Photinus pyralis (firefly) luciferase (flucBb) (174).
Any B. burgdorferi promoter of interest can then be cloned directly upstream the
firefly luciferase for quantification. Therefore, luciferase signals from flucBb
promoter fusions can be normalized to luciferase signals from flaBp-rlucBb. In this
manner, the number of spirochetes in a sample do not artificially affect the flucBb
luciferase signals. Luciferase signals can be distinguished between the two
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enzymes due to substrate utilization, where FlucBb and RlucBb oxidize luciferin and
coelenterazine respectively. We demonstrated the selectivity, sensitivity, and
functionality of this technique using well-defined and differentially active
environmental promoters (279) (Chapter 4). This was the first dual reporter system
created for B. burgdorferi and requires no sample extraction or purification,
allowing rapid quantification without extraneous sample manipulation.
Previously, manual counting of B. burgdorferi or optical density at 600 nm (OD600)
was used for normalization techniques of FlucBb (174, 221, 247), which can be time
consuming and not possible with complex samples such as tick extracts.
Alternatively, qPCR can be used, but requires purifying spirochete DNA from
samples (217). Furthermore, these described normalization alternatives fail to
distinguish between live and dead organisms. We demonstrated that relative
RlucBb signals directly correlate to live B. burgdorferi, and serves as a reliable
methodology to detect promoter activities in a strand specific manner (279)
(Chapter 4). Conceivably this approach can be used easily during in vitro
cultivation of spirochetes. Luciferase fusions to flucBb can be created directly in the
B. burgdorferi vector containing flaBp-rlucBb and analyzed. While there is no defined
minimal media for in vitro molecular mechanism studies of B. burgdorferi, physical
and chemical alterations of in vitro growth conditions are possible and have been
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shown to cause transcriptional changes (81, 82, 84, 104). Additionally, a dual
reporter system allows development of high-throughput genetic screens. For
instance, DNA libraries could be constructed and fused to flucBb, and screened for
promoter activity in an environment of interest, normalized to RlucBb activity. The
dual luciferase reporter vector could also be reengineered to create translational
fusions of FlucBb, testing protein production of a transcript of interest. Other
combinations of luciferase enzymes could also be explored (i.e. Vargula hilgendorfii
luciferase, Vluc, and its substrate vargulin) and adapted for B. burgdorferi, perhaps
even expanded to triple reporter systems (315).
While we tested our dual luciferase approach during a murine infection of
B. burgdorferi, we were unable to quantitate signals of RlucBb (279) (Chapter 4)
perhaps due to high background signals and bioavailability of the coelenterazine
substrate, as previously described by others in infectious disease research (251,
267). Yet, our method effectively measures spirochete transcriptional activity from
feeding ticks at the acquisition and transmission stages of the spirochete’s
infectious cycle. Understanding tick-pathogen interactions is critical for B.
burgdorferi research. Consider the first vaccine for Lyme disease was based on the
tick-specific protein OspA (41). Further, with the newly sequenced Ixodes scapularis
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genome (269) many new possibilities of studying tick-spirochete interactions are
conceivable.
Dissecting Novel B. burgdorferi Transcripts which Contribute to Pathogenesis
The progression of Lyme disease is mediated by the successful transmission of B.
burgdorferi from an infected tick, avoidance of human immune responses,
dissemination, and colonization of various tissues. Thereby, given that virulence
factors have been classically defined as the components which allow pathogenic
bacteria to effectively cause disease (316), any B. burgdorferi gene which critically
contributes to the spirochete’s survival in the tick vector or vertebrate host has
been broadly categorized as virulent encoding (1). These include conventional
bacterial virulence factors such as B. burgdorferi adhesions (317), motility (264), and
chemotaxis (318), but also nutrient scavenging systems which are essential in
specific environments due the spirochete’s inability for de novo synthesis of these
metabolites (24, 69, 205). Yet, it has also been proposed that subsets of “virulence
factors” which do not actively target host systems, such as nutrient acquisition and
motility systems should be reclassified as “niche factors” given that commensal
bacteria also share these properties (319). Identifying transcripts expressed during
B. burgdorferi’s infectious cycle can subsequently result in identifying novel
virulence or niche factors critical for pathogenesis. We used BbIVET as a means to
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discover putative B. burgdorferi mammalian infection active promoter sequences
(Bbives) and 5’RNA-seq to associate in vitro TSSs to these sequences (221)(Chapter
2). This resulted in two distinct categories (1) culture and mammalian expressed
transcripts with an in vitro identified TSS in associated-proximity to the infectionidentified Bbive and (2) putative mammalian-specific promoters which consisted
of Bbives with no in vitro-associated TSS.
A variety of unique genes have been documented to play critical roles in B.
burgdorferi tick and mammalian infection (283, 320-322). In general, ~33% of
upstream-ORF Bbives were putative promoters for hypothetical proteins (221)
(Chapter 2). Herein, we biochemically and pathogenically characterized a unique
hypothetical protein in B. burgdorferi which was found to be murine infectionexpressed through BbIVET, which also harbored an ORF-associated TSS by
5’RNA-seq (Chapter 5). Bbive67 was located 14 nts upstream gene bb0562, which
we validated to be transcribed during murine infection, but also at constitutively
low levels throughout all life stages of infected ticks (Chapter 5). Notably, as our
lab has previously demonstrated, a lack of differential expression across
environmental samples and/or the low presence of a B. burgdorferi transcript does
not indicate a lack of importance in pathogenesis (176). Further biochemical
examinations revealed bb0562 encodes an ~20 kDa membrane associated protein
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and targeted deletion of gene bb0562 demonstrated that its function is critical to B.
burgdorferi’s ability to form colonies on solid plates (Chapter 5). This is not an
entirely new phenotype for B. burgdorferi as a previous high passage clone, missing
multiple plasmids, was not able to form colonies on solid media (323). This
insinuates that multiple genes in B. burgdorferi contribute to the spirochetes ability
to form colonies, as bb0562 is chromosomally located. The mechanism behind this
is unknown and under current investigation. Possible explanations may result
from metabolism transitioning for spirochetes forming colonies, where innermost
cells are deprived of preferred food sources, compared to spirochetes in liquid
culture, which are encased in an even nutrient pool. Somewhat similarly,
disruptions in quorum sensing, while not fully characterized in B. burgdorferi (324,
325) could pose inhibitory consequences for spirochetes attempting to grow in
colonies. We observed that the plating deficiency was less prominent in plated
logarithmic bacteria compared to those in stationary phase (Chapter 5). Although
the expression of bb0562 has been shown to remain consistent among growth
phases (201), perhaps under starvation the function of bb0562 becomes more
critical. Recent RNA-seq data which examined the stringent response in B.
burgdorferi showed that bb0562 expression is upregulated by RelBbu, the producer
of the starvation signaling molecule (p)ppGpp, in stationary phase and starvation
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(104). It could also be proposed that bb0562 effects cell division and replication. In
E. coli, the Fts proteins serve important roles in septation, with their removal
resulting in filamentous cells (326, 327), which are alive yet unable to form colonies
on solid plates (328, 329). A variety of these proteins are inner membrane
associated, as we propose for BB0562, including: FtsY, FtsE, and FtsX (330). Cell
division in B. burgdorferi is somewhat uncharacterized, with studies just beginning
to uncover novel mechanisms for division and peptidoglycan synthesis (331).
Alternatively, the removal of BB0562 from the bacterial membrane may affect the
durability and resilience of the spirochete membrane to external stress.
Considering that B. burgdorferi are plated within BSKII media surrounded by agar,
rather than conventional surface-plating, the force of the encompassing media
may rupture Δbb0562 spirochetes or cause bacterial static responses. While no
obvious morphological phenotype was observed for the Δbb0562 B. burgdorferi
under routine dark field microscopy, future studies are aimed at more closely
imaging these spirochetes both during liquid and solid cultivation.
To our knowledge, no B. burgdorferi study has tested the contribution of
bb0562 to murine infection. A signature tagged mutagenesis approach to define
genes essential for B. burgdorferi mouse infectivity failed to disrupt bb0562 with a
transposon insertion, although insertions in genes bb0563 and bb0564 advocates
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bb0563 to be essential for infection (157). Here we demonstrated that bb0562 is
critical for mammalian infectivity by needle inoculation and tick bite (Chapter 5).
Occasionally Δbb0562 spirochetes could colonize the murine host, but
preferentially upon an increased dose of bacteria and still could not recapitulate
wild type levels of bacterial burden (Chapter 5).
Determining the function of unique hypothetical proteins in Borrelia
(Borreliella) species is challenging due to the lack of conservation of these
sequences to other bacteria (61). Yet, these genes are of interest as they could play
important uncharacterized roles in spirochete pathogenesis and theoretically
make good targets for future Lyme disease specific therapeutics, considering they
are not conserved in other organisms. Continued investigations into unique
spirochete genomic sequences partition genes required for B. burgdorferi
pathogenesis versus those that are dispensable during the spirochete’s infectious
cycle. Using the aligned BbIVET and 5’RNA-seq datasets as a honing mechanism
for selecting genes to target for mechanistic studies, these investigations can be
streamlined. While we have demonstrated an instance of an in vitro culture and
infection expressed transcript, bb0562 (identified both through BbIVET and
5’RNA-seq) as critical for B. burgdorferi pathogenesis, there are likely other
important transcripts to investigate which we classify as putatively only murine
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infection expressed (identified solely through BbIVET) (Chapter 2). Future studies
should continue to elucidate both classifications, striving to discover novel
attributes of Lyme disease pathogenesis.
Future Directions
Transcriptome Investigations
Significant information is gained through global analysis of pathogen
transcription. Following 5’ RNA-seq, additional transcriptome applications would
contribute valued insight into the biology of B. burgdorferi. Mapping of the
spirochete’s 5’ ends revealed many transcriptional nuances and potential
regulatory features (221) (Chapter 2). Similarly, 3’ end mapping would describe
termination of transcripts and identify long 3’ UTRs, which have been shown to
be rich in regulatory RNAs (332). The 5’ RNA-seq protocol created herein could be
modified for 3’ end enrichment using a 3’ linker prior to library fragmentation
(193). Combined, these data sets could theoretically estimate entire transcriptional
units and predict gene operons. The disadvantage for 3’ end mapping is that due
to early transcriptional termination and processing of RNAs, it can be difficult to
truly identify 3’ ends. Alternatively, simultaneous sequencing of 5’ and 3’ ends
may be achievable. Targeted methods already exist, which circularize RNA
transcripts with linker sequences. In these single transcript analyses RNA is
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circularized with T4 RNA ligase, converted to cDNA by nested PCRs, and
sequenced to identify 5’ and 3’ ends simultaneously (333). Combining global 5’
and 3’ end RNA-seq techniques, using barcoded RNA linkers, with RNA
circularization would be an elegant system to definitively and globally map the
transcriptome.
With new appreciation of small proteins (306) and regulatory features of
non-coding RNAs (126). It becomes increasingly important to identify the coding
potential of transcripts. Ribosome profiling, or Ribo-seq (334), effectively
determines the transcripts that associate to ribosomes. This approach has
demonstrated that small proteins can be highly abundant in bacterial cells (162).
Moreover, B. burgdorferi has been shown to initiate transcription from atypical start
codons (274), and Ribo-seq may elucidate other such instances, fine-tuning
genomic annotations.
Searching for B. burgdorferi RNA Regulation
With the discovery of many un-annotated RNAs, both from our own work (221)
(Chapters 2 and 3) and others (201, 222) the field of RNA regulation in B. burgdorferi
should be further explored. The challenge for RNA mechanistic studies is
identifying suitable targets to explore. The antisense RNA studies described in this
dissertation (Chapter 3) demonstrate that simply selecting any sRNA for
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mechanistic analysis may not always be straight forward in dissecting regulatory
mechanisms. Ideally, RNAs should be selected which are differentially regulated
among tick and murine infected samples, as this could indicate their role in B.
burgdorferi pathogenesis. This is cofounded by challenges to perform global
sequencing analyses from infection relevant environments due to low numbers of
spirochetes in ticks and mice. However, with growing advancements in RNA-seq
technologies, this will one day likely not be a hindrance. Meanwhile, growth of B.
burgdorferi in dialysis membrane chambers in the intraperitoneal cavities of rats
has served as one approach to obtain large quantities of bacteria for transcriptional
analysis (87). Notably, this environment is not ideal in that it is protected from
murine immune factors and creates a non-biological concentration of spirochetes.
However, it may be feasible to perform RNA-seq from samples such as these, or
at the least high-density oligonucleotide microarray analysis which span the
genome (335). Culture derived, in vitro manipulations of spirochetes have already
documented 431 sRNAs which are differentially regulated by temperature using
RNA-seq (222). Subsets of these RNAs could be potential starting points, and any
overlaps between these RNAs and BbIVET suggests putative mammalianimportant RNAs. Ultimately the B. burgdorferi field desperately requires global
transcriptional information, including un-annotated RNAs, from across all stages
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of the infectious cycle. New sequencing approaches are also being developed
which simultaneously analyze bacterial and host transcriptomes during infection
(150)
As an alternative to identifying RNAs which are expressed in various
environmental conditions, classifying transcripts which bind RNA chaperones can
also indicate functional purposes of the RNAs. A variety of techniques can be used
to achieve such studies. Considering that an orthologue of Hfq has been identified
in B. burgdorferi (137) RNA-seq approaches can be used to pull down Hfq and its
targets (238). HfqBb epitope tagging, purification, and RNA-seq would elucidate a
variety of sRNAs which bind to the RNA chaperone. Newer, refined approaches
such as RIL-seq (RNA interaction by ligation and sequencing) (336) may be even
more suitable, as this technique, along with identifying those sRNAs which
interact with Hfq, determines sRNA targets. By this methodology, any mRNA
which is already characterized to have roles in pathogenesis could be prioritized
for mechanistic studies via the sRNA which directly interacted with them.
Alternatively, global small non-coding RNA target identification by ligation and
sequencing (GRIL-seq) approaches have also been successful for identify direct
sRNA targets and elucidating novel regulatory features (337).
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The molecular mechanisms of antisense RNAs in bacteria continues to remain of
high debate among bacterial genetic research groups. Organisms have continued
to devote energy into the transcription of putative non-coding sequences through
homo sapiens where 72-85% of the genome is transcribed and only 1.5-2% encodes
documented proteins (338). This conservation suggests functionality of these
transcriptional events. Despite the lack of a regulatory mechanism observed for
the asRNA appO2 in this work (Chapter 3), further experimentation may give rise
to a function. Considering the similarities between the OppA proteins in B.
burgdorferi (233), appO2 may target the other oppA transcripts which should be
examined. Genetic screens have also demonstrated that antisense RNAs, which
are predicted to act in cis, can serve as trans regulators (336), bind Hfq (238), and
form double-stranded RNA interactions with targets (237), indicating relevance
for these transcripts.
RNA binding proteins involved in regulation, classically Hfq and CsrA, are
continuing to be discovered in bacterial species. Only recently, ProQ was
identified as an abundant RNA-binding protein and influencer of gene expression
(131). RNA-seq approaches which sequence transcripts in combination with
gradient sedimentation of associated proteins (Grad-seq) (131) can lead to nuances
in RNA-binding partners. Given the Lyme disease spirochete’s biphasic lifestyle
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and necessity to quickly respond to environmental conditions, it’s probable that a
variety of RNA regulatory mechanism are waiting to be characterized.
Riboswitch Identifications
The presence of long UTRs in B. burgdorferi and the Northern blot analysis
performed in this dissertation (221) (Chapter 2 and Figure 6–1) provide evidence
which supports the presence of regulatory features in 5’ UTRs, including
riboswitches. Classically many techniques have been designed to test the abilities
of transcripts to act as a riboswitch. Because Borrelia (Borreliella) species lack
conservation among other bacteria, bioinformatics approaches to identify
characterized riboswitches are hindered. Alternatively, since riboswitch sequences
are usually highly conserved among bacteria (339), candidate sequences can be
analyzed by conservation among all Borrelia (Borreliella) species which also fold
into alternative RNA secondary structures. These sequences serve as molecular
switches which in the presence/absence of a ligand control either mRNA
transcription or translation. Candidate riboswitches, defined in this dissertation
(221) (Chapter 2 and Figure 6–1), can first be explored using the molecular
precursors and products of the mRNA (i.e. nicotinamide and nicotinic acid for the
putative pncA riboswitch). Other bacterial systems have the advantage of minimal
media, by which researchers can add specific metabolites to screen for riboswitch
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ligands, which can be modified for high-throughput approaches. In these models,
putative riboswitch sequences are transcriptionally/translationally fused to a
reporter gene and examined for activity based on the readout of the reporter (340).
Unfortunately, there is currently no such growth medium available for B.
burgdorferi cultivation except the nutrient rich and complex BSKII medium, likely
because the organism lacks many of the genes for metabolite de novo synthesis.
Alternatively, these experiments could be carried out using surrogate systems,
such as E. coli or Salmonella enterica. Theoretically RNA should behave similarly no
matter the bacterial species, making these experiments possible. Otherwise,
targeted ligand binding assays could be performed in vitro, outside the cell, using
in vitro transcribed RNA sequences and radioactive ligands with equilibrium
dialysis chambers (341). Other global screening tools include SELEX (systematic
evolution of ligands with exponential enrichment) which also utilizes in vitro
transcribed RNA to identify aptamers of specific ligands (342). Collectively, much
of the data reported herein provides major advancements in prospects for future
B. burgdorferi riboswitch studies.
Defining Mechanisms for bb0562 and Other Novel Transcripts
Barriers to streamlining mechanistic studies of B. burgdorferi transcripts critical to
the spirochete’s infectious cycle include the dissimilarity and lack of conservation
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among many B. burgdorferi annotated-ORFs and other bacterial pathogens (61, 64).
Considering our discovery of B. burgdorferi gene bb0562 as an important
component for B. burgdorferi’s pathogenesis (Chapter 5), it becomes meaningful to
characterize the mechanistic function of the gene. Due to the proximity and a
shared motif in genes bb0563 and bb0564, targeted deletions and evaluations of
their role in B. burgdorferi pathogenesis should be examined. Based on the finding
that 100% of mice were infected when needle-inoculated at 107 spirochetes/mouse,
but not at 104 or by tick bite (Chapter 5), there is possibly a reduction in the amount
of Δbb0562 spirochetes surviving the initial immune response. Components of
innate immunity, such as macrophages, neutrophils, and antimicrobial peptides,
should be evaluated for preferential killing of Δbb0562 spirochetes considering
these factors are present in NSG (immunodeficient) mice, which were found to
attenuate Δbb0562 spirochetes (Chapter 5). As preliminary evidence, we examined

269

3 mice that successfully reisolated Δbb0562 spirochetes from infected tissues, post
a 3-week infection at an initial inoculation of 104 spirochetes/mouse (Figure 6–2).

Figure 6–2. Δbb0562 spirochetes have a delayed bacteremia.
Three mice were needle-inoculated with 104 spirochetes, bled approximately every
three days, and plated for CFUs or outgrowth of individual Δbb0562 spirochetes.
Horizontal lines indicate the means.
Successful dissemination of Δbb0562 and bb0562+ spirochetes was determined by
measuring spirochetes/ml of blood throughout the initial stages of infection.
Plated CFUs for bb0562+ spirochetes, or instances of bacterial outgrowth from
single spirochetes in 96-well plates for Δbb0562 spirochetes, demonstrated a delay
of Δbb0562 spirochetes for the days examined. B. burgdorferi bb0562+ achieved
robust bacteremia at day 5, similar to the amount of wild type B. burgdorferi
undergoing blood dissemination, as previously characterized (45). However,
Δbb0562 spirochetes were not present in the blood at day 5, and only at the
subsequent time point (day 8), at which bb0562+ spirochetes had potentially fully
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disseminated to the tissues. Collectively this preliminary data suggests that
Δbb0562 spirochetes are either preferentially killed at initial inoculation and/or fail
to effective disseminate into the blood compared to bb0562+ spirochetes,
suggesting roles for bb0562 in innate immune evasion. Alternatively, a nutritional
weakness should also be considered. However, the inability of Δbb0562
spirochetes fully infect at a dose of 107 likely rule out a direct role for bb0562 in
nutrient acquisition, considering previously characterized nutritional mutants fail
to infect at this inoculum (24, 182, 205). Motility and chemotaxis experiments (318)
should also be explored to distinguish functionality of BB0562.
Global approaches such as RNA-seq could be used to identify other
transcriptional changes resulting from spirochetes lacking gene bb0562.
Additionally, while synthetic lethal screens have yet to be performed in B.
burgdorferi, it is feasible for such methods to be developed. These systems identify
linked genes in essential molecular pathways (343, 344). Given that gene bb0562 is
non-essential in culture with no growth defect (Chapter 5), it could be removed
and complemented under an inducible promoter on an unstable reporter vector,
containing gfp. Following chemical mutagenesis, spirochetes could be screened for
retaining the reporter plasmid using fluorescence activated cell sorting (FACS), as
previously optimized for B. burgdorferi (345). This combats the inability of Δbb0562
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B. burgdorferi to form efficient colonies on solid plates, as these screens are typically
conducted. Thereby, any gene which essentially requires bb0562 expression would
be identified (i.e. the reporter plasmid would always be selected for in these
instances). However, one limitation to this approach is that plasmid partitioning
is not fully characterized in B. burgdorferi (68) and efforts would have to be first
directed at characterizing an unstable plasmid for the spirochete.
A variety of other transcripts identified through BbIVET could contribute
to B. burgdorferi pathogenesis and should be further examined. We previously
performed promoter fusions for several BbIVET sequences (Bbives36, 161, 175, and
252) which had no in vitro culture associated TSS by 5’RNA-seq (221) (Chapter 2).
Therefore, we hypothesized that these sequences were putatively limited to
expression during mammalian infection. Yet, none of these sequences were shown
to be preferentially expressed during murine infection via transcriptional fusion
to luciferase and live in vivo imaging (221) (Chapter 2). As there are ~100 additional
putative mammalian specific promoters in this category (221) (Chapter 2) other
Bbives should be screened. Following identification of any promoter sequence
uniquely active or induced during murine infection, promoter bashing (as
performed in Chapter 3) could be used to disrupt transcription. This is preferred
over targeted transcript removal, considering that the TSS is unknown.
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Collectively, the datasets and methodology developed from this dissertation usher
new research directions to identify novel transcripts which contribute to Lyme
disease pathogenesis.
Significance
This work provides the first characterization and distinction of transcriptional
start sites from 5’ end processing in the B. burgdorferi transcriptome. The 5’RNAseq data is a significant resource for all future genetic applications in B. burgdorferi
biology and lays the foundation for future RNA-based mechanistic studies in the
Lyme disease spirochete. Synergistic comparison of 5’RNA-seq and BbIVET
datasets revealed novel RNAs, including un-annotated internal and antisense
transcripts, expressed during murine infection. Targeted approaches using these
identified transcripts can identify new factors in B. burgdorferi’s ability to persist in
the tick vector and mammalian host, as exemplified herein with gene bb0562.
Furthermore, this work creates a new molecular microbiology technique to
overcome the challenges of quantifying RNA expression in complex
transcriptional loci through a dual luciferase reporter system which is strand
specific and applicable to tick-pathogen interactions. The summation of the studies
described in this dissertation provide innovative approaches to define
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transcription of the Lyme disease spirochete and discover novel components of B.
burgdorferi’s pathogenesis.
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